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Abstract 
Introduction 
Hypoxic-ischaemic encephalopathy (HIE) is experienced by 1-6 neonates per thousand in the 
developed world. Untreated, it results in death in 15-20% of cases, and significant disability 
in a further 25%. These rates have been reduced since the introduction of therapeutic 
hypothermia (TH) treatment over the past decade. HIE symptoms evolve during the first days 
of life and close monitoring is critical for treatment decisions and for the prediction of long-
term outcome in the infant. Neurological assessment, neuroimaging and continuous 
electroencephalography (EEG) are used to track symptom evolution. Severity of 
encephalopathy grade is usually assigned using the Sarnat and Sarnat system. 
Protocols to measure childhood outcomes following neonatal HIE must consider when best 
and how best to assess neurodevelopment. By school-age, neuropsychological and 
educational difficulties emerge in a significant minority of children post-HIE with no motor 
disability. Research studies have typically reported outcome by HIE grade. Severe HIE results 
in significant mortality and morbidity, with variable outcome for moderate HIE suggestive of 
a heterogenous diagnostic category. Little is known about outcomes following mild HIE, but 
the consensus until recently has been of a benign condition. Thus, only infants with moderate 
to severe neonatal HIE were included in the TH RCTs that took place during the early 2000s. 
To progress knowledge of the neonatal and long-term course, all grades of HIE in children 
require repeated monitoring into school age to capture the non-linear pattern of 
development. TH treatment decisions are made by 6 hours of age in the infant, requiring a 
continued focus on how HIE manifests in the first hours and days of life, and the value of 
tools such as EEG for prognostication. 
The aims of this research study were to assess the neurodevelopmental outcome, at age five 
years, of a prospective cohort of infants following all grades of neonatal HIE. It further sought 
to:- (i) Determine the predictive value of neonatal neurological assessments and outcome at 
24 months; (ii) Investigate stability of development at 6, 12 and 24 months of age and 5-year 
outcome; (iii) Compare the age 5 outcomes of the HIE group with a comparison group across 
Sarnat and EEG grades and analyse their predictive value; (iv) Examine neuropsychological 
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profiles of children with and without intact outcome; (v) Record comprehensive vision 
outcomes. 
Methods 
Participants were recruited at birth from two prospective cohorts and followed up at age five 
years. The HIE cohort (n=65) was recruited in the pre-TH era. All newborns with HIE and born 
between May 2003 and December 2005 from the three Cork regional maternity centres were 
invited. The comparison cohort of healthy newborns (n=80) were recruited between October 
2005 and August 2007, for a neonatal EEG sleep study. The HIE cohort underwent 
neurological assessment using the Amiel-Tison Neurological Assessment at Term (ATNAT) on 
days 1, 2 and 3 of life, and a NICU discharge exam. Sarnat grade was assigned at 24 hours, 
and continuous video-EEG monitoring commenced before the sixth hour of life and 
continued for up to 72 hours. EEG recordings were also available for the comparison cohort. 
EEGs were assigned background pattern severity scores at 6, 12, and 24 hours of age, and a 
seizure burden score. The HIE cohort were assessed at 6, 12 and 24 months of age using the 
Griffiths Mental Development Scales (0-2) – revised (GMDS-R). 
In the current study, at age five years, the parents/carers of children from the HIE cohort and 
from the comparison cohort who met the target age criteria (n=42 of the 80) were invited to 
participate for follow-up. Intellectual abilities were assessed using the Wechsler Preschool 
and Primary Scale of Intelligence 3rd UK version (WPPSI-IIIUK). Neuropsychological processes 
were assessed using the NEPSY-II, and a verbal working memory task from the Children’s 
Memory Scale (CMS). Neurological examination assessed tone, balance and reflexes. 
Detailed demographic, and clinical information was obtained via parent/carer interview. HIE 
cohort children also attended ophthalmic and orthoptic examinations. An ‘overall outcome’ 
category (normal/abnormal) was assigned to each child. Abnormal outcome was defined as 
death, cerebral palsy (CP), IQ >1SD below the norm, sensory impairment, clinical diagnosis 
of a neurodevelopmental disorder (NDD) and/or in receipt of multidisciplinary early 
intervention. Correlations and predictive values between the ATNAT scores and 24 months 
outcome were calculated. Stability of GMDS-R quotients at 6, 12 and 24 months was 
examined, as was their associations with five-year outcome. Prediction of neonatal Sarnat, 
and EEG grades for 5-year IQ and overall outcome were calculated using AUROCs. The 
neuropsychological profiles of children from the HIE cohort with an otherwise intact 
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outcome at 5 years was compared with the comparison cohort, and differences by Sarnat 
and EEG grade was examined. Detailed vision data was compared between children with 
intact and non-intact outcome. 
Results 
At five years, outcome was available for 81.5% (53/65) of children from the total HIE cohort 
and 71.4% (30/42) of children from the comparison cohort who met the age criteria. In the 
HIE cohort, 47.2% (25/53) had an abnormal outcome: 6 had died, 8 had CP, 1 had hearing 
impairment, 4 had IQs > 1 SD below the mean, 4 had NDD, and 2 were attending early 
intervention. This contrasted with 3.3% (1/30) of the comparison cohort. Processing speed 
and verbal short-term memory was significantly below the norm for the HIE cohort. 
ATNAT scores in the first three days of life were associated with 24 month outcome, with 
best predictions for day 3 ATNAT (AUROC(95% CI)=0.75(0.58-0.93), p=.012) and discharge 
examination (AUROC(95% CI)=0.79(0.64-0.96), p=.005). ATNAT correlated with age 5 Full-
Scale IQ (FSIQ) score (r=-0.47, p<.01) as did 9 of the test items which assessed neonatal 
passive muscle tone, neurosensation and palmar grasp. 
GMDS-R developmental quotients at 6, 12 and 24 months of age correlated with 5-year FSIQ, 
Verbal and Performance IQ, with correlations improving over time (best correlation: GMDS-
R and FSIQ (ρ=0.64, p<.001)). Within-child GMDS-R scores were inconsistent across 24 
months. All children with normal GMDS-R at 24 months (n=30) had a normal 5-year FSIQ. All 
children with abnormal GMDS-R at 6 months (n=6) had an overall abnormal 5-year outcome.  
Rates of abnormal outcome differed by Sarnat HIE grade, with 27% for mild, 47% for 
moderate and 83% for severe. No differences between the IQ scores of those following mild 
or moderate Sarnat HIE were found, and both grades, though normal, were significantly 
below comparison group IQs. Intact survival at 5 years varied across neonatal EEG grade at 6 
hours of life: 75% for EEG mild grade 1, 46% for moderate grade 2, 43% for major Grade 3 
and 0% for inactive grade 4. An EEG grade of >=2 at 24 hours of age had superior positive 
predictive value (74%; AUROC(95%CI)=0.70(0.55-0.85) for abnormal outcome at age five 
than EEG of >=2 at 6 hours (68%; AUROC(95%CI)=0.71(0.56-0.87). 
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NEPSY-II scores revealed that children post-HIE had finger dexterity, design fluency and 
memory for names skills in the borderline range. Of 25 tasks, 52% were significantly below 
the comparison group, with a higher burden of low-scoring tests per child. Furthermore, 28% 
of tasks remained lower for children post-HIE with otherwise intact outcome, principally in 
language, sensorimotor and specific memory areas. Finger dexterity remained in the 
borderline range. No differences in the scores were found between children following mild 
and moderate Sarnat groups, or EEG grades 1 and 2. 
Ocular biometry at age 5 was not affected by the presence of HIE. Incidence of strabismus 
however was higher than expected and occurred despite normal motor outcomes. 
Conclusion 
This thesis has confirmed the importance of detailed follow-up at age 5, not only to identify 
children with abnormal outcomes across ALL grades of HIE, but also, to document patterns 
of learning which may suggest differential impacts of HIE. In this study, children post-HIE 
presented with lower dexterity skills, verbal short-term memory, and graphomotor 
processing speed, and a higher burden of low scores on neuropsychological tasks. 
The importance of detailed serial neurological and continuous EEG recording across the 
neonatal period has been demonstrated to track the evolution of HIE symptomatology. 
Scores either remained constant or improved in the first three days of life. Early neonatal 
scores are now crucial for treatment decisions, whilst later neonatal scores have higher 
predictive value for outcome in early childhood. This was shown for day 3 ATNAT, and 24-
hour age background EEG scores. Repeated development assessments in the first two years 
were inconsistent but are warranted to track the non-linear nature of developmental 
progression. Normal development at 24 months was the most reassuring for a normal IQ at 
five years but not necessarily for an overall intact outcome. 
Finally, newborns with mild HIE have lower rates of intact survival at five years than the 
comparison group and have cognitive and neuropsychological outcomes similar to children 
with moderate HIE. This research adds to the emerging evidence that mild HIE is not a benign 
diagnosis for the neonate, and supports the evidence for a rationale to examine the potential 
of TH treatment for these infants.  
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CHAPTER 1 
1 Introduction 
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1.1 Encephalopathy in the Newborn – Important Definitions 
Neonatal encephalopathy (NE) is a heterogenous condition which is clinically defined and 
describes the evolution of symptoms of disturbed neurology in the new-born period. It is 
tracked clinically and electrographically in the first hours and days of life. Neonatal hypoxic-
ischaemic encephalopathy (HIE) is a subset of NE thought to demonstrate that a significant 
period of oxygen deprivation (hypoxia) and/or blood flow (ischaemia) to the brain – termed 
perinatal or birth asphyxia (PA) - has occurred either before or during labour and birth of the 
infant and is severe enough to cause altered physiological and neurological signs in the 
infant. 
1.1.1 Neonatal Encephalopathy 
NE symptoms include “difficulty with initiating and maintaining respiration, depression of 
tone and reflexes, subnormal level of consciousness and … seizures" (1). The largest studies 
of NE to date have included a Western Australia population cohort recruited between 1993-
95, and the Vermont Oxford network register from 2006 onwards. These and others used a 
broad definition of moderate to severe grade NE, which didn’t assume an asphyxial cause. 
Results showed, that in addition to hypoxic-ischaemic episodes such as an acute sentinel 
event (8-25%) and other markers such as bradycardia (35%), NE symptoms were also found 
to be preceded by maternal fever and inflammation (16-27%) (2, 3), small-for-gestational-
age (SGA) (16-17%) (3, 4), and non CNS birth defects (4-11%) (3). All of these signs can lead 
to long term adverse outcome. The authors cautioned that HI aetiology may be under-
represented, because more specific measures - such as cord blood to measure acidosis and 
base deficit - were unavailable. Notwithstanding this, the cause of NE in many cases remains 
unclear, and hence the importance of clearly defining NE Vs. HIE and the avoidance of using 
the terms interchangeably. 
This leads to much debate about the validity of the terms used to describe PA, HIE and NE, 
and their commensurate aetiologies (5-9). Some argue for NE as the preferred term as it is 
not yet possible to isolate out all causes of NE although those of HI origin are the best 
understood (9), whilst others argue for the importance of using the term HIE, albeit only 
when appropriate assessment tools evidenced to detect hypoxia-ischaemia are used (5). 
What is not in debate is the fact that a proportion of children, whether they experience NE 
or it’s subset HIE, are at risk of developing cerebral palsy (CP) and other neurodevelopmental 
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disorders. For example, in a recent outcome study using a population cohort of children with 
CP following moderate to severe NE, it was found that 41% met the criteria for HIE. Those 
who did, had greater evidence of deep grey matter injury on MRI with higher rates of severe 
quadriplegic CP, levels of physical disability and non-verbal communication, than those who 
developed CP without birth asphyxia (10). 
There are many routes to the development of CP and non-CP neurodevelopmental 
outcomes. It is important to acknowledge that NE, HIE and PA in isolation or combination 
with one another, may lead to a normal outcome, or CP or other adverse 
neurodevelopmental outcomes (see Figure 1.1) (1, 7).  
 
Figure 1.1 Venn diagram outlining the associations between neonatal encephalopathy (NE), perinatal 
asphyxia (PA), cerebral palsy (CP), and other non-CP adverse neurodevelopmental sequelae (Other 
NDD), and normal outcome (solid blue shapes). Reprinted from Seminars in Paediatric Neurology, 
11(1), M.I. Shevell, The “Bermuda Triangle” of neonatal neurology: Cerebral palsy, neonatal 
encephalopathy, and intrapartum asphyxia, pp 24-30, Copyright (2004), with permission from 
Elsevier. 
 
The focus in this thesis is limited to encephalopathy that has arisen from a presumed HI insult 
or episode in the perinatal period. Our studied cohort was recruited prospectively and had 
EEG and clinical signs of an evolving encephalopathy in keeping with HIE. Other causes, such 
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as sepsis or inborn errors of metabolism were excluded. The remainder of this introduction 
will thus focus on HIE studies. 
1.1.2 Hypoxic-Ischaemic Encephalopathy 
HIE affects between 1 to 6 infants per thousand born full-term (11, 12), and is caused by a 
presumed acute hypoxic-ischaemic event. According to the 2013 Global Burden of Diseases 
report, ‘neonatal encephalopathy (due to birth asphyxia/trauma)’ (i.e. HIE) remains as one 
of the top ten causes of death in infants under 1 month of age globally and is one of the top 
ten contributors to years of life lost in this age group (13). When left untreated, between 15-
20% of affected infants die in the neonatal period, and a further 25% will have permanent 
neurological disabilities such as cerebral palsy (CP) or intellectual disability (ID). The reported 
outcomes for children following neonatal HIE varies widely, primarily due to the severity of 
encephalopathy but also due to research design variables. Severity is most usually graded 
using the clinical Sarnat Score (see Section 1.4.1.2) (14). However, the incidence of HIE varies 
depending on the criteria used to define it (15). 
Clinical agreement about the specific criteria for the measurement of HIE has changed over 
the past decade and has been latterly influenced by the diagnostic criteria used for the 
therapeutic hypothermia (TH) treatment randomised controlled trials (RCTs) (16-18). It is 
also suggested that previous consensus criteria may have been restrictive, and also 
confounded by the timing of the injury, and whether or not late preterm (born at 35-36 
weeks) babies were included in cohorts, where hypotonia due to immaturity could be 
misconstrued as a clinical sign of HIE (8). Some of the most common markers include 
abnormal foetal heart rate, poor umbilical cord gases, and low Apgar scores (19). 
The most recent consensus statements on the measurement of HIE published jointly by the 
American Pediatric Association and the American College of Obstetrics and Gynaecology 
(ACOG) (20) are outlined in Table 1.1. 
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Table 1.1 ACOG consensus statement of the measurement of HIE 
Neonatal Signs of an 
Acute Event 
Signs which increase the likelihood 
that a peripartum HI/H event has 
occurred that leads to NE 
Signs which decrease the 
likelihood that a peripartum 
HI/H event has occurred that 
leads to NE 
Low Apgar Score at 5 
and 10 minutes 
Apgar score <5 at 5mins and 10mins 
Increase relative risk of cerebral palsy 
Apgar >=7 at 5 minutes 
Foetal umbilical artery 
acidaemia 
Artery pH < 7.0, or base deficit >= 12 
mmol/L, or both increase likelihood of 
hypoxic episode but does not define 
timing of onset 
Arterial cord gas pH > 7.2 – 
hypoxia unlikely 
Evidence of acute brain 
injury on brain MRI or 
MRS 
Best define nature and extent of 
cerebral injury in NE 
Cranial US and CT lack 
sensitivity 
 Patterns of abnormality observed 
>=35 weeks gestation, and have 
prognostic value for outcome 
No injury observed by 
neuroradiologist after 24 
hours of life. However, full 
injury may not be evident until 
after first week 
 MRI at 24-96 hours of life more 
sensitive to timing of injury, whilst at 
10 days (7-21days) better describes 
extent of injury 
Measurement of precise 
timing remains challenging 
Multisystem organ 
failure (includes renal, 
hepatic, haematologic, 
cardiac, metabolic, 
gastrointestinal 
injury/abnormality 
Presence increase risk of HIE Doesn’t always correlate with 
severity of injury seen on 
neuroimaging. 
Information in this table adapted from ACOG 2014. HI = hypoxic-ischaemic; H = hypoxic; mmol/L = 
millimoles per litre 
 
1.1.3 Perinatal Asphyxia 
The term perinatal asphyxia (intrapartum/late antepartum asphyxia) describes an 
interruption to the normal gas exchange resulting in (i) hypoxia – low oxygen levels, 
hypercapnia (high CO2 levels) and causes metabolic acidosis – measured in blood by the base 
deficit, and (ii) ischaemia – inadequate blood supply to meet the system’s needs. Ischaemia 
initially affects the nonessential organs, but if it persists the brain, heart and adrenal glands 
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become affected (8). If acute, it affects the brain very quickly, in particular the basal ganglia 
and thalamus. 
Despite a large body of research dedicated to the topic, there is still no gold standard for the 
diagnosis of PA in the newborn, although a plethora of neonatal signs have been implicated. 
The difficulty remains that single clinical signs, for example the Apgar score, used in isolation 
do not exclusively mark for PA (7).  
Many children who experience PA in the neonatal period have a normal outcome, but if PA 
leads to encephalopathic signs in the first days of life, then the long-term prognosis becomes 
poorer. This is also true for accuracy of prediction of outcome (21-23). 
1.2 Mechanism of Hypoxic Ischaemic Injury 
1.2.1 Pathogenesis of HIE 
Due to detailed studies in the domains of animal research, and neuroimaging, the 
pathophysiology of brain injury in the neonate with HIE is becoming better understood. It is 
generally conceptualised as injury that evolves over days and weeks (24). However, much 
remains to be learned from this complex process. Pioneering studies based on Vanucci’s 
animal-model of brain damage observed following induced unilateral H/I injury in rat pups 
(25) described the following: (i) ipsilateral damage was found in the cortical, subcortical and 
periventricular regions, (ii) the damage was not observed in hypoxia alone (iii) reperfusion 
injury is different in the adult and immature brain (26). An understanding of how, where and 
when the damage occurs is critical to the ongoing development of novel treatments. 
Since the 1980s, neonatal brain injury has been conceptualised in two phases. The first phase 
is the injury caused by the primary hypoxic-ischaemic insult and is seen in the initial hours. 
This is followed by a latent phase of apparent recovery and homeostasis is obtained. This 
however is quickly followed in severe H/I by a secondary stage, which happens 6-12 hours 
after birth, and is the sequential cascade of biochemical processes in the nerve cells triggered 
by the initial injury, which leads to eventual, mainly programmed cell death. This is a multi-
faceted complex process and is summarised below. TH is administered before 6 hours of age 
to suppress the secondary stage cascade of injury. 
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Glucose metabolism is altered by H/I and works differently in the immature brain, not least 
because of higher metabolic load demanded by the growing brain at this time (especially the 
subcortical white matter), and the ability of the immature brain to recruit energy from 
ketones in addition to glucose (27). Low energy supply in cells leads to a build-up of calcium 
and to de-polarisation of the neurones and glia causing seepage of excitatory amino acids 
into the extracellular space. Excitotoxicity results from high levels of glutamate, due to 
reuptake failure and the overactivation of N-methyl-D-aspartate (NMDA) receptors which 
increases the calcium levels between cells and lowers the blood pH (lactic acidosis). This sets 
in motion the cellular processes leading to cell death (26). NMDA plays an important role in 
brain development, facilitating the increase and migration of nerve cell precursors and later 
synaptic development and plasticity. Because of this, there is a higher density of glutamate 
receptors on NMDA in the neonate, thus compounding vulnerability to damage from the 
excitotoxicity process described above (27). In human neonates, higher glutamate levels can 
be measured via proton magneto-spectroscopy and is observed in the CSF (cerebrospinal 
fluid) of babies with severe HIE. In addition, excitotoxicity of the neurons can lead to seizures 
as measured by the EEG (electroencephalogram). 
A separate source of excitotoxicity is also gaining attention, with evidence that de-
polarisation of neurons also leads to the release of ATP (adenosine triphosphate) into the 
synaptic cleft, causing increased adenosine receptor activation on the synapse. Evidence is 
accruing that this may be implicated in inhibited axonal growth and white matter formation 
(27). 
The pathway to cell death arising from excitotoxicity from overactive NMDA receptors results 
from the activation of neuronal nitric oxide synthase (nNOS) which produces nitric oxide. 
This leads to mitochondrial malfunction, oxidative damage and cell death. Calcium also builds 
up in the mitochondria of the cell (28). The immature brain is particularly vulnerable to  this 
dysfunction due to its sensitivity to oxidative stress (26). Oxidative stress can be defined as 
increased free radical production arising from oxidative metabolism due to pathology. This 
is seen in H/I injury due to the primary ischaemia which reduces the delivery of oxygen and 
other nutrients transported in the blood, and the secondary damage caused by reperfusion 
of blood to hypoxic cells thus inducing oxidative stress.  
The cellular response to H/I, reperfusion, infection and inflammation, is guided by cytokines 
which play a systemic and local role in this response. 
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Two processes of cell death – necrosis and apoptosis, are seen in neonatal H/I injury. Necrotic 
death is often seen after severe injury and occurs as a result of a weakening of the cell 
membranes, leaking of cytoplasm outside the cell, and a secondary inflammatory response. 
There is also emerging evidence that some necrosis can also become programmed in some 
situations termed necroptosis (29). Apoptosis is a regulated process of programmed cell 
death via nuclear shrinkage. Cell remnants then break off as apoptic bodies and are absorbed 
by adjacent cells (26). Apoptosis in the neonatal brain behaves differently following H/I injury 
compared with the mature brain, and appears to be the principal mode of cell death in 
neonates (27). 
A recent review suggests that pathogenesis of perinatal brain injury should include ongoing 
processes termed tertiary forms defined as ‘those that worsen outcome, predispose a patient 
to further injury, or prevent repair or regeneration after an initial insult to the brain. (p.557)’ 
(30). Thus far, these processes have been suggested in the main from animal studies, but 
knowledge is accruing from specialised neuroimaging techniques. The processes suggested 
includes long-term microglial activation, (although not directly studied in relation to HIE), 
altered inflammatory processes, and epigenetic changes which are suggested to lead to 
gliosis, delayed maturation of oligodendrocyte progenerator cells (OPC), altered 
proliferation and synaptogenesis and epigenetic dysfunction. If true, this could help explain 
the long-term memory and learning difficulties experienced by children due to myelination, 
white matter and connectivity issues, even following mild HI insults (30). 
As knowledge and techniques become more sophisticated in the quest for a model to explain 
perinatal insults, multifactorial aggregate (‘multiple hit’) models are attracting interest such 
as the ‘sensitisation’ model which purports that susceptibility may have its origins in the 
antenatal phase where inflammation, maternal stress, hypoxia, malnutrition and genetic 
factors may sensitise the foetus to experiencing a hypoxic-ischaemic insult, with postnatal 
factors (pain, drug administration, inflammation, genetic factors) intensifying the injury 
impact (31). Gender is also thought to play a role with evidence from a small pool of studies 
suggesting male susceptibility to worse injury and prognosis (32). 
1.2.2 Pattern and Timing of Brain Injury in HIE 
The pathophysiology described in the previous section affects brain areas in different ways 
reflecting underlying vulnerabilities, gestational age and type of insult. The brain regions 
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most vulnerable, are those with the highest metabolic load. MRI studies have contributed 
greatly to an understanding of the topology of same. This knowledge has accumulated since 
the 1980s, when early MR studies identified two principal patterns of neonatal brain injury 
– (i) ‘BGT’: deep grey matter nuclei (i.e. thalami, basal ganglia and peri-rolandic cortex) and 
(ii) ‘WS’: white matter and cortex damage in the intravascular boundary zones – the regions 
between the territories served by the major cerebral arteries (i.e. ‘watershed’ region) (33). 
When infant MRIs are repeated in childhood, injury patterns tend to be consistent (34). Over 
time, scoring systems which correlated with early childhood outcome were devised, which 
met best accuracy if administered after the first week of life. Many use the Barkovich scoring 
system or an adapted version (see Table 1.2). Other brain areas implicated include the 
posterior limb of the internal capsule (PLIC) (35), hippocampus and brain stem (in severe 
cases) often associated with type (i) pattern, and the cerebellum. BGT are generally 
associated with acute, severe, sentinel events such as placental abruption. The WS injury 
pattern is associated with a more chronic partial asphyxia, with uni- or bi-hemispheric 
involvement, attributed to hypotension, hypoglycaemia, and  infection (19). However, 
further studies cast doubt on this clear dichotomy, with later MRIs showing that most post-
HIE injuries with WS injury also have evidence of BGT injury. Also, BGT injury may also display 
abnormal signal intensity in the central sulcus, interhemispheric fissure and insula cortex 
regions. Those with cortical and white matter injury (WMI) alone are often caused by 
perinatal stroke with no HIE signs (36). 
Recent evidence from term-births, suggests another pattern of injury, (previously more often 
attributed to prematurity) that demonstrates periventricular WMI associated with milder 
encephalopathic signs. A recent study of 49 infants with HIE revealed that 11 (23%) 
presented with WMI on MRI (37). 
Theories on the precise timing of damage acquisition in the encephalopathic neonate have 
vacillated and have medicolegal implications. A large cohort study analysed MRI findings for 
two groups of infants, the first who met the criteria for neonatal encephalopathy following 
presumed perinatal insult and the second group who presented with seizures in the first 
three postnatal days. Results found 80% and 69% of MR evidence of perinatal cause of injury 
in the respective groups, with little evidence of antenatal causation (38). Comparison of 
results such as these across studies is confounded by the configuration of neonatal signs used 
for inclusion criteria. 
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In term infants, patterns of MR injury have proved a useful tool to compare brain injuries 
between infants cooled and not cooled in TH trials. In addition the administration of TH does 
not appear to affect accuracy of predictive value of MR for later outcome (39). In summary, 
MRI is an excellent tool to determine the pattern of injury and for prediction of outcome if 
the MRI is acquired after the first week of age.  
 
Table 1.2 The Barkovich MRI Scoring System (Adapted from Barkovich et al., 1998) (33). 
Score Finding 
Basal Ganglia  
0 = Normal or isolated focal cortical infarct 
1 = Abnormal signal in thalamus 
2 = Abnormal signal in thalamus and lentiform nucleus 
3 = Abnormal signal in thalamus, and lentiform nucleus, and perirolandic 
cortex 
4 = More extensive involvement 
Watershed  
0 = Normal 
1 = Single focal infarction 
2 = Abnormal signal in anterior or posterior watershed white matter 
3 = Abnormal signal in anterior or posterior watershed cortex and white 
matter 
4 = Abnormal signal in both anterior or posterior watershed zones 
5 = More extensive cortical involvement 
Basal ganglia/ watershed  
0 = Normal 
1 = Abnormal signal in basal ganglia or thalamus 
2 = Abnormal signal in cortex 
3 = Abnormal signal in cortex and basal nuclei (basal ganglia or thalami) 
4 = Abnormal signal in entire cortex and basal nuclei 
Summation 
     Arithmetic sum of BG and W 
Enhancement  
0 = No enhancement 
1 = Enhancement in white matter only 
2 = Enhancement in deep grey matter nuclei 
3 = Enhancement in cerebral cortex 
4 = Enhancement in cortex and deep grey matter or white matter 
Adapted from: Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen, F, Ferriero DM. 
Prediction of neuromotor outcome in perinatal asphyxia: Evaluation of MR scoring system. AJNR Am 
J Neuroradiol; 1998; 19: 143-9. 
1.3 Treatment for HIE 
The only recommended treatment for neonatal HIE is therapeutic hypothermia (TH). This 
developed from the discovery that the two-stage model of pathogenesis in HIE (see section 
1.2.1) provides a therapeutic window of opportunity in the first hours of life, before the 
secondary wave of energy failure brain damage occurs. First described in animal research, a 
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number of small pilot studies led to large RCTs in the 2000s which confirmed the efficacy and 
safety of this treatment in human babies. The NICHD NRN (National Institute of Child Health 
and Human Development Neonatal Research Network) (40), Toby (17), CoolCap (41), ‘China’ 
study (42), neo.nEuro.network (43) and ICE (44) RCTs have all published broadly similar 
findings, which are outlined in detail in Section 1.5.2. Despite significantly lower morbidity 
and mortality rates, the proportion of children who die and are long term disabled is still 
considerable and new treatments are being pursued (45). 
Little is known about whether TH in the first days of life has an impact on the long term subtle 
neuropsychological outcomes for children. Those RCTs which did include NP measures were 
not designed to have power to show significant effects for these secondary measures. At this 
point, the American Academy of Pediatrics recommends cooling therapy solely for moderate 
and severe encephalopathy grades (46). 
There are a number of RCTs currently underway to increase the armament of treatments for 
neonatal HIE. These include Xenon administration in conjunction with TH, melatonin, 
allopurinol, erythropoietin, and free radicals. Stem cell research also holds promise for future 
therapies (30, 47). 
1.4 Tracking the Course of Neonatal HIE 
Clinical assessment at birth of the compromised infant will typically include the Apgar Score 
(48). Developed and standardised by Dr. Virginia Apgar in the 1950s, it includes five 
elements: (i) colour, (ii) heart rate, (iii) reflexes, (iv) muscle tone, (5) respiration. Each is 
allocated a score of 0, 1, or 2. Thus it ‘quantifies clinical signs of neonatal depression such as 
cyanosis or pallor, bradycardia, depressed reflex response to stimulation, hypotonia, and 
apnea or gasping respirations’ (pg.e52) (49). It is recorded at 1, and 5 minutes and thereafter 
every five minutes if the score < 7. This valuable score however was not designed to predict 
HIE, albeit a lower score at 5 and 10 minutes confers a greater relative risk of the incidence 
of CP in population studies (49, 50). Notwithstanding, many infants with low Apgar scores 
will have a normal neurological outcome, for example 20.8% of infants with a 10-minute 
Apgar score of 0 in the NICHD TH trial had intact outcome (51). If a HI insult is suspected, 
additional assessment is required, and because of the variable timing of HI insults, most of 
which are intrauterine, it is not possible to directly measure hypoxia-ischaemia in terms of 
oxygenation and blood flow. Instead, markers of these events are taken such as the pH of 
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arterial cord blood (52), and serum lactate level which marks the cell change from aerobic to 
anaerobic metabolism. Two measures may be used, lactate level and time to lactate 
normalisation (53).  
There is a tremendous interest in the identification of useful new biomarkers for HIE, and a 
host of lab-based biomarkers hold promise for the future. These include investigating 
umbilical cord blood, urine and CSF for metabolomics etc. (54). However, the focus of this 
PhD thesis is not to investigate the value of single markers of outcome, and a discussion of 
these biomarkers is beyond the scope of this review. 
HIE is an evolving condition, which requires accurate and frequent measurement in the first 
week of life. The next section will principally provide a review of some of the most commonly 
used assessment measures to track HIE over time. These include neurological assessment, 
HIE grading systems - in particular Sarnat grade - and electroencephalography (EEG). 
1.4.1 Neurological Assessment 
1.4.1.1 Summary of Neurological Assessment 
The fundamental aim of the neurological assessment of the full-term newborn is to identify 
the CNS maturity or neurobehavioural state of the baby. Classical measures focus on muscle 
tone and eliciting primitive reflexes, but many also include other additional behavioural 
signs. Some of the most common include those devised by Dubowitz, Brazelton and Amiel-
Tison (55-57).  Infant behaviours are included in some systems, such as orienting to 
environmental stimuli such as sound and sights, and behavioural states (alertness) (57). The 
value of neonatal neurological assessments for the prediction of outcome has been 
investigated, and assessment at discharge has been reported to predict outcome (58). It has 
been suggested that tracking early neurological signs may have better prognostication value 
than other biomarkers such as Apgar and blood gas pH (59). 
Claudine Amiel-Tison and her colleagues developed a neurological assessment which has 
evolved from the initial studies of her predecessors Andre-Thomas and Saint-Anne 
Dargassies, and by further work by Sarnat, who reviewed anatomic and physiologic 
correlates of early neurological development (60). She suggested that the assessment of 
cortical control in the infant is a useful add-on (61), and that the assessment should focus on 
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the usual locus of damage – the cerebral hemispheres and the integrity and maturation of 
the upper control system - rather than reflexes elicited by the brainstem. 
Cortical control can be clinically elicited through passive and active tone in the axis, alertness 
tested by visual fixation and pursuit, and cranial signs. Brainstem functions are elicited by 
primary reflexes and passive tone in limb flexor muscles. Neural maturation can be observed 
through the gradual uptake of control by the upper system in the first two years of life (62). 
Amiel-Tison purports that the stage of maturation of the two motor control systems 
(subcorticospinal and corticospinal) can be clinically evaluated in the term infant (63). Serial 
assessments have been recommended for two reasons: (i) to reduce the confounder of 
transient clinical signs caused by medical treatments, and metabolic processes (64); (ii) to 
discriminate between a ‘static’ neurological profile more usually seen in infants with prenatal 
damage, and an ‘evolving’ profile more commonly seen in HIE and ‘normal’ babies (65). 
Evidence suggestive of an old prenatal insult includes a high-arched palate, ‘cortical’ thumb, 
and cranial ridges on every suture (64).  
The Amiel-Tison Neurologic Assessment at Term (ATNAT) (60) has been developed to provide 
a framework for observing the above. There are 35 items clustered into 10 groups.  It has 
been shown to predict cerebral palsy following birth asphyxia (61, 62), to correlate with 
outcome at 12-15 months (62, 65) and is easy to administer, with no expensive equipment 
needed. Mild and severe abnormal scores are good predictors of normal and later disability 
respectively, and the moderate abnormal score less so. There can be a tendency for false 
positives, however, in one study, negative predictive value of a normal examination in the 
first two days was 100% for one year outcome (62). 
Neonatal examination used in combination with a modified Sarnat score at 6 hours of age 
with amplitude integrated EEG (aEEG) has been found to enhance the ability of the aEEG to 
predict neurological outcome at one year (66). Amess et al. also found that neonatal 
neurological assessment was a useful aide to magnetic resonance spectroscopy, with late 
examinations (> 7 days) having superior predictive sensitivity of 12-month outcome than 
early examinations (< 48 hours) (62). 
A system such as the ATNAT holds the advantage that it can also track the infant into the first 
and second year of life using the same system. This allows the assessment of later-elicited 
responses (e.g. postural reactions) which may possess superior predictive qualities (67). 
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Further analysis of the individual items of the ATNAT may reveal markers for later outcome, 
because it includes behavioural and communication items, which share construct validity 
with later developmental assessments (68). The ‘Amiel-Tison triad’ of signs seen in the first 
18 months, for example, may suggest damage due to a focal lesion. The signs are uni- or 
bilateral phasic stretch reflex, imbalance of passive axial tone, and cranial signs on the 
squamous ridge of the skull (69). 
A main advantage of the use of neonatal neurological assessment is that it can be used in 
low-resource environments, that have no access to more technically-sophisticated modes of 
assessment. 
1.4.1.2 Sarnat and other Grading Systems 
In 1976, Sarnat and Sarnat published their seminal paper ‘Neonatal encephalopathy 
following fetal distress: a clinical and electroencephalographic study’ (14). Four decades 
later, it’s staging system for NE is the most comprehensively studied neurological status 
grading system in neonatal HIE. Its predictive value has also been well scrutinised. The 
system aims to stage the evolving encephalopathy using three grades, - mild, moderate and 
severe. This grade may change or remain constant across the first days of life. It comprises 
clinical and electroencephalographic elements, and the components are presented in Table 
1.3. A considerable drawback of the Sarnat grading outcome studies is the neonatal age at 
which the infant is graded using Sarnat – typically 24 hours. However, Sarnat (or other 
reliable grading tools) are required by six hours of age if they are to be used for decisions 
around suitability for TH (70). In addition, advances in the NICU include ventilation, sedative 
and anticonvulsive drugs which can interfere with accurate Sarnat scoring (19). The way in 
which the individual neurologic signs are assessed continue to frustrate standardised 
inclusion of children into these categories (71, 72). 
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Table 1.3 Summary of Sarnat stages of encephalopathy (Sarnat & Sarnat, 1976) 
From Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress, a clinical and 
electroencephalographic study. Arch Neurol. 33:696, 1976; with permission). 
Until recently it was generally accepted that infants with a Sarnat grade I (mild) score at birth 
would have a good outcome, without long term neurological deficit. Those with Sarnat grade 
III (severe) HIE progress to severe neurological deficit and/or death, and that the prognosis 
for those with a Sarnat grade II (moderate) score was less predictable, with between 20-40% 
progressing to neurological disability. It remains difficult to predict which infants in this group 
might experience negative outcomes, and what forms of difficulty might arise (71, 73), 
however the solution may lie in the differential power of the individual neurological signs 
within this category to predict outcome, the most obvious being the presence of seizures 
(71). 
Long-term follow up studies, such as those devised by Robertson and Finer (74), and Marlow 
et al. (75), which also included comparison/control groups utilised more detailed 
neurological, cognitive, educational attainments and behavioural assessments to observe 
outcome. These studies allowed for more specific indicators of neuropsychological sequelae 
within each grade of encephalopathy severity. One pertinent finding was that those within 
the moderate group (both with and without motor impairment) had lower cognitive and 
educational attainments functioning when compared with the mild group or the control 
group. Research is thus required to further analyse predictors for cognitive difficulties in the 
absence of motor impairment, to improve prognostic data (76). 
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There had been a consensus in the literature that Sarnat mild grade encephalopathy is a 
benign condition, hence it was not included in initial TH RCT trials, and are an understudied 
group compared to the moderate and severe grades. In Robertson and Finer’s cohort some 
differences were found between the mild encephalopathy group and the control group. 
However, this is a dated cohort. More recently, in a retrospective study, children following 
mild HIE had greater than expected rates of specific memory and learning difficulties (77, 
78), and white matter changes on MRI have also been reported (36, 79, 80). Robertson and 
Perlman (2006) (8) recommend follow up of children with mild HIE who experienced 
hypotonia at any stage (especially low shoulder girdle hypotonia), because they noted that 
studies in the 1990s that reported adverse outcome for those following mild encephalopathy 
had transient hypotonia and/or suppressed reflexes (71). Overall outcome findings will be 
reviewed in further detail in Section 1.5 – childhood outcomes. 
Sarnat and Sarnat’s grading system has remained the most commonly reported in research 
studies. However, no matter what grade is chosen, definitional difficulties exist (72). An 
alternative system, the Thompson grade has also gained considerable interest. It has the 
advantage of a simple scoring system (0-3, where 0 is normal) comprising nine items to be 
assessed: tone, level of consciousness, fits, posture, moro, grasp, suck, respiration, and 
fontanelle (81). It has been shown to have high sensitivity and specificity for death and severe 
outcome (such as the development of severe epilepsy) in the short-term in both uncooled 
and cooled infants (82). 
To conclude, current views of observing dysfunction focus on a continuum or spectrum 
model of disability from normal to severe. It could be argued that encephalopathy is no 
different, and that there is insufficient evidence-based rationale to discriminate individual 
grades such as ‘mild’, ‘moderate’, and ‘severe’ (75, 83, 84). 
1.4.2 Electroencephalography 
The EEG, developed by Hans Berger in 1929, is a recording of summated post-synaptic 
electrical activity in the cerebral cortex close to the skull surface of the scalp (85). This is 
achieved with the application of electrodes to the scalp in specified patterns (i.e. the 
montage). For infants, typically 9 are positioned using the 10-20 pattern (see Figure 2.1 in 
the methodology chapter). In order to standardise practice, the American Clinical 
Neurophysiology Society has recommended adherence to this 10-20 pattern (86). For 
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accuracy, it is important that electrodes have good contact and symmetry, and in a new-born 
sick baby, this can take up to an hour to achieve (87). 
Continuous multichannel EEG recordings are the gold standard (86) as they provide 
comprehensive spatial information about newborn brain function and provide information 
about synchronous/asynchronous patterns between the cerebral hemispheres. Amplitude 
integrated EEG (aEEG) has become more popular because of its ease of use but it does have 
limitations. Until recently it was argued that aEEG pattern recognition was easier to use and 
interpret than continuous EEG, however studies have shown poor inter-rater reliability (88). 
aEEG originally relied on cerebral functional monitoring from 1 channel, developed for use 
with adults, although used in a number of the TH trials (87). Information about spatial 
patterns, synchrony/asynchrony and lower amplitude seizures can be lost. Two channel 
recordings (either C3 and C4 but more often P3 and P4) allows the detection of 
interhemispheric asymmetries not detected with one channel (86).  aEEG is now used 
concurrently with access to at least two channels of continuous EEG trace, especially for 
surveying background activity. For seizure detection, continuous multi-channel EEG remains 
the best choice where available (86). 
Factors that affect the accuracy of the EEG reading include artefact from the electrical noise 
of the NICU, other physiological processes in the infant including movement, ocular, cardiac 
and breathing, and administration of drugs to sick babies including phenobarbitone, 
diazepam, pethidine, morphine, midazolam and lignocaine (87, 89). 
There is a burgeoning interest in the potential of machine learning algorithms to detect EEG 
patterns. Quantitative analysis using mathematical models can, for example, compute the 
area of burst suppression (90), grade abnormality in EEG (91), and provide a detection system 
for the evolution of EEG which discriminates mild and moderate instances (92). These 
programmes continue to be developed to improve prognostic utility. Some studies are 
limited by the number of samples, and the length of EEG epochs under scrutiny (93). 
In newborns, EEG is assessed in qualitative and quantitative ways. Qualitative is generally 
used by clinicians, using visual pattern recognition. Quantitative is being developed but not 
yet in clinical practice (94). Typically, the background activity is characterised by the 
neurophysiologist, sleep and wake states are identified, and seizures if present are identified 
and described in terms of amplitude, frequency, location and morphology (87). The 
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background features of the EEG have received most attention. They are the baseline actions 
of the brain at rest, when awake and during sleep. The principal features analysed are 
continuity, amplitude, frequency, synchrony and symmetry, maturational characteristics, 
state differences and reactivity (89). The pattern of the sleep-wake cycle (SWC) is important. 
There are three phases in a cycle (quiet sleep, active sleep and wakefulness). A study of the 
SWCs of 91 healthy term infants suggest that an EEG recording of 2.5 hours is required to 
capture the entire SWC duration in neonates (95), with active sleep contributing to, on 
average, 52.1%,of active and 38.6% quiet sleep per SWC. 
A normal neonatal EEG has a unique pattern, different to all other stages of life. It will have 
a background frequency of 0.5-12Hz, and amplitude range of 50-100μV, a continuously 
synchronous and symmetrical discharge pattern across the hemispheres, show a definitive 
SWC in the immediate postnatal period and react to tactile and auditory stimuli. The 
maturational features that can be identified at term are anterior slow dysrhythmia (first 
appears from 35 weeks) and frontal sharp transients (89). 
1.4.2.1 EEG and HIE 
After hypoxia-ischaemia, early presence of a normal background EEG recording usually 
predicts positive outcome, whilst severely abnormal readings are associated with major 
adverse neurological sequelae.   The predictive value of a moderately abnormal EEG is 
affected by time of recording, and recovery on serial recordings (96). Holmes and Lombroso 
(1993) in a review of studies observed that the background EEG patterns were more 
important in prognosis than EEG discharges (97). One study cited that 85% of children with 
neonatal seizures combined with normal background had normal outcome.  
In a more recent systematic review of the ability of background features of EEG and aEEG to 
predict outcome in infants following HIE, it was found that low voltage, burst suppression 
and flat trace predict adverse outcome with high sensitivity (0.78-0.92) and specificity (0.82-
0.99) (98). However, heterogeneity of background definitions confound the findings 
highlighting the need for a universal definition, such as that proposed by the American 
Clinical Neurophysiology Society (99). In addition, the background grades were dichotomised 
for statistical purposes into ‘normal’ (normal/minor/mildly abnormal) and ‘abnormal’ 
(moderate/severe/death). Thus, the analysis precluded investigation at the finer grade level. 
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EEG continues to offer the best option for temporal tracking of HIE evolution and recovery 
in neonates, with the potential to enable a better understanding of when to treat. Although 
few in number, studies demonstrate that repeated recordings at regular intervals enhance 
prognostication (96, 97, 100-102), and are recommended at least every 24 hours (99). In a 
detailed review (up to 2011), Walsh et al. (103) found that only six studies commenced 
continuous EEG at or before 24 hours (14, 101, 104-107) of age. In two of the studies, an 
exact commencement time was not stated, but EEG was initiated,  ‘as soon as possible’, or 
shortly after birth (14, 106). A comparison of the outcomes was confounded by the different 
EEG montages and grading systems employed with the infants. Grade descriptions differed, 
and the number of grades per system ranged from two ‘normal/abnormal’ to six. Outcome 
for these children was measured at between 12-30 months. This review also highlighted that 
time of recording had a significant impact on prediction accuracy. In the cohort of infants 
used in this thesis, this point of timing was clearly demonstrated when EEG epochs taken at 
6, 12, 24 and 48 hours were compared with 24 month outcome (105). A normal EEG achieved 
by 6 hours of age always predicted a normal developmental score at 2 years. 
In addition to the importance of the background pattern, the EEG is also essential for seizure 
detection. This has been recognised for over sixty years. Neonatal seizures are often 
subclinical, with no outward behavioural signs (108). EEG allows earlier and more accurate 
diagnosis of same. Other clinical markers of HIE such as acidosis and Apgar scores are 
ineffective predictors of seizure compared to EEG (108).  
The association between EEG and MRI for outcome has been investigated, and findings 
suggest a high correlation between normal/abnormal findings on EEG at day 3 and MRI in 
the first month with later outcome (109). Weeke et al., were the first to investigate these 
associations in infants that had undergone TH (110). In this study, serial EEGs at 24, 36 and 
48 hours, and MRI scans at the end of the first week were compared and prognostic values 
with two-year outcome were presented. Results showed no associations with EEG at 24 
hours, but strong correlations between EEG at 36 and 48 hours, and MRI findings with 2-year 
outcome. Background activity was a stronger predictor than seizure burden on EEG. 
However, methodological limitations include the use of a small sample and incomplete 24-
month standardised development scores (using the Bayley III scales) for a number of the 
children measured at follow-up. This study also highlighted that, similar to aEEG, continuous 
EEG may have lower predictive values in cooled compared to non-cooled infants (111-113). 
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Two explanations for this observation have been noted in the literature: (i) the delayed 
recovery of burst suppression in TH on aEEG (113, 114) and (ii) that seizure burden may be 
reduced by TH (115). 
In summary, EEG is particularly useful for monitoring brain function in neonates with HIE 
because (i) it is very sensitive to physiological changes associated with alterations in 
oxygenation and blood pressure (87), (ii) it confirms the presence of subclinical seizures 
activity (108), and (iii) it demonstrates excellent prognostic properties for later outcome. EEG 
can be used sooner than other neuroimaging techniques and, critically, in the first six hours 
after birth. 
1.4.3 Conclusion: 
This section sought to provide a summary review of some of the most commonly used 
assessment methods for tracking HIE progress in the neonatal period. In addition to tracking 
progress, the second major use of neonatal markers is in the prognostication of outcome for 
the infant. The next section will provide a review of childhood outcomes following HIE and 
their association with neonatal assessment measures. 
1.5 Childhood Outcomes following HIE 
There has been a substantial body of research undertaken in comparative, experimental and 
clinical areas to investigate the long-term effects of HIE. In general, studies have progressed 
from an initial emphasis on the outcomes of perinatal asphyxia (PA) focusing on mortality 
and severe CP, to now include a broader assessment of the extent of outcome following HIE. 
Short-term outcomes primarily at 12, 18 and 24 months have been extensively reported, and 
the focus has now extended to observational studies into childhood and beyond. Most is 
known about the prevalence of survivors of HIE who develop motor (namely cerebral palsy), 
intellectual and sensory difficulties. Less is known, but interest has increased in subtle 
sequelae including social-emotional and neuropsychological outcomes. This represents a 
departure from the now outdated 2003 statement from the American College of Obstetrics 
and Gynecology (ACOG) (116) that adverse cognitive patterns did not occur in the absence 
of a child developing CP following a perinatal asphyxial event (76). 
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Dilenge et al. undertook a comprehensive review of longitudinal studies following PA in the 
pre-TH treatment era (117). Having reviewed the prognostic indicators of PA they concluded 
that children in studies which employed a diagnosis of HIE had higher rates of moderate and 
severe outcome than those studies that limited themselves to using one or more markers of 
PA. For example, one study reported lower than expected rates of poor outcome but only a 
single marker (acidosis) was used (117, 118). 
Moster et al. (21), in a Norwegian cohort looked retrospectively at low 5 min Apgar scores in 
combination with 3 signs of neonatal encephalopathy. Those children with PA and NE signs 
who were nonimpaired had significantly higher minor signs than those with low Apgar alone 
or the reference group. Feeding difficulties were found to have the best predictive value of 
the three neonatal signs measured. However, the NE was not graded and could not in all 
cases be presumed to have been caused by a HI episode. Additionally, standardised 
measures were not used for outcome assessment. 
Thus, individual markers of perinatal asphyxia such as pH or base deficit (BD) alone remain 
of limited value due to the nonspecific nature about what they can predict (76). 
1.5.1 HIE Outcome Studies in the Pre-Hypothermia Epoch 
The principal cohorts of children who were followed into school age in the pre therapeutic 
hypothermia era include the influential work of Robertson and Finer of children born in 
Canada in the 1970s and 1980s (58, 71, 74, 106, 119, 120), the Hammersmith cohort (121, 
122) the Utrecht/Hammersmith cohort born in the 1990s (38, 77, 78, 83, 123, 124), and a 
number of smaller significant cohorts. Well-designed retrospective studies have also 
reported outcomes following neonatal encephalopathy (75, 125). These studies were among 
the first to focus on outcomes other than cerebral palsy and intellectual disability, and of 
particular interest, reported adverse minor outcomes in the absence of motor (and 
sometimes cognitive) deficit (23, 74-76, 121, 126). 
Overall rates of mortality and morbidity following HIE vary across studies. For those that 
followed all grades of encephalopathy, mortality ranged from 11-16% (12, 58, 121), and in 
one study, as high as 28% (77). By grade, rates were 0% mild, 4-5% moderate, and 75-100% 
severe (58, 77, 127). Rates of CP ranged from 10-40% (58, 122) (35-50% in moderate grade 
(12, 128), and rates of intellectual disability (variable diagnostic criteria employed) were 25-
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58% (58, 122), (30-50% in moderate grade) (117). Sensory (hearing and vision) assessments 
revealed abnormal vision outcomes as 5.5% (58) (vision <20/60) or legal blindness (vision < 
20/200) in best eye following correction; Hearing 6.5% (58). Epilepsy rates are 10% (8, 58). 
Overall morbidity rates in those that survived were 11-19% (12, 58, 129) (mild 0%, moderate 
21%, severe 100%) (58). Even before the onset of TH as standard of treatment for HIE, there 
is evidence across studies over the past 40 years suggesting minor improvements in these 
mortality and morbidity rates (129), presumably arising from improvements in antenatal and 
perinatal medical care where available. At first glance, it appears that children following mild 
HIE survive unscathed. This is true for mortality and for major morbidity such as motor or 
intellectual disability. However, as will be shown in this section, when detailed studies of 
learning processes and educational attainment are reviewed it is seen that mild HIE and 
contemporaneous control groups do not always obtain similar results. 
With regards to the measurement of IQ, many post-HIE children will obtain IQs within the 
‘average’ range. Those studies that used comparison groups, typically reported mean IQs in 
the comparison group approaching the high average range (71, 74, 75, 77, 119, 124), rather 
than the test norm mean of 100. This denotes the importance of using an ecologically valid 
comparison group especially with respect to the study of outcomes of mild HIE, to evaluate 
any group score discrepancies. For example, in the Utrecht cohort, significantly lower 
estimated IQ scores (derived from four subtests) were found for those with mild and 
moderate NE (without CP) than for the comparison group, with no significant difference 
between NE grades (77, 124). In relation to verbal IQ, one study described an association 
between the severity of brain injury to the watershed area in the neonate and lower verbal 
IQ at age four years (130). 
A pattern of learning domains vulnerable to HI damage has emerged in studies reporting 
long-term cognitive and neuropsychological outcome. Tables 1.4 and 1.5 summarise the 
design and outcomes from research in the pre-TH era that followed children longitudinally 
and reported outcome in relation to HIE grade after the age of three years. These findings 
are grouped by overall IQ, verbal/language, auditory, non-verbal/performance, visual motor, 
executive functioning, memory areas, and the impact on rate of educational progress. 
Significant differences between mild, moderate and comparison children (where referred to 
in studies) are highlighted in Table 1.5. 
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Auditory and language skills acquisition has been identified as one area vulnerable to HIE 
injury. This includes significantly lower scores in children following moderate HIE (with and 
without motor impairment) compared to peer comparisons in the areas of  verbal concepts 
(119), receptive language (119, 131), auditory attention/discrimination, sound blending 
(131) and for the language domain of the NEPSY (neuropsychology test) (75). Impaired verbal 
learning in 9-10 year-old children following mild and moderate grade NE has also been 
reported, with no discernible differences between the grades found (77). 
Visual-motor and visual perceptual skills, many of which depend on underlying fine motor 
skills are a second area vulnerable to HIE damage, and with a higher proportion of mild as 
well as moderate HIE scoring lower than their peers. Lower skills in the moderate group 
included visual motor skills and perceptual speed (58, 74, 119, 131), which is more 
pronounced in younger than older children, sensorimotor neuropsychological skills (75), and 
delayed fine motor skills (58). Skills below peers for mild and moderate grade include 
performance IQ (measured on the Wechsler but NOT seen using the British Ability Scales), 
visual attention (131), general motor performance, and manual dexterity (123). 
Memory has been the most comprehensively studied domain due to (i) early identified 
trends of difficulty in studied children and (ii) the known association between memory loss 
and hippocampal damage. Retrospectively studied isolated case studies of children and 
adolescents with specific memory difficulties in the area of episodic (but not semantic) 
memory shared a neonatal experience of asphyxia (125, 132, 133). Other specific areas of 
memory where children post-NE have displayed lower scores than peers across studies are 
verbal working memory, sentence repetition, narrative memory (remembering story 
content), and a broader range of memory difficulties in moderate NE with no CP including 
verbal and visual long term episodic memory and verbal working memory (23, 75, 124, 131). 
Of note, the memory difficulties were not wholly explained by differences in IQ between the 
groups (124). 
Interestingly, other areas of neuropsychological function have not, to date, been consistently 
associated with HIE damage and include areas of cognitive control and inhibition with mixed 
results (23, 75). However, as Maneru points out, these executive functions rely on the 
prefrontal cortex, which had not reached maturity when some children were assessed, and 
the children may therefore have been too young to be reliably assessed for these functions  
(23).
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Table 1.4 Summary of longitudinal studies from the pre-therapeutic hypothermia era, with neonatal encephalopathy grades that measured long-term (over 36 months) 
cognitive, neuropsychological and academic outcome following neonatal HIE. 
Study Age at 
Outcome 
Design Inclusion Criteria Encephalopathy Grade Definitions 
1(i): 
Robertson & Finer 
(1985) (58) 
3.5yrs 
Born 1974-79 
Prospective. 
N=167/226. 
Mild=66, mod=94; 
severe=7 
Abnormal neurological exam AND one of - foetal 
distress (abn HR); Apgar<5 at 1 or 5 mins; birth 
resuscitation (bag and mask or intubation with 
ventilation) 
Mild (hyperalert/ hyperexcitable); 
Moderate (hypotonia and suppressed primitive reflexes); 
Severe (stuporous, flaccid and absent primitive reflexes). 
The most severe grade in the 1st week was assigned 
(seizures in hyperalert infants without suppressed 
reflexes assigned mild grade) 
Clinical staging similar to Sarnat grading. 
1(ii): 
Robertson & Finer 
(1988) (119) 
5.5yrs 
Born 1974-79 
Prospective. 
n=149/167 seen at 3yrs 
N=127/149 
(nondisabled) 
Controls=167 
Mild=56, mod=71 
Controls: neonatal 
recruits = 71 age 5 
recruits = 188 
As above.  
At 5.5yrs only non-disabled children were 
examined. 
As above 
1(iii): 
Robertson et al. 
(1989) (74) 
8yrs 
Born 1974-79 
Prospective 
N=145/226. 
Mild=56; mod=84 (non-
dis=66, imp=18); 
severe=5 
Control=155 
As above.  
All study children examined. 
As above 
1(iv) 
Robertson & Grace 
(1992) (131) 
8yrs 
Born 1974-79 & 
1982-86. 
Prospective 
Mild=56, Mod non-
dis=66 
Control=61. 
As above 
Non-disabled subgroup examined. 
As above 
2. 
Marlow et al.,  
(2005) (75) 
7yrs 
Born: 1992-94. 
Retrospective 
N=68/130; 50/68 non-
disabled 
>=35 weeks gestation with neonatal seizures OR 
‘encephalopathy’. 
Outcomes focussed on those with no CP. 
Moderate: Seizures alone or any 2 (lasting >= 24 hours) 
of: abn. consciousness, difficulty maintaining respiration 
(central origin), abn. tone and reflexes. 
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Study Age at 
Outcome 
Design Inclusion Criteria Encephalopathy Grade Definitions 
Mod (no CP)=32; 
Severe=18 
Matched Control=49. 
Severe: At least one of: ventilation for >24hrs, 2 or more 
anti-convulsant treatments, comatose or stuporous 
Grade criteria based on Badawi et al. criteria for NE 
(134), not HIE. 
3(i) 
Van Kooij et al. 2010 
(77, 123)  
9-10yrs 
Born 1993-97 
Prospective 
80/118 survivors 
Controls=52 
37-42 weeks gestation AND 3 of: signs of -foetal 
distress; Apgar <7 at 5mins; arterial umbilical 
pH<7.10; delay in onset of spontaneous 
respiration; multiorgan failure. 
Mild (NE1): Symptoms for <24 hrs. Hyperalertness, 
uninhibited Moro and stretch reflexes, sympathetic 
effects and normal EEG. 
Moderate (NE2): Obtundation, hypotonia, strong distal 
flexion, multifocal seizures. 
Main distinction between NE1 and NE2 was presence of 
neonatal (clinical/subclinical on aEEG) seizures. 
Highest Sarnat score achieved in 1st week 
3(ii) 
Van Handel et al. 
2012) (124) 
9-10yrs 
Born 1993-97 
Prospective 
81/170 survivors 
Controls=53 
As above. As above. 
4. 
Maneru et al. (2001) 
(23) 
15yrs 
Born 1978-86 
Retrospective 
28/401. 
Mild=8; Mod=20 all 
nondisabled. 
Matched controls=28 
At least 2 of:- umbilical pH artery <=7.15; Apgar 
<=6 at 5mins; meconium stained; presence of 
intrapartum bradycardia; respiratory distress in 1st 
24 hrs of life; O2 supply after delivery; neurological 
anomalies in 1st 48 hours (abnormal tone, 
neurological depression, primitive reflex 
anomalies, seizures, etc.) 
AND 
history of ‘good outcome’ (no CP, ID or 
neurosensory deficit) 
Mild and moderate PA based on Sarnat grade 
Abn=abnormal; HR=heart rate; mod=moderate grade; hrs=hours; mins=minutes; imp=impaired; non-dis=non-disabled; CP=cerebral palsy; ID=intellectual disability.  
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Table 1.5 Summary of outcomes from long term studies (identified in Table 1.4) that include control, mild and moderate grade HIE/NE groups for intellectual ability, 
verbal/language, nonverbal, memory, neuropsychological and educational areas. 
Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 INTELLECTUAL 
ABILITIES 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(i) Global IQ Stanford Binet L-M (Terman 
Merrill, 1973) 
Composite 100(16)  102D  92 B  
1(ii)* Global IQ  Stanford Binet L-M (Terman 
Merrill, 1973) 
Composite 100(16) 108C 106C 99 A,B   
1(iii) Full Scale IQ WISC-Revised (1974) Composite 100(15) 112C,D,E 106C,D,E 102 A,B 95 A,B 68 A,B 
1(iv) Full Scale IQ WISC-Revised (1974) Composite 100(15) 115B,C 106 A 102 A   
2 General Cognitive 
Ability 
British Ability Scales (BAS II) 1994 Composite 100(15) 114  112   
3(i) IQ estimation  WISC-III NL (2005) short form 4 
subtests 
Composite 100(15) 109B,C,E 99 A,E 92 A,E  70 A,B,C 
 VERBAL IQ and 
SUBTESTS 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(iv) Verbal IQ WISC-R (1974) Composite 100(15) 111C 105 100 A   
2 Verbal Domain Score BAS II (1994) Composite 100(15) 116  114   
1(iv) Information 
(general knowledge) 
WISC-R subtest – Information Scaled 10(3) 11 10 10   
1(iv) Similarities 
(verbal concepts) 
WISC-R subtest – Similarities Scaled 10(3) 13C 12C 10 A,B   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
1(iv) Arithmetic 
(working memory) 
WISC-R subtest – Arithmetic Scaled 10(3) 11 11 10   
1(iv) Vocabulary 
(verbal concepts) 
WISC-R subtest – Vocabulary Scaled 10(3) 12C 12C 10 A,B   
1(iv) Comprehension  WISC-R subtest – Comprehension Scaled 10(3) 12 11 10   
 LANGUAGE – receptive, 
expressive, auditory 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(i) Receptive vocabulary Peabody Picture Vocab Test 
(PPVT) 1965, mean IQ 
Standard 100(15)  104D  93 B  
1(ii) Receptive Vocabulary PPVT, (1965), mean IQ Standard 100(15) 107C 104C 97 A,B   
1(ii) Receptive Language PPVT and Zimmerman Verbal 
abilities subtest and/or Carrow 
Test of auditory comprehension 
    A,B   
1(iii) Receptive Vocabulary PPVT (Dunn et al., 1981) Standard 100(15) 100D,E 99D,E 95 87 A,B 62 A,B 
1(iv) Receptive vocabulary PPVT (1981) Standard 100(15) 102 99 95   
1(i) Expressive language Mean Length of morpheme 
Utterance (MLU)(1973) 
SD away from 
predicted CA 
score 
0  1D  0 B  
1(ii)  Expressive Language Zimmerman, MLU, Brown’s Post-
stage V. 
       
1(iv) Producing sentences CELF (1969) Raw  38C 35 30 A   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
1(ii) Auditory Attention for 
related symbols  
Detroit Tests of Learning 
Aptitude, rev, (Baker, 1967) 
Standard 100(15) 97C 94C 90 A,B   
1(iv) Auditory attention for 
related symbols 
(sentences) 
Detroit auditory attention for 
related symbols (sentences) 
  88C 77 72 A   
1(iv) Auditory attention for 
unrelated symbols 
Detroit auditory attention for 
unrelated symbols 
  86 C 79 71 A   
1(ii) Auditory discrimination 
of sounds in words 
Auditory Discrimination Test, 
(Wepman 1973) 
SD away from 
predicted CA 
norms 
0 +.73 C +.23 C -.23 A,B   
1(iv) Auditory discrimination Wepman Auditory Discrimination Raw out of 40 28 C 28 C 26 A,B   
1(ii) Sound blending Gates McGinnitie Reading Test STen 5 (1.96) 5.9 C 5.1 C 4.8 A,B   
1(iv) Sound blending Illinois Psycholinguistics sound 
blending 
Scaled 36 45 C 43 41 A   
1(iv) Phonetics Roswell-Chall Phonetics (1962) Raw  82 C 80 C 67 A,B   
1(iv) Auditory closure Illinois Psycholinguistics auditory 
closure 
  34 C 33 31 A   
1(iv) Free associations Detroit (1967) Free associations   124 C 114 104 A   
1(iv) Verbal absurdities 
(comprehension) 
Detroit Verbal absurdities 
(comprehension) 
  135 C 128 116 A   
2 Language NEPSY (1997) Domain Composite 100(15) 120 C  109 A   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 NON-VERBAL/VISUAL 
IQ 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. To 
1(ii) Mental maturity and 
detail recognition  
Goodenough-Harris Drawing 
Test, (Harris, 1963) 
Standard 100(15) 96 C 91 C 86 A,B   
1(iv) Performance IQ WISC-R (1974) Composite 100(15) 114B,C 106 A 103 A   
1(iv) Picture Completion WISC-R subtest Scaled 10(3) 13 C 11 10 A   
1(iv) Picture Arrangement WISC-R subtest Scaled 10(3) 13 B,C 11 A 11 A   
1(iv) Block Design WISC-R subtest Scaled 10(3) 13 B,C 10 A 10 A   
1(iv) Object Assembly WISC-R subtest Scaled 10(3) 12 11 11   
1(iv) Coding WISC-R subtest Scaled 10(3) 11 10 10   
2 Non-verbal (visual) 
composite 
BAS II (1997) Composite 100(15) 110  109   
2 Non-verbal reasoning BAS II Standard 100(15) 110  110   
2 Spatial reasoning BAS II Standard 100(15) 109  106   
 VISUAL-MOTOR SKILLS    A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. To 
1(i) Visual 
Motor/Perceptual 
motor skills 
Visual Motor Integration Test 
(VMI) 1967 
Months below 
CA 
0  -1D  -5 B  
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
1(ii) Visual 
motor/perceptual 
motor 
Test of VMI (Beery, 1967) Scaled 10(3) 9.1 C 9.4 C 7.7 A,B   
1(iii) Perceptual-Motor Test of VMI (Beery, 1982) Scaled 10(3) 9.3 D 9.0 D 8.7 7.4 A,B 3.9 
1(iv) Visual perceptual/visual 
motor 
Dev. Test of VMI (Beery) (1982) Scaled 10(3) 10 9 9   
1(iv) Visual motor Bender VM Gestalt (1946) Standard 100 99 97 92   
1(iv) Visual field 
independence/ 
dependence 
Embedded Figures (Benton, 
1963) 
  23 21 19   
1(iv) Perceptual Speed 
(visual matching & 
spatial relations) 
Woodcock-Johnson Perceptual 
Speed (1977) 
Raw Out of  482 C 476 472 A   
1(iv) Visual attention – 
letters 
Detroit Tests visual attention 
(1967) 
  114 B,C 104 A 98 A   
1(iv) Visual attention - 
objects 
Detroit Tests visual attention 
(1967) 
  122 B,C 100 A 98 A   
4 Perceptual motor speed Digit symbol (WAIS/WISC-R) Scaled 10(3) 13.3 C 12.0 11.2 A   
2 Visuospatial reasoning NEPSY (1997) Domain Standard 100(15) 118  113   
 FINE and GROSS 
MOTOR 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
4 Motor performance Purdue Pegboard Test   36.3 C 32.6 31.9 A   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
4 Motor performance Hand sequencing (Luria)   45.9 41.0 39.9   
3(i) Motor performance 
(Total impairment 
score) 
Movement ABC (Dutch 
instructions, 1998) 
(Sum of 3 subtests below) 
Sum of raw 
scores 
0-15 
(0=highest 
score) 
8.0 B,C 11 A 11.5 A   
3(i) Motor performance 
(manual dexterity) 
Movement ABC (Dutch 
instructions, 1998) 
Raw 0-5 
(0=highest 
score) 
4.0 B,C 5.0 A 4.5 A   
3(i) Motor performance 
(ball skills) 
Movement ABC (Dutch 
instructions, 1998) 
Raw 0-5 
(0=highest 
score) 
1.0 C 1.0 2.5 A   
3(i) Motor performance 
(static and dynamic 
balance) 
Movement ABC (Dutch 
instructions, 1998) 
Raw 0-5 (0-
highest 
score) 
2.25 C 2.5 4.3 A   
3(i) Motor score Proportion of 
abnormal/borderline/normal 
(excluded children with CP) 
Proportion 
abn/borderlin
e/ 
normal 
n/a 7/10/33 
B,C 
9/9/13 A 12/9/11 A   
2 Sensorimotor NEPSY (1997) Domain Composite 100(15) 111 C  104 A   
1(i) Fine motor  % with >6mth 
delay 
n/a  2 D  15 B  
1(i) Gross motor  % with >6mth 
delay 
n/a  5 D  18 B  
 SHORT TERM & 
WORKING MEMORY 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
1(iv) Auditory Digit Span 
subtest 
(WISC-R)(1974) Scaled 10(3) 11 C 10 9 A   
1(iv) Visual-auditory short-
term memory 
Visual Aural Digit Span Test 
(STM((1977) 
  100 C 96 93 A   
3(ii) Visuospatial ST memory Spatial Memory (Kaufman-ABC, 
1983) 
  16.11 15.90 14.95 n/a 12.68 
4 Verbal short-term 
memory 
WISC-R/WAIS Digit span forwards   6.4 C 5.8 5.5 A   
3(ii) Verbal short-term 
memory 
Digit Span forwards (WISC-III NL, 
2005) 
  7.43 7.39 6.96 n/a 6.24 
2 Sentence repetition NEPSY (1997) Mem & Learn 
subtest 
Scaled 10(3) 11.1 C  9.0 A   
4 Verbal working memory WISC-R/WAIS Digit Span 
Backwards 
  5.1 4.6 4.9   
3(ii) Verbal working memory Digit Span Backwards (WISC-III 
NL, 2005) 
  4.80 4.88 4.82 n/a 3.67 
3(ii) Verbal working memory Memory Search Using Letters 
(Amsterdam NP tasks, ANT, 
2005): Load 
Raw (Reaction 
time in 
seconds) 
 1322 C 1336 C 1600 A,B n/a 1759 
3(ii) Verbal working memory Memory Search Using Letters 
(Amsterdam NP tasks, ANT, 
2005): Distraction 
Raw (Reaction 
time in 
seconds) 
 1644 C 1658 1912 A n/a 2331 
3(ii) Verbal working memory Memory Search Using Letters 
(ANT, 2005): Load 
Raw(No. of 
errors) 
 5.65 6.52 7.97 n/a 11.64 
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 MEMORY and 
LEARNING 
VERBAL MEMORY 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
2 Memory and Learning NEPSY (1997) Domain Composite 100(15) 107  105   
4 Auditory verbal learning Rey’s Auditory Verbal Learning 
Test (RAVLT) 
Immediate word list recall 
Sum of words  55.9 C 52.1 52.0 A   
4 Delayed word list recall RAVLT (delayed recall)   12.9 C 12.0 11.5 A   
3(ii) Verbal LT episodic 
memory 
Learning capacity (15 Words Test, 
1986) 
  11.7 C 10.7 C 9.3 A,B,E  7.1 C 
3(ii) Verbal LT episodic 
memory 
Recall (15 words Test, 1986)   9.7 C 9.3 C 6.2 A,B  4.9 
3(ii) Verbal LT episodic 
memory  
Learning words (15 Words Test 
(1986) 
  B,C A A   
3(ii) Verbal LT episodic 
memory  
Recognition (15 Words Test 
(1986) 
  29.2 C 29.0 C 28.2 A,B  27.3 
3(ii) Verbal associative 
memory learning – 
learning capacity 
Learning Names (RAKIT, 1993)   9.3 C 9.1 C 6.5 A,B  5.5 
2 Memory for Names NEPSY (1997) Memory & 
Learning subtest 
Scaled 10(3) 10.1  10.0   
2 Narrative memory NEPSY (1997) Memory & 
Learning subtest 
Scaled 10(3) 12.4 C  10.7 A   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 VISUAL MEMORY    A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
4 Visual memory WMS-R: Visual reproduction test 
– immediate 
  38.2 37.1 37.3   
4 Visual memory WMS-R: Visual reproduction test 
- delayed 
  36.9 C 37.3 C 32.4 A,B   
3(ii) Visuospatial LT episodic 
memory 
Rey Visual Design Learning Test 
(RVDLT, 1991) – Learning 
capacity 
  9.5 C 9.1 C 6.5 A,B  4.7 
3(ii) Visuospatial LT episodic 
memory 
RVDLT (1991) – Recall   9.5 C 9.3 C 5.8 A,B  5.1 
3(ii) Visuospatial LT episodic 
memory 
RVDLT (1991) – Recognition   28.3 C 28.2 C 25.8 A,B  24.7 
3(ii) Visuospatial LT episodic 
memory 
Rey Complex Figure Test 
(RCFT)(1995) – Copy 
  26.7 C 25.0 C 20.8 A,B  17.8 
3(ii) Visuospatial LT episodic 
memory 
RCFT (1995) – Recall   15.2 C 13.6 C 8.3 A,B  6.8 
2 Memory For Faces NEPSY (1997) Mem & Learn 
subtest 
Scaled 10(3) 9.95  10.6   
2 Orientation NEPSY (1997) Mem & Learn 
subtest 
Scaled 10(3) 11.8  11.5   
2 Everyday memory Everyday Memory Impairment 
Score. (Sunderland and Baddeley 
(1983)) 
  17.8  19.0   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 EXECUTIVE 
FUNCTIONING 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(iv) Freedom from 
distractibility 
WISC-R (1974) Composite 100(15) 106 C 100 96 A   
4 Word generation 
(by letter) 
Controlled Oral Word Association 
Test (COWAT) 
  42.7 34.3 34.4   
4 Executive functions Wisconsin Card Sorting Test   5.7 5.3 5.2   
4 Inhibition Stroop Test Word   101.8 98.1 92.0   
4 Inhibition Stroop Test Colour   69.4 68.4 62.4   
4 Inhibition Stroop Test Colour-Word   44.4 C 40.8 35.1 A   
4 Attentional control Continuous Performance Test 
adapted (identical pairs) 
Median Rxn. 
Time (Secs) 
 554 654 589   
4 Attentional control Continuous Performance Test No. of errors  2.3 3.7 3.9   
2 Attention and Executive 
Function 
NEPSY (1997) Domain Standard 100(15) 115  109   
 EDUCATIONAL 
ATTAINMENTS 
Psychometric Test (Year 
Published) 
Score Metric Test Norms Control 
Group 
Mild HIE Moderate HIE: 
No Disability 
Moderate 
HIE: All 
Moderate 
HIE: With 
Disability 
 READING SKILLS    A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(ii) Reading Metropolitan Reading Test – 
Composite score 
Stanine 5(1.96) 4.3 4.4 3.8   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
1(ii) Language reading skills Metropolitan Reading Test 
(auditory memory, rhyming, 
school language and listening, 
quantitative language) 
Stanine 5(1.96) 4.0 4.1 3.7   
1(ii) Visual reading skills Metropolitan Reading test 
(letter recognition, visual 
matching) 
Stanine 5(1.96) 4.4 4.9 4.2   
1(iii) Word reading and 
reading passages 
McCracken Standard Reading 
Inventory (1966) 
% ≥ 1 grade 
below 
 15 C 13 C 35 A,B n/a 78 
2 Reading UK education curriculum level ≈% failed to 
reach UK peer 
level 
 16 C  39 A   
2 Speaking and listening UK education curriculum level ≈% failed to 
reach UK peer 
level 
 16  35   
 SPELLING SKILLS    A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(iii) Spelling Edmonton Spelling Abilities Test 
(1968) 
% ≥ 1 grade 
below 
 8 C 2 C 18 A,B n/a 72 
2 Spelling UK education curriculum level ≈% failed to 
reach UK peer 
level 
 29 C  50 A   
2 Writing UK education curriculum level ≈% failed to 
reach UK peer 
level 
 20  44   
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Study 
no. 
(Table 
1.4) 
Domain/Skill Psychometric Test 
(Year Published) 
Score Metric Test Norms Control 
Group 
 
(A) 
Mild HIE 
 
 
(B) 
Moderate HIE: 
No Disability 
 
(C) 
Moderate 
HIE: All 
 
(D) 
Moderate 
HIE: With 
Disability 
(E) 
 MATHEMATICS SKILLS    A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(iii) Arithmetic Keymath Diagnostic Arithmetic 
Test (Connolly et al. 1982) 
% ≥ 1 grade 
below 
 12 C 16 20 A n/a 83 
2 Shape, size and 
measurement 
UK education curriculum level ≈% failed to 
reach UK peer 
level 
 15  25   
2 Numbers and algebra UK education curriculum level ≈% failed to 
reach UK peer 
level 
 18  27   
2 Using and applying UK education curriculum level ≈% failed to 
reach UK peer 
level 
 22  30   
 EDUCATIONAL 
PROGRESS 
   A Signif. 
to 
B Signif. 
to 
C Signif. to D Signif. 
to 
E Signif. to 
1(iii) Educational 
attainments (reading, 
spelling, mathematics 
McCracken Reading, Edmonton 
spelling, Keymath 
Delay in at 
least one of 
reading, 
spelling, 
maths (%) 
 19 D 21 D n/a 36 A,B n/a 
1(iii) Curriculum/School Educational support - special 
class, resource help 
%  20 11 n/a 38 n/a 
3(ii) Curriculum/School Requires special education %  0 9.3 21.6  54.5 
1(iii) Curriculum/School Repeated a school grade %  5 12 n/a 21 n/a 
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NOTE: It was unclear from some research articles whether or not they investigated significant differences between mild and moderate HIE grade, or whether there were 
simply no significant differences to report for the study. Severe HIE groups and some impaired moderate HIE groups were not analysed in some of the studies due to 
obvious lower scores and low ‘n’. *Study 1(ii) did not report significance values for any mild NE vs comparison group scores. 
The between-group significance from research studies are presented using the letters A to E to indicate which columns differ. For example, the ‘control group’ column has 
been assigned the letter ‘A’, and labelled ‘A sig. to’ (‘A’ significantly different to..). Letters in superscript denote the column(s) to which the current column differs 
significantly. For example, 15C denotes that ‘15’ (the control group score) is significantly different to column ‘C’ (Moderate HIE group with no disability score). A Signif. to= 
Column A is significantly different to..; B Signif. to = Column B is significantly different to..; C Signif. to = Column C is significantly different to..; D Signif. to = Column D is 
significantly different to..; E Signif. to =Column E is significantly different to..; ‘A’=Control Group column; ‘B’=Mild HIE column, ‘C’=Moderate HIE: No Disability column, 
‘D’=Moderate HIE: All, ‘E’=Moderate HIE: With Disability. Mod=moderate grade; ‘Composite’, ‘scaled’, ‘standard’ relate to age-corrected standard scores; No.=Number; 
IQ=intelligence quotient; WISC=Wechsler Intelligence Scale for Children; BAS=British Ability Scales; R, rev=Revised; PPVT=Peabody Picture Vocabulary Test; MLU=mean 
length of utterance; SD=standard deviation; CA=chronological age; CELF=Comprehensive Evaluation of Language Function; Discrim=discrimination; STen=standard ten 
score; NEPSY=Neuro-Psychological Test Battery for Children; VMI=Visual Motor Integration; Dev.=Developmental; excl.=excluding; CP=cerebral palsy; STM=short term 
memory; WAIS=Wechsler Adult Intelligence Scale; NL=Netherlands; ANT=Amsterdam Neuropsychology Test; Mem=memory; Rxn=reaction; RAVLT=Rey’s Auditory Verbal 
Learning Test; LT=Long term; WMS-R=Wechsler Memory Scale - Revised; RVDLT=Rey Visual Design Learning Test; RCFT=Rey Complex Figures Test; COWAT=Controlled Oral 
Word Association Test; UK=United Kingdom.  
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Many would argue that the real-life implications for the altered learning styles of children 
following neonatal HIE are to be found in the analysis of their educational and school 
performance. To this end, a pattern of delayed school readiness, increased educational 
resource support and lower attainments in reading, spelling and mathematics are found 
when compared with peers at age 7 (75), or are at least one grade below peers by age 8 (74). 
A more recent study reported the following rates for children in receipt of special education 
for mild (9%), moderate (22%) and severe (55%) NE, compared with the comparison group 
(0%). See Table 1.5 for more detail. These educational delays are considerable, although this 
pattern is based on too few studies. 
The behavioural and emotional wellbeing of children following HIE has not received sufficient 
attention amongst researchers to date. Studies that have reported these outcomes have 
suggested that, when asked, parents and teachers reported higher rates of overall significant 
behavioural difficulties in the moderate (parents: 16%; teachers: 14%) and severe HIE 
(parents: 50%; teachers: 40%) groups compared with the comparison groups (parent: 9%; 
teacher: 11%). This reached significance for the severe group for parental reported 
hyperactivity and teacher reported hyperactivity and social/emotional areas (75). Attention 
difficulties were also rated higher in a Dutch cohort, although not high enough to warrant 
clinical diagnosis. Elevated (though not diagnostically significant) scores were also seen in 
social, anxiety/depression - and for mild HIE - thought problems (78). A Swedish study 
reported behavioural patterns in an adolescent cohort (aged 15-19 years) following 
moderate neonatal HIE, and found significantly higher scores on inattention and a screening 
tool for Asperger’s syndrome compared with peers (128). 
Some outcome studies controlled well for demographic variables, for example the Utrecht 
cohort controlled for maternal education (124), and the Robertson & Finer studies analysed 
confounding effects using regression analyses. Factors which contributed to the variance of 
scores included gender (74), family socio-economic status (SES) (74), maternal education 
(74), and also clinical confounding effects including low-birthweight for gestational age (119), 
abnormal discharge exam, and neonatal convulsions (58, 74, 119). Design issues that 
frustrated clear comparisons between studies were the different inclusion criteria, the 
retrospective assignment of encephalopathy grade, the exclusion of mild encephalopathy in 
some studies, and the varied reporting of moderate encephalopathy. Some studies provided 
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global outcome studies for moderate grade whilst others subdivided the moderate group 
into normal motor and/or IQ and abnormal IQ and/or motor outcome. 
Small and uneven numbers of groups reduce the validity of using inferential statistics. For 
example, in one study of only 8 children in the mild group, there were no statistically 
significant differences reported between the neuropsychological scores of mild HIE and a 
comparison group despite a consistent pattern of lower scores in the mild group (23). Some 
retrospective studies who sought recruitment in middle childhood have had lower uptake 
rates of children enrolled. For example, in one group of 7-year-olds, 58% of the potential 
study group were included (75). 
1.5.2 Childhood outcomes in the hypothermia trials 
The cohort data published from the major randomised controlled trials (RCTs) of the 
treatment effects of therapeutic hypothermia (Head cooling - ‘China’ study (42), CoolCap-
(head cooling in conjunction with milder body cooling) (18, 41); Total body cooling - NICHD 
NRN (16, 135-138), Toby (17, 41, 139), NEO.nEURO (43); ICE (out-born whole body cooling) 
(44)) allow not only the observations of treatment but also more up to date mortality and 
morbidity rates from their ‘normothermic’ control groups. RCTs recruited infants presenting 
with moderate or severe HIE within 6 hours of birth (with some analysis of mild HIE in the 
China and ICE studies), and randomly assigned them to TH for 72 hours or normothermic 
treatment conditions. Early childhood outcomes including comparison between 
normothermic and cooled babies are summarised in Table 1.6. Mortality rates in the cooled 
infants ranged from 20-38% compared with 27-57% in the control groups.  Overall, when the 
primary outcome of combined morbidity and mortality were studied, reduced rates were 
reported for cooled infants, significantly so in the majority of cases (see Table 1.6). 
Unfortunately, TH does not appear to be as an effective treatment for the most severely 
affected infants. Meta-analytic review of these studies report significant reductions  in the 
mortality  rates  for moderate and severe HIE, however only those with moderate HIE also 
displayed significant reductions in morbidity (45).
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Table 1.6 Mortality and morbidity rates at 18-24 months from the principal therapeutic hypothermia RCTs. 
Study Description of RCT Outcome measurement Cooled Normo-
thermic 
p-value 
(sig level) 
CoolCap (41) 1999-2002: >=36 weeks, clinical and aEEG dx, Sarnat 
grade II & III; Cooled at 6hrs for 72hrs. Cooled n=108; 
Control n=110 
Primary outcome: Death or severe 
disability at 18mths 
48% 66% 0.02 
(sig<.01) 
NICHD (40) 2000-2003: >=36 weeks, clinical signs to dx, 
mod/severe HIE; Cooled at 6hrs for 72 hrs. Cooled 
n=102; Control n=106 
Primary outcome: Death or mod-
severe disability at 18-22mths 
44% 62% 0.01 
(sig<.05) 
Toby (17) 2002-2006>=36 weeks, clinical and aEEG signs for dx, 
cooled n=163, controls n=162 
Primary outcome: Death or severe 
neurodisability at 18mths 
45% 53% 0.17 
NEO.n* (43) 2001-2006, >=36 weeks, clinical and aEEG/ EEG for dx, 
TH n=53, controls n=58. Whole body TH and morphine 
Primary outcome: Death or severe 
disability at 18-21mths 
51% 83% 0.001 
China (42) 2003-2005: >=37 weeks, clinical dx, Sarnat grades, 
head cooling. TH n=100, Controls n=94 
Primary outcome: Death or severe 
disability at 18mths 
31% 49% 0.01 
(sig<.05) 
ICE* (44) 2001-2007 >=35 weeks, clinical signs for dx, 
mod/severe HIE using Sarnat. Out-born infants 
treated with temporary ice pack in transit. TH n=107, 
Controls n=101 
Primary outcome: Death or major 
sensorineural disability at 24mths 
51% 66% 0.03 
(sig<.05) 
Study Domain assessed n/a Cooled Normo-
thermic 
p-value 
CoolCap (41) Death  33% 38% 0.48 
NICHD (40) Death  24% 37% 0.08 
Toby (17) Death  26% 27% 0.78 
NEO.n* (43) Death  38% 57% 0.09 
China (42) Death  20% 29% 0.16 
ICE* (44) Death  25% 39% 0.04 
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Study Domain assessed Outcome measurement tool Cooled Normo-
thermic 
p-value 
CoolCap Motor Severe Neuromotor (GMF 3-5) 19% 31% 0.12 
NICHD Motor Disabling CP 19% 30% 0.20 
Toby Motor Severe Neuromotor (GMF 3-5) 20% 31% 0.06 
NEO.n Motor Disabling (GMF 3-5) 13% 48% 0.007 
China Motor Cerebral palsy N=10 N=19 n/a 
ICE Motor Mod-severe CP 20% 22% 0.8 
CoolCap Development global Bayley overall <70 30% 39% 0.27 
NEO.n Development global Griffiths <2SDs 21% 57% 0.009 
China Development global Gesell <70 5% 21% 0.01 
NICHD Development mental Bayley II <70 (mental) 25% 39% 0.18 
Toby Development mental Bayley II <70 (mental) 24% 35% 0.09 
ICE Development mental Bayley (II/III) <70 mental 23% 28% 0.55 
NICHD Development motor Bayley II <70 (psychomotor) 27% 35% 0.39 
Toby Development motor Bayley II <70 (psychomotor) 24% 34% 0.09 
ICE Development mental Bayley (II/III) <70 mental n=26 N=28 0.81 
CoolCap Vision Cortical blindness 10% 17% 0.22 
NICHD Vision Blindness 7% 14% 0.20 
Toby Vision No useful vision 7% 11% 0.30 
NEO.n Vision Bilat. cortical visual deficit 3% 5% n/a 
ICE Vision Legal blindness 1 0 0.99 
NICHD Hearing Severe hearing impairment 4% 6% 0.47 
Toby Hearing Hearing loss not corrected by aids 4% 6% 0.31 
NEO.n Hearing Severe hearing loss 0% 12% n/a 
ICE Hearing Deafness req. amplification 2.5 3.4 0.75 
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*NEO.nEURO and ICE studies were abandoned early due to introduction of TH treatment for neonatal HIE during the course of this RCT. These studies had higher 
proportions of severe HIE due to out-born births, and treatment with opioids. Dx=diagnosis. Column header (sig level) refers to the significance level  (shown in brackets) 
set for the RCT where reported. 
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School age outcomes from the TH trials were recorded in three studies – the NICHD study 
(16, 135), the Toby Trial (139) and the CoolCap trial (18). The NICHD and Toby trials used the 
Wechsler scales to assess intellectual abilities and different versions of the NEPSY to assess 
neuropsychological functioning. The results are presented in Table 1.7. The ‘CoolCap’ trial 
reported 7-8 year outcome in the context of the predictive value of a standardised 
developmental score at 18 months of age (using the Bayley scale) and WeeFIM parent ratings 
of adaptive behaviour at 7-8 years, with a high correlation being reported for many of the 
adaptive behaviour domains measured at school age (18). 
Table 1.7 School age cognitive and neuropsychological outcome reported in the NICHD and Toby 
therapeutic hypothermia RCTs. 
TH RCT Test used Domain measured Score Metric Hypo-
thermia 
Normo-
thermic 
Controls 
P 
value 
NICHD WPPSI III/WISC IV Full Scale IQ Mean 81.9 75.3 0.22 
Toby WPPSI III/WISC IV Full Scale IQ Mean 103.6 98.5 0.07 
NICHD WPPSI III/WISC IV Full Scale IQ Percentage of 
scores < 70 
27% 33% 0.51 
Toby WPPSI III/WISC IV Full Scale IQ Percentage of 
‘normal’ scores 
77% 63% 0.05 
NICHD WPPSI III/WISC-IV Verbal IQ Mean 85.9 86.4 NS 
Toby WPPSI III/WISC-IV Verbal IQ Mean 105.2 101.1 0.16 
NICHD WPPSI III/WISC-IV Performance IQ Mean 91.3 90.5 NS 
Toby WPPSI III/WISC-IV Performance IQ Mean 101.1 96.7 0.12 
NICHD WPPSI III/WISC-IV Processing Speed Q Mean 93.2 92.4 NS 
Toby WPPSI III/WISC-IV Processing Speed Q Mean 98.7 95.3 0.22 
NICHD NEPSY Attention 
/Executive Function 
Mean 94.5 92.6 NS 
Toby NEPSY-II Attention 
/Executive Function  
Mean: 10(3) 9.6 8.6 0.03 
NICHD NEPSY Visuospatial Mean 98.5 96.5 NS 
Toby NEPSY-II Visuospatial Mean: 10(3) 10.4 9.6 0.17 
Toby NEPSY-II Memory & Learning Mean: 10(3) 10.0 9.4 0.18 
Toby NEPSY-II Sensorimotor Mean: 10(3) 8.1 7.1 0.06 
Toby Working memory 
Test Battery for 
Children 
Digit recall 
(auditory short-
term memory) 
Mean 104.1 106.1 0.54 
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TH RCT Test used Domain measured Score Metric Hypo-
thermia 
Normo-
thermic 
Controls 
P 
value 
Toby Block recall Visual working 
memory 
Mean 97.0 94.7 0.49 
Toby Digit span 
backwards 
Verbal working 
memory 
Mean 96.1 95.3 0.81 
Toby Manual ability 
classification 
system 
Manual ability Percentage of 
‘normal’ scores 
77% 61% 0.04 
*Standard scores have a mean(SD) of 100(15) unless otherwise stated, NEPSY subtest scores of 
10(3). TH RCT = Therapeutic hypothermia randomised controlled trial; NS= not statistically 
significant. 
1.5.3 Conclusion 
This section provides a review of the major studies describing long term outcome in children 
following HIE, categorised by encephalopathy grade. In sum, van Handel et al.’s 
recommendations remain relevant a decade after they were written (83) – that is, that a 
better grading system is needed which is sensitive enough to capture the gradual dose 
response effects of neonatal HIE, and further studies are required to determine whether HIE 
injury has a global dampening effect across the intellectual spectrum as measured by lower 
IQs and/or a distinct configuration of areas of intact and impacted thinking skills. Moreover, 
to associate these with severity and pattern of neural injury. Post the introduction of TH 
treatment we can add the questions of how and to what extent TH will alter these patterns. 
Investigation of the ways in which an initial hypoxic/ischaemic episode leads to brain injury 
which may have long term manifestations for the child, requires an acknowledgement of the 
complex nature of brain growth and development in childhood. The next section seeks to 
present features of brain development considered relevant to this area of inquiry. 
1.6 (Brain) Development in Childhood 
The study of the brain in childhood, especially from a psychological perspective has been 
heavily influenced by broader developmental theories of growth in childhood. The quality 
and relevance of longitudinal research involving children depends on the scientific value 
placed on the outcome measures that are chosen to represent stability and change over 
time. These outcome measures, in various guises, attempt to measure a subset of external 
behaviours that represent the internal thought and memory processes of the brain of the 
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individual. These measures have been influenced by the prevailing psychological paradigms 
and theories of their time. 
The enormous influence of ‘nature’ and ‘nurture’ theories have been central to the field. 
Sameroff, in a ‘rough history’ of the nature-nurture debate has summarised how this 
pendulum has swung over the past 130 years: 1880s-1940s – nature – research on inherited 
differences and instincts; 1920s-1950s - nurture – behavioural learning theories (behavioural 
reinforcement) and psychoanalytic theories; 1960-1970s – nature – ethology (species 
differences), behavioural genetics and cognitive psychology; 1980s-1990s – nurture – studies 
on poverty and social ecology; 2000-2010s – nature – molecular biology and neuroscience 
(140). The current state of play is that most researchers realise the integrated and bi-
directional influences between nature and nurture. 
1.6.1 Traditional Stage Theories of Development 
A number of stage models have been developed to describe the increasingly complex 
cognitive behaviours of humans across the lifespan. The most influential cognitive stage 
model of child development is that proposed by Jean Claude Piaget. Piaget’s central 
contention (based on child observation) was that if the child is provided with a stimulating 
environment in which to explore, they will construct their own knowledge of the world, 
constrained only by the maturational stage of their brain at any time. This promoted the idea 
of the child as an active agent in their own learning rather than as a passive recipient of 
‘taught’ knowledge. Table 1.8 summarises the cognitive stages of the model. Children 
achieve learning through mental representations of the world, called schema. When 
presented with a novel experience in the environment, the child either assimilates the 
experience into an existing schema, or makes accommodations to their schema to account 
for the new information (141). 
Table 1.8 Piaget’s stages of cognitive development (adapted from Santrock, 1998) (142). 
Stage Age Range Description 
Sensorimotor Birth to 2 years The infant progresses from reflexive, instinctual 
actions at birth to the beginning of symbolic 
thought. The infant constructs an understanding 
of the world by coordinating sensory 
experiences with physical actions 
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Stage Age Range Description 
Preoperational 2 to 7 years The child begins to represent the world with 
words and images; these words and images 
reflect increased symbolic thinking and to 
beyond the connection of sensory information 
and physical action. 
Concrete 
Operational 
7 to 11 years The child can now reason logically about 
concrete events and classify objects into 
different sets. 
Formal Operational 11 to 15 years The adolescent reasons in more abstract and 
logical ways. Thought is more idealistic. 
Adapted from: Santrock, JW. Child Development. 1998. Columbus, Ohio: McGraw Hill Publishers. 
The three main criticisms of his approach are, firstly, that the role of the adult or others in 
nurturing development was not fully considered, that Piaget relied on outward signs of 
behaviour as evidence for task mastery at any stage, and that there was insufficient evidence 
on the qualitative differences between each discrete stage of the theory to merit a stage 
model. Newer, more sophisticated research paradigms such as the measurement of eye-
tracking devices to study infant habituation to novel stimuli, suggest that Piaget 
underestimated the cognitive potential of infants aged 0-2 whose intent could not yet be 
fully demonstrated through intentional movement or speech (143). Additionally, 
neuroimaging studies can now show the intention of infants in the first year of life by 
observing evoked potentials of the brain areas responsive to environmental stimuli. 
1.6.2 Systems Theories of Development 
Systems theory has widened the lens through which child development is studied. Urie 
Bronfenbrenner’s influential social ecological systems theory (1977) (144) has been at the 
forefront in the social sciences, and has helped to articulate an argument away from a 
medical towards a social model of disability in the context of child development. 
This leads to the conceptualisation of the brain, whether intact or damaged, being nested 
within a baby, within a family, within a neighbourhood, within a society and the interactions 
between all elements of this system represents the totality of the child’s experience. It is 
argued that complex models such as these are required to account for the large number of 
confounding variance factors in predictive longitudinal studies (140).  
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In regard to HIE, as outlined earlier in Section 1.5, a handful of longitudinal studies have 
analysed the role played by demographic variables for child IQ, with gender, particularly 
maternal education level, and family income contributing to variance (74, 124).  In the NICHD 
NRN and Toby TH trials, the interaction effects of maternal education for child IQ were 
investigated with mixed results. Whilst in the Toby trial no interaction effect was found for 
maternal high school completion on the primary outcome of survival with intact IQ (139), in 
the NICHD trial, a prediction model using linear regression reported that children whose 
mothers had completed high school had adjusted IQs that were, on average, 7.5 points 
higher (p = .02), than for those children whose mothers hadn’t completed high school (135). 
These studies broadly follow what is already known about the influence of social and 
educational disadvantage on IQ scores. 
There is a dearth in HIE outcome studies in relation to the contribution that other family 
factors related to emotional connectedness, such as the availability to the infant of quality 
early warm reciprocal attachment relationships, the role of maternal mental health and 
parental coping styles will have on the wellbeing and subsequent outcomes for the child. 
However, there is a clear rationale for considering these issues given the knowledge base of 
how these issues can affect brain architecture, and lead to poorer social and cognitive 
outcomes for the child (145).  
In attempting to devise a unified theory of development, Sameroff has overlaid 
Bronfenbrenner’s social ecological model with a deeper within-child paradigm whereby the 
(nested) child’s self, comprises of psychological and biological processes that interact with 
each other. The specific biological and psychological elements are outlined in the grey and 
black spheres in Figure 1.2. This process model is developmental, in that the elements of the 
model undergo quantitative and qualitative shift and growth from birth throughout 
childhood into adulthood. 
 [49] 
 
 
Figure 1.2 Sameroff’s Biopsychosocial Ecological model. Reprinted from Child Development, 81(1), A 
Sameroff, A Unified Theory of Development: A Dialectic Integration of Nature and Nurture, pp 6-22, 
Copyright (2010), with permission from Wiley Publishers 2010, © the Author(s). Journal 
Compilation_2010, Society for Research in Child Development, Inc. All rights reserved.0009-
3920/2010/8101-0002. 
In the words of Sameroff: 
“Over time the body changes, the brain changes, the mind changes, and the environment 
changes along courses that may be somewhat independent of each other and somewhat a 
consequence of experience with each other.” (2010, p. 20) (140). 
1.6.3 Neonatal Brain Injury and Future Development 
Structural definitions of injury (i.e. site of damage) are not sufficient to explain learning 
outcomes. The consequent experience of HIE also plays a role, and there are individual 
differences (146) to injury response. 
In order to understand the processes by which early damage affects later outcome there are 
a number of issues to be considered: (i) the skill being assessed at one time point represents 
a location on the assumed trajectory path for that skill (e.g. language - see Figure 1.3); (ii) 
this trajectory is influenced by the maturational status of the CNS (see Figure 1.4); (iii) early 
damage alters the course of these trajectories. Therefore, the call for repeated measures 
assessment in longitudinal designs is crucial. In the case of children with HIE, these 
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considerations have taken on a new light with emerging theories of HIE damage now 
including a tertiary phase of injury extending weeks if not years into life with richer evidence 
of, for example, delayed myelination and poorer white matter connectivity (24, 30). If true, 
these considerations about developmental trajectories become more important to the field. 
 
Figure 1.3 Human brain development. Reprinted from The Lancet, 369(9555), S Grantham-McGregor, 
Y.B. Cheung, S. Cueto, P Glewwe, L Richter, B Strupp et al., Developmental potential in the first 5 
years for children in developing countries. pp 60-70, Copyright (2007), with permission from Elsevier 
Publishers. Adapted from original graph by Thompson and Nelson 2001, p.8. (147). APA granted 
permission for reuse. 
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Figure 1.4 “The stages of brain development (top) and different windows of vulnerability (bottom). 
Developmental processes occur in phases, setting the stage for potential periods of vulnerability. 
Insults early in life (bottom) will be assimilated into innervation patterns, whereas a later pre-
pubertal insult will cause functional changes that are more adaptive.” Reprinted from Neuroscience 
& Biobehavioral Reviews, 27(1-2), S. L. Andersen, Trajectories of brain development: point of 
vulnerability or window of opportunity?, pp 3-18, Copyright (2003), with permission from Elsevier 
Publishers (148). 
 
1.6.3.1 Early Plasticity or Early Vulnerability? 
The role that neurodevelopmental processes play in the eventual consequences for a child 
who has experienced brain injury is unquestionable (149). There are conflicting theories in 
the field of developmental cognitive neuroscience in relation to whether brain injury, 
inflicted early in life is ‘preferable’ in developmental terms when compared to injury 
acquired later in childhood. 
This role was initially investigated in the early studies of Kennard in the 1930s, and Hebb in 
the 1940s with conflicting results. Kennard compared the effects of acquired unilateral injury 
to the motor cortex of monkeys in infancy to that acquired in adulthood. These studies 
demonstrated better recovery for early onset lesions, and Kennard was one of the first to 
posit that this may be due to functional abilities arising from cortical reorganisation, perhaps 
recruitment of intact brain tissue in the contralateral hemisphere (‘Kennard’s principle’) 
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(149-151). This suggests that injury sustained earlier in life has a better outcome than injury 
acquired later, due to brain plasticity. Studies of children following left-sided perinatal stroke 
show considerable development in language skills that would not be observed for adult-
onset stroke. However, whilst many language skills do develop, they are not equivalent to 
those of their peers in many subtle ways, and they reflect a pattern of delay and catch up 
throughout childhood. Furthermore, language skills may demonstrate more potential for 
plasticity than, for example, spatial cognition (152, 153). For activities that require 
recruitment of different functional brain regions,  for example in the case of emotion 
labelling, less functional recovery from focal lesions is observed (152). Of late, the 
suggestions of an interactional effect of plasticity has emerged which stresses how the injury 
‘becomes a factor in the developmental trajectory of the individual child’ p.20 (153). 
In contrast to the plasticity thesis, the work of Hebb suggests, based on studies of children 
with frontal damage, that early injury may be deleterious because damage is occurring at a 
time when the brain is in the initial stages of organisation (151). This alternative early 
vulnerability model has re-emerged and recently gained support, as seen in the work of Vicki 
Anderson and colleagues (154). In a well-designed study that sought to compare the 
developmental impact of focal brain injuries at different times in childhood, it was found that 
injuries acquired at six different time points – early prenatal (1st-2nd trimester), perinatal 
(3rd trimester to month 1 of life), infancy (2 months to 2 years), preschool (3 to 6 years), 
middle childhood (7 to 9 years), and later childhood (10 years and over), could be collapsed 
into those that sustained injury before and after three years of age. For cognitive skills 
measured in adolescence, age at insult was the strongest predictor of outcome and an injury 
acquired before 3 years of age was associated with more severe and diffuse learning 
difficulties. However, the findings are confounded by other differences between the groups 
other than age, including the cause of injury, which tended to be developmental in those 
under three years, and traumatic after 3 years with higher burden of seizures in the younger 
group (155, 156). These results are interpreted in the context of the early vulnerability model 
suggesting that early injury disrupts neural pathways which have not met a level of maturity 
to avail of sparing of what has already been learned. This damage may also impact the future 
pattern and quality of neural circuitry.   
In the context of HIE, a recent ‘tertiary injury’ model has proposed that inflammatory 
responses lead to long term epigenetic and other difficulties that alters the brains ability to 
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learn and remember, because it interferes with the brain’s neurogenerative capacities (30, 
31). This supports the early vulnerability model described above. 
Although much remains unknown about the specific damage processes of HIE, three results 
are of relevance to the current study. Firstly, diffuse early injury to an immature brain is not 
good, especially in the perinatal period during cell migration, proliferation, axonal/dendritic 
growth and myelination. Secondly, similar outcome behaviours may mask recruitment of 
different brain locations and networks to achieve the behaviour, and, tracking this over a 
longer period of time can reveal compromised functioning in higher order tasks. Thirdly, the 
environment and the child’s experiences modulate plasticity of the damaged brain. Thus 
research models need to track functional reorganisation at different developmental stages 
of childhood (157, 158).  
1.6.3.2 Protracted Development 
Recent advances in the discipline of developmental neuroscience have revealed patterns of 
protracted development in some areas. Previous estimates of the age at which different 
brain regions reach full maturity have now been extended. In the case of prefrontal cortex 
for example, full neural maturity is not completed until well into adulthood. This has 
implications for the requirement to continue assessing different domains of learning until 
maturity is reached. Animal studies have shown that if a skill is assessed too soon in 
development, the results merely reflect immaturity of the skill in both the brain-injured and 
the comparison group. Once the brain area under study has matured, the comparison group 
will display expected skill competence and this can be used as a benchmark for the brain-
injured group (76). This implies that follow-up of children up to 24 months as described in 
most studies, precludes valid assessment of future emerging cognitive and 
neuropsychological processes especially those dependent on prefrontal cortex maturity such 
as executive functions like planning, attention and inhibition. 
The time course for synaptic proliferation and later pruning differs per brain region, and, 
consequently for the behavioural outcome being measured. For example, synaptic density 
in the visual cortex reaches adult levels by preschool age. In the prefrontal cortex this is not 
complete until adulthood. Similarly, myelination is greatest in the first two years, but 
continues in the white matter until adolescence (159). Longitudinal studies of children 
following a perinatal injury revealed that the children’s IQs were significantly lower after the 
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age of seven years than at an earlier time-point. Importantly this finding did not reflect loss 
of knowledge but rather a slower rate of development than in the normative population 
(152). 
The next section will review pertinent longitudinal study design issues in light of the 
aforementioned discussion of explanatory models of brain damage in a developmental 
context. 
1.7 Outcome Studies – Design Issues 
1.7.1 Neurodevelopmental Outcome Research: Theoretical and Design 
Considerations 
Neurodevelopmental outcome research is inherently complex because the constructs being 
measured are evolving over time. Schmidt and Teti (2006) contend that longitudinal research 
identifies age-related developmental change and employs the following variables: age, 
cohort and time. These are often given different emphasis especially as different disciplines 
have different theoretical preferences (e.g. psychologists might focus on ‘age’). It is argued 
that these phenomena cannot be isolated to constitute true independent variables, and 
require multi-disciplinary expertise and complex models for investigation (160).  
The non-linearity of human development calls for multiple repeated measures over time to 
capture differential effects of growth and the effects on changing developmental trajectories 
and to tap differential developmental outcomes. This is especially true to capture brain areas 
with more protracted maturity as outlined in the previous section.  
Prospective studies can lead to an understanding of the mechanisms by which a brain that is 
damaged before a cognitive system has been realised (e.g. language), can adapt by 
generating alternative neural organisations for that behavioural function (152), and whether 
(or not) this leads to a functional compromise in another cognitive system. These can also 
track the optimum times for plasticity factors and the brain’s ability to accommodate for the 
loss by changing the underlying sites for which the purpose was developed. For example, 
children with left hemispheric lesions develop language but at a cost to the normal 
development of the spatial areas of the right hemisphere. 
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Annaz et al. (161), describe the importance of tracing developmental trajectories using a 
‘neuroconstructivist’ approach, because of the possible ‘cascading’ effects of a small 
impairment on future mental attainments. They argue that a phenotype measured at one 
time point is limited in the information it can provide about predictive validity because what 
is ideally required is to observe (i) how the phenotype originated at the beginning of a 
developmental trajectory as well as (ii) knowing where it will lead in the future trajectory. 
This is especially true of an atypically developing brain, where a small insult could alter the 
usual interconnectivity of early cortical development later permeating all parts of the cortex. 
Neurodevelopmental outcome studies benefit from being theory and method driven. 
Friedman et al. caution against the temptation to be driven by the availability of outcome 
assessment tools  (162). Choosing ecologically valid, psychometrically sound, standardized 
tools enhance comparisons across disciplines and between research protocols. The need for 
uniformity in test methods across studies is particularly important, because the use of 
outcome measures can be a major source of bias in research trials (163). The challenge lies 
in finding measures that allow for meaningful description of continuity and change (164), 
that are reliable and valid (see Figure 1.5) 
 
Figure 1.5  Pictorial representation of reliability and validity measures, where the bulls eye represents 
the concept being assessed. (original source unknown). Available at © Nevit Dilmen [CC BY-SA 3.0 
(https://creativecommons.org/licenses/by-sa/3.0) or GFDL (http://www.gnu.org/copyleft/fdl.html)], 
via Wikimedia Commons 
In conclusion, well designed, long-term developmental outcome studies in conjunction with 
electrophysiological and scanning techniques may enable us to better link neurocognitive 
outcomes to lesion areas, or timing of injury if demonstrable on scanning. Interpreting 
“neuroimaging of the developing brain involves a theoretical attitude of mind, a truly 
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developmental framework, and a focus on progressive change.” (Karmiloff-Smith, 2010, 
p.937) (165). 
In order to improve our understanding of the utility and validity of the assessment of 
neurodevelopmental outcome, it has become clear that a more unified model to help link 
the progression of knowledge and skills acquisition through childhood needs to exist. From 
neurological assessment in the neonatal period through developmental assessment in early 
childhood to assessment of cognitive and neuropsychological processes in school age 
children, prediction will only improve if the theoretical links are strengthened through the 
inclusion of behavioural criteria that can be measured over time (166). This begins with 
primitive reflexes and ends with higher order thinking (167). 
These types of assessment will now be reviewed in more detail. 
1.7.2 Developmental Assessment 
Some of the earliest well defined longitudinal studies of infants resulted in the publication of 
childhood development scales. These include Arnold Gesell’s (1880-1960) work on motor 
development at Yale and Bayley’s work on intellectual, social and motor development at 
Berkeley in the late 1940s. These were, in the main, descriptive in nature (168). Gesell was 
in conflict with the main influence of behaviourist theories of the time, and he believed that 
child development was a maturational process that unfolded in a predetermined sequence. 
In addition, he was one of the first to recognise that different domains of child development 
are interdependent (168). Scales developed from these works including the Gesell and 
especially the Bayley scales are in widespread use to this day. The majority of the early 
childhood developmental tests assess the following domain areas – gross motor, fine 
motor/eye-hand coordination, language, cognitive and personal/social/adaptive 
functioning. 
Dr. Ruth Griffiths was a pioneering psychologist and medic who systematically observed the 
natural development of hundreds of babies, infants and young children. This work resulted 
in the publication of the Griffiths Mental Development Scales. In her 1954 publication, ‘The 
Ability of Babies’ she outlined a sophisticated ‘avenues of learning’ model (see Figure 1.6) 
which acknowledged the intrinsic and environmental factors which influence infant 
developmental milestones acquisition (169). 
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Figure 1.6 Ruth Griffiths’ ‘Avenues of Learning’ Model. Reprinted from R. Griffiths. The Abilities of 
Babies. Copyright (1954). Permission granted from ARICD (Association for Research in Child 
Development). © ARICD. 
 
The literature demonstrates that in the general population the ability of early developmental 
assessment to predict school age cognitive outcome is relatively poor. However, in the 
clinical population, the predictive value improves significantly (170). 
Early developmental assessment may not be sensitive enough to capture the later-emerging 
deficits that, for example in our case, mild grade HIE might be associated with. 
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It has been suggested that for developmental tests, assessments at 6 months capture genetic 
data but as a child grows into the second year the impact of the quality of the environment 
plays a larger role as the child must use their potential skills in real settings (171). Test-retest 
reliability values are much better in the second year than the first year, showing the 
individual rates of development in normally developing infants (172). 
Some criticisms of developmental assessments are that they have high false positive rates in 
early childhood, that some difficulties persist whilst others are transient, and that there is 
high variability and discontinuity in early development (57). 
1.7.3 Assessment of Intellectual Ability 
Intelligence is a social construct, that since the turn of the 20th century has been bound up in 
the notion of how it is assessed. The original rationale for assessing intelligence emerged 
from the focus on methods of quantification and diagnostics in medicine, education and 
psychology at the turn of the 20th century and for the measurement of the suitability of 
children for education. 
In its current form, ‘intelligence’ - as assessed by the most commonly used IQ tests - is based 
on an underlying general mental ability potential, called ‘g’, which is a well-supported 
construct based on Spearman’s factor analysis. IQ tests measure ‘fluid’ (our inherent 
potential) intelligence and ‘crystallised’ intelligence (acquired knowledge). The notion that 
the totality of human intellect can be found in the results on an intelligence test is a 
contentious one. The principal criticisms relate to this being too reductionist, and the fact 
that significant cultural bias may exist in this type of assessment. 
IQ tests reflect a more traditional model of intelligence which favours analytical and 
quantitative skills, which are generally highly valued by many societies. This contrasts with 
more recent models of intelligence proposed in the main by Robert Sternberg and Howard 
Gardner, which use a broader model including creativity and other domains (173, 174). 
The content of intelligence tests differs but typically include verbal tasks such as word 
vocabulary, comprehension, general verbal knowledge, visual tasks such as block design, 
matrices; processing speed tasks and working memory tasks. The quality and accuracy of 
intelligence tests depend upon their underlying psychometric properties and the extent to 
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which the standardisation sample represents the actual population. The most commonly 
used tests for children are the Stanford-Binet, Wechsler, British Ability Scales and Kaufman 
tests. Over the past twenty years, revised versions of IQ tests have included indexes and 
subtests that have been more theory-driven. Most notably, they have been influenced by 
the Cattell-Horn-Carroll (CHC) theory of multiple cognitive abilities, which, through detailed 
factor analytic studies, have developed a set of broad and narrow abilities. Broad abilities 
include fluid intelligence, crystallised intelligence, visual processing, short-term memory, 
long-term storage and retrieval, auditory processing, processing speed, and quantitative 
knowledge. Researchers have suggested that the CHC model of abilities provides a common 
language or taxonomy that can be used across different IQ tests to describe the underlying 
constructs measured and as an important tool for interpretation of test scores (175).  
Results on IQ tests are associated with genetic, environmental and epigenetic factors. One 
study suggests that a child whose parents are educated, and who is nurtured both physically 
and intellectually is 24 times more likely to have a higher IQ than a child with 4 or more 
environmental risk factors such as low parental education, parental mental health 
difficulties, command-led discipline, and/or stressful life events (Sameroff, 1989) (176). 
1.7.4 Neuropsychological Processes 
The functional correlates of neurological changes are not simple and need to be 
contextualized in terms of the impact of neurological damage on active developmental 
trajectories. This forms the basis for the need for neuropsychological assessment which is 
unique in its ability to track functional domains, which can allow for the observation of the 
impact of a lesion on complex cognitive processes such as the ability to remember something 
or selectively attend to something. 
In Alexander Luria’s influential text, ‘the Working Brain’, he described the importance of 
neural networks between brain regions, and how the brain processes information. “In early 
childhood a lesion of a brain area responsible for relatively elementary mental activities 
inevitably provokes a secondary ‘system’ effect manifested in underdevelopment of higher 
superposed structures” (Luria, 1973a, p.75, cited in Glozman (2013) pg11 (177)). His writings 
have influenced the development of a variety of neuropsychological assessment 
instruments, because he emphasised the importance of qualitative clinical observations, and 
believed much could be gleaned about a person’s learning, through the observation of the 
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error patterns made on cognitive tasks, thus revealing difficulties with underlying processes 
(178). 
Neuropsychological follow-up can also contribute to the measurement of ‘high 
prevalence/low severity dysfunction’ (p.234) termed by Aylward to describe the myriad of 
attention and executive behaviours that are sensitive to neonatal brain damage. It allows the 
measurement of mental activities at the process level. These mental activities have systemic 
effects across different domains of learning (177), and are less influenced by environmental 
factors as they more directly observe underlying physiological functions (179). 
Neuropsychological tasks have the advantage of measuring skills at a more basic level than 
IQ subtests (180), however, subtest content will require different sensory, motor and 
cognitive demands (the aforementioned ‘elementary mental activities’) which recruit 
different brain regions and influence a child’s performance. It is therefore critical to consider 
the contribution of these underlying basic element skills to the child’s score (181). Indeed, 
these elements will have cross-domain influence. For example, if processing speed is the skill 
of interest, scores are dependent on the task demands, which may include memory, 
scanning, auditory, verbal, or visual-motor demands. 
One test developed specifically developed for use with children is the NEPSY tool. It is based 
on a process-based Lurian model (178),  within a developmental theoretical context, and not 
as a downward extension of an adult scale (182, 183). It measures components of attention 
and executive functioning, language, memory and learning, sensorimotor, visuospatial 
processing and social perception. The subtests contributing to each domain contain both 
basic and complex components. Some elements of these components will affect 
performance on tasks across other domain areas. The intra-domain subtest reliability 
correlations are also low as different tasks within the same domain areas recruit different 
brain regions, for example memory for faces compared with memory for names.  
Patterns of deficit are age-dependent. The age at which neuropsychological outcomes are 
measured reflect the task performance at a certain time-point for a dynamically maturing 
brain, capturing measurements of brain processes at varying stages of maturation. Different 
brain regions are recruited at different ages for the same cognitive task, as learning becomes 
more automated with maturity (184). Low scores may reflect transient delay which catches 
up with time (71, 185), or more pervasive difficulties. Likewise, a ‘normal’ score may reflect 
a robust normal score, or a score measuring a developmentally immature skill which is not 
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yet sensitive to later emerging difficulties when the load on this skill increases (24, 149, 186). 
This example demonstrates the need for interpretation in a developmental context and the 
importance of repeated assessments across childhood. 
1.7.5 Conclusion 
This section has provided an overview of important design issues to consider for longitudinal 
research that aims to capture neurodevelopmental skills in a developmental context. This 
acknowledges the challenges faced in determining patterns of learning in a dynamically 
growing brain. This subsection was followed by a description of standardised developmental 
assessments, IQ assessments and neuropsychological tests, and their potential for the 
measurement of neurodevelopmental outcome. 
1.8 The Current Project – Rationale and Aims 
1.8.1 Rationale 
The long-term outcome for children who have experienced neonatal HIE has attracted 
considerable research interest because of the devastating neurodevelopmental 
consequences experienced by a considerable proportion of these children. The era of 
therapeutic hypothermia hopefully marks the beginning of a new wave of potential 
treatments for neonatal HIE. In the meantime, ongoing research that can contribute to an 
enhanced understanding of the neurodevelopmental vulnerabilities in the long term can 
support infants and their families/carers with informed knowledge of the condition, make 
recommendations for the type, frequency and age at which ongoing assessment and 
monitoring should be offered during early and middle childhood, and may enhance 
understanding of the neurocognitive effects of the neural damage caused by HIE. 
Much is known about the mortality and severe morbidity caused by HIE, but less is known 
about the long term subtle neurodevelopmental adverse sequelae in this population. This 
casts a light on the importance of using sensitive psychometrically valid cognitive tools that 
can identify these difficulties over developmental time. In addition, the time-sensitive nature 
of therapeutic intervention increases the importance of assessing the evolving nature of HIE 
in the neonatal period, especially when treatment decisions such as the administration of TH 
are only currently offered to those infants who meet a moderate or severe encephalopathy 
criteria within six hours of birth. The ability of early assessment tools such as continuous EEG 
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and Sarnat grading systems have taken on a new importance, and their predictive ability for 
later outcome becomes more valuable. This is especially true for moderate grade 
encephalopathy which appears heterogenous in nature, and emerging isolated long-term 
studies which have found neuropsychological difficulties in children diagnosed with mild HIE 
at birth. Because infants with mild HIE were not recruited to the recent TH RCT cohorts, their 
long-term outcomes have not been as well documented. Thus, the importance of the 
continued surveillance of all children with HIE is warranted. 
1.8.2 Aims 
 The aim of this PhD thesis is to assess the long-term neurodevelopmental outcome in a 
cohort of term infants who have experienced neonatal HIE in an Irish-born population. These 
infants, who were born shortly before the widespread introduction of TH treatment, have 
previously received (i) detailed neurological assessments shortly after birth; (ii) early 
continuous EEG monitoring for up to 72 hours, commenced within 6 hours of birth; (iii) serial 
detailed neurological and developmental assessments up to the age of 2 years. The specific 
objective is to examine the association of the neurological, cognitive and neuropsychological 
outcome data with the early Sarnat grading and the continuous early EEG background 
grading. In doing so it is hoped to identify the utility of these grades in the prediction of 
outcome at five years. A community comparison sample of children with normal neonatal 
neurological and EEG findings will be assessed at five years with an identical battery of the 
neurodevelopmental assessments. 
The specific aims of the thesis are: 
1) To investigate the predictive value of serial neurological assessments in the first 
neonatal days with developmental outcome at 6, 12 and 24 months. It is hypothesised 
that later neurological assessment will better stage neonatal HIE and therefore 
provide more accurate prediction of outcome. Closer inspection of the ATNAT items 
will be undertaken in relation to their associations with five-year outcome. 
2) Track the neurodevelopmental course of these children across early childhood, using 
detailed assessments at 6, 12, 24 and 60 months. Furthermore, to compare the 
predictive values of standardised developmental assessment at 6, 12 and 24 months 
with cognitive and overall outcome at 5 years. It is hypothesised that assessment at 
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24 months will provide the best prediction due to the higher order cognitive processes 
that are available to measure at this age. 
3) To compare the five-year outcomes between the HIE and comparison cohorts of 
children, and to investigate the role of mild, moderate, and severe HIE assignation, 
graded with both early EEG and clinical assessment. Furthermore, to compare the 
predictive value of an EEG background feature grade assessed at 6 hours and 24 hours 
of age with five-year outcome. 
4) (a) To describe the neuropsychological abilities of children at five years following 
neonatal HIE, and to investigate whether the scores of those with normal motor and 
IQ outcome will differ from the comparison group. It is hypothesized that 
neuropsychological difficulties will be present in children following HIE with otherwise 
normal motor and intellectual outcome;  
 
(b) To compare the neuropsychological findings at five years of all children with all 
Sarnat and EEG grades with the comparison group. It is hypothesised that each Sarnat 
and EEG grade of the HIE group will have poorer outcome than the comparison group 
in a ‘dose-response’ fashion. 
5) To improve understanding of visual outcome following HIE, by describing 
comprehensive vision outcome in five-year-old children to include ophthalmic and 
orthoptic measures, and to compare the findings with developmental and cognitive 
assessment. 
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CHAPTER 2 
2 Methodology 
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2.1 Participants 
2.1.1 HIE Sample 
2.1.1.1 Neonatal Measures 
The HIE sample was comprised of a prospective cohort of 65 newborn term infants 
(gestational age (GA) ≥ 37 weeks) who experienced neonatal HIE. They were recruited to a 
previous study based in three Cork maternity hospitals between May 2003 and December 
2005. The inclusion criteria at birth for HIE was 2 or more of the following: 
- Initial pH < 7.1; 
- Apgar score < 5 at 5 minutes; 
- Lactate > 7mmol/L; 
- Abnormal neurology or seizure. 
Infants were excluded if they presented with co-existing congenital anomalies, or significant 
co-morbidity. 
The previous researcher (Dr. Deirdre Murray) (187) recorded comprehensive clinical data in 
the neonatal period. Abnormal neurology was assessed using the Amiel-Tison Neurological 
Assessment at Term (ATNAT). This was evaluated daily for the first three days (see Appendix 
J). A separate neurological examination by NICU staff at discharge was completed. This exam 
was graded as follows: ‘0’ for normal, ‘1’ for moderate with any suspect findings such as head 
lag, and ‘2’ for severe signifying significant neurological abnormalities (increased peripheral 
tone, poor suck, marked head lag). Time to commencement of oral feeding was also 
recorded. 
A modified Sarnat encephalopathy grade was assigned at 24 hours. The modified version was 
used to exclude EEG criteria as this was separately evaluated. These grades are summarised 
in Table 2.1 (14, 188). 
Table 2.1 Modified Sarnat Score based on Levene et al. criteria (188) 
Grade I 
(mild) 
Grade II 
(moderate) 
Grade III 
(severe) 
Irritability Lethargic Comatose 
‘Hyperalert’ Seizures Prolonged seizures 
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Grade I 
(mild) 
Grade II 
(moderate) 
Grade III 
(severe) 
Mild hypotonia Marked abnormalities of tone Severe hypotonia 
Poor sucking Requires tube feeding Failure to maintain 
spontaneous respiration 
Early continuous video-EEG (v-EEG), was recorded from within the first 6 hours of life and 
continued until 24-72 hours. A bedside 16 channel Viasys NicOne Video-EEG system was used 
to record multi-channel EEG using the 10-20 system of silver-chloride electrodes placement 
modified for neonates (189) (See Figure 2.1). The electrodes were placed at F3, F4, C3, C4, 
T3, T4, O1, O2 and CZ. 
The EEGs were graded according to background activity, as follows: Grade 0 (normal) - 
continuous background pattern with normal physiologic features; Grade 1 (normal/mild 
abnormalities) - continuous background pattern with slightly abnormal activity (mild 
asymmetry, mild voltage depression, or poorly defined sleep wake cycle (SWC); Grade 2 
(moderate abnormalities) – discontinuous activity with inter-burst interval (IBI) of <10s, no 
clear SWC, or clear asymmetry or asynchrony; Grade 3 (major abnormalities) – discontinuous 
activity with IBI of 10-60s, severe attenuation of background patterns or no SWC; Grade 4 
(inactive EEG findings) – background activity of < 10µV or severe discontinuity with IBI of 
>60s (105). 
 
Figure 2.1 Recommended modification of 10-20 montage for neonatal EEG (189). The electrodes in 
bold mark the placements for the neonate. Figure from Boylan, GB. Principles of EEG. In JM Rennie, 
NJ Robertson, CF Hagmann (eds) Neonatal Cerebral Investigation.2008. p.3-21. Cambridge:  
Cambridge University Press (87). With permission. 
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Clinical markers for HIE were recorded. These included initial pH, base deficit and lactate 
levels (mmol/L) within 30 minutes of birth. Time to normal lactate, Apgar scores, and 
nucleated red blood cell counts were taken. Clinical data pertaining to the time of injury 
comprised cardiotocograph (CTG) (foetal heart trace readings) readings from the maternal 
file notes, and maternal antenatal data was reviewed retrospectively by Obstetricians.  
2.1.1.2 Follow up at 6, 12, and 24 months 
Long term neurodevelopmental outcome was measured at 6, 12, and 24 months using the 
Griffiths Mental Developmental Scales (0 - 2) – Revised version (GMDS-R) (172). It was used 
to obtain standardised developmental assessments. Children were seen by Dr. Deirdre 
Murray, a Griffiths’ certified trained paediatrician either at home or at the outpatients’ clinic. 
A neurological examination assessing peripheral tone, axial tone and deep tendon reflexes 
was completed on each occasion (see Fig 2.4 for flow-chart of HIE cohort).  
The Griffiths is a standardised assessment of infant and child development and was chosen 
for its clinical utility, psychometric properties and ecological validity. The scales were 
scientifically constructed based on item analysis and developmental theory. Items are 
categorised into five subscales, ‘Locomotor’, ‘Hearing and Language’, ‘Personal-Social’, ‘Eye-
Hand Co-ordination’ and ‘Performance’, with standardised subscale means ranging 100.2–
101.1 (15.9–16.3) for the standardisation sample (172). The overall Griffiths’ developmental 
quotient (GDQ) mean is 100.5 (11.8). An ‘abnormal’ score in this study was considered a GDQ 
≤88. 
2.1.2 Comparison Sample 
The comparison sample was originally recruited to a birth cohort study (n=80) of healthy 
neonates born in the same Cork maternity hospitals as the HIE cohort between October 2005 
and August 2007. These infants had been recruited in the postnatal wards at birth (by Dr. 
Irina Korotchikova) and the study aimed to examine normal neonatal brain functioning as 
measured on continuous video EEG (94). The inclusion and exclusion criteria are outlined in 
Table 2.2. For outcome, all children from the cohort who met the age criteria at the time of 
testing were contacted for follow-up (n=42). A flow chart outlining the cohort flow from birth 
to five can be found in Figure 2.4.  
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Table 2.2 Inclusion and exclusion criteria for recruitment of the comparison sample at birth. 
Inclusion Criteria (comparison group) Exclusion Criteria (comparison group) 
Gestation ≥ 37 weeks Maternal epilepsy or diabetes 
No requirement for resuscitation Birth weight < 2.5 kg 
Apgar scores > 8 at 5 minutes Congenital anomalies 
Normal cord pH (>7.1) Admission to the neonatal unit for special 
or intensive care 
 
2.1.3 Sample Characteristics 
The hospitals where both cohorts were born were the sole maternity service-providers to 
the Cork City and County areas in Southern Ireland, and served public and private patients. 
This was beneficial because all children resided in the hospitals’ catchment area representing 
mixed urban/rural and SES areas, and it also controlled for potential differences in obstetric 
and neonatal care services. Furthermore, the comparison cohort had EEG confirmed normal 
neonatal neurology from which to compare our HIE group.  
To examine the representativeness of the study samples, Table 2.3 outlines key neonatal and 
demographic variables for the HIE and Comparison groups at 5 years. Relevant information 
from the total HIE cohort was also available. Additionally, data from Ireland’s largest national 
birth cohort study, the ‘Growing Up in Ireland: National Longitudinal Study of Children’ (190) 
was included, which recruited 11,100 families to their infant cohort in 2008. This provided a 
national reference for the comparison cohort. Of note, our Comparison group is generally 
consistent with the national cohort, however boys are underrepresented, and more of the 
births followed an unassisted delivery. The proportion of mothers who had completed 
secondary level education was very consistent across the groups. A detailed comparison 
between the HIE and Comparison group children at age five-years on clinical and 
demographic factors can be found in Table 5.2 in Chapter 5. 
 
  
[7
0
] 
Table 2.3 Birth and demographic variables for the HIE cohort, Comparison cohort, and Growing Up in Ireland National Infant Cohort 
Variable HIE Cohort at 5 years 
(n=47) 
HIE Birth 
Cohort: Total 
(n=65) 
Comparison Birth Cohort at 
5 years (n=30) 
Growing Up in Ireland 
National Infant Cohort 
(n=11,100) 
Gender: male n (%) 28 (59.6%) 37 (56.9%) 13 (43.3%) (51.3%) 
Birth Weight: mean (SD) 3431.0 (618.3) 3411.2 (615.8) 3567.7 3470.0 
First Born n(%) 36 (78%)  11 (37%) (41%) 
Mode of delivery (NVD) 8 (17%) 14 (22%) 22 (73%) (58%) 
Age assessed at 5-year outcome: 
mean (SD) 
64.1 (5.7) n/a 67.6 (6.8) n/a 
Has siblings at 5 years n (%) 32 (73%) n/a 29 (97%) n/a 
Maternal Education 
(completed secondary school) n 
(%) 
35 (79%) n/a 25 (84%) (82%) 
Parent Occupation (highest): n (%) 
- Professional/Manager: 
- Semi-
professional/Technical/Clerical: 
- Skilled manual: 
- Semi-/Unskilled: 
 
15 (34%) 
8 (18%) 
8 (18%) 
13 (30%) 
n/a  
12 (40%) 
8 (27%) 
5 (17%) 
5 (17%) 
 
(53%) 
 
 
(11%) 
The last column contains information from the largest Irish national cohort – the Growing Up in Ireland Study. Findings were presented as percentages in the research 
report thus ‘n’ values not included in the cells of this column. Parent occupation categories were not directly relatable to the ‘social class’ categories in the national cohort 
so only equivalent category information is included. SD = standard deviation, NVD = normal vaginal delivery. 
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As with all research including a control or comparison group, the individual characteristics of 
parents/carers who are more likely to consent to participate in research cannot be controlled 
for but needs to be acknowledged. Additionally, a confounding variable is the willingness 
and/or motivational factors of parents of sick infants versus healthy newborn babies in the 
differential impact of decision making around informed consent (191, 192). 
2.2 Materials 
This section outlines the materials used for the five-year follow-up study which forms the 
basis for this PhD thesis. The term ‘current researcher’ or ‘I’ is used to clarify which aspects 
of the work that I (i.e. Catherine O’Connor) independently undertook. 
The materials were researched and chosen by the current researcher for use in this thesis. 
The psychometric tools chosen for the five-year outcome are described in detail below in 
order to acknowledge the importance of reliability and validity issues when considering their 
use and interpretation in the research setting. 
2.2.1 Consent Forms 
The parent/carer consent forms consisted of a description of the purpose of the consent 
form, the nature and duration of the research procedures, potential risks and benefits and 
possible alternatives. Two versions of the consent form were created, one for the parents of 
the HIE cohort (Appendix D), and a second version for the parents of the comparison cohort 
(Appendix H).  
2.2.2 Parent Questionnaire 
The Parent Questionnaire (see Appendix I) was devised by the current researcher to obtain 
information in relation to each of the participant’s (i) relevant medical information, (ii) need 
for early intervention services such as occupational therapy, physiotherapy, speech and 
language therapy, and/or psychology and (iii) demographic data. The medical section sought 
to gather information about adverse medical experiences in the intervening period since the 
child was last seen by the research team at 24 months of age. Questions about hospital 
admissions, experience of head injury, seizures/epilepsy, current medications and health 
conditions such as asthma and allergies were included. The demographic questions related 
to number of siblings and birth order, nationality/ethnicity, first language, marital status at 
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birth and currently, maternal education level, occupation and household income. The 
demographic questions were adapted from questions used by the Irish Government’s 
Central Statistics Office national census 2006 questionnaires (193).  
2.2.3 The Wechsler Preschool and Primary Scale of Intelligence – 3rd 
Edition (UK version) (WPPSI-IIIUK) 
 
2.2.3.1 Introduction to the WPPSI-IIIUK 
The WPPSI-III (Figure 2.2) is an individually administered clinical instrument for assessing the 
intelligence of children aged 2 years 6 months to 7 years 3 months, and is used worldwide 
(194). The third version is a major revision of the test,  providing updated standardised norms 
and adhering more closely to a hierarchical model of intelligence based on the Cattell-Horn-
Carroll (CHC) model (182). There are two age-range bands (2-6 to 3-11, and 4-0 to 7-3), which 
use different subtests to obtain composite quotients. The administration of the core subtests 
yields a Verbal IQ (VIQ), Performance IQ (PIQ) and Full-Scale IQ (FSIQ). An additional 
Processing Speed Quotient (PSQ) is calculated for the older age band. A General Language 
Composite (GLC) is calculated using supplemental/optional subtests. 
The complete test for the 4-0 to 7-3 age band comprises core, supplemental and optional 
subtests which are summarised in Table 2.4. The core subtests are used to calculate the VIQ, 
PIQ, and FSIQ. The FSIQ = VIQ subtests (information, vocabulary, word reasoning) + PIQ 
subtests (block design, matrix reasoning, picture concepts) + one PSQ subtest (coding). There 
are two verbal supplemental subtests (comprehension, similarities), two performance 
supplemental subtests (picture completion, object assembly) and one processing speed 
subtest (symbol search). The optional subtests - receptive vocabulary and picture naming – 
are used to calculate the GLC. 
The WPPSI-IIIUK was chosen for a number of reasons in addition to its strong psychometric 
properties. Firstly, for its clinical utility as it is the most commonly used IQ test for young 
children in Irish educational and clinical contexts. Secondly, it includes a domain for 
processing speed which an important skill shown to be vulnerable in children with 
neurological conditions. Thirdly, for comparison purposes with other research studies that 
use this tool including the Toby TH trial. The continued use of the Griffiths scales at age five 
was decided against because although the extended revised version (2006) can be used with 
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children to 8 years, it essentially comprised two tests where the 2-8 year section was 
restandardised at a different time and with a different sample to the 0-2 year version. In 
addition, an IQ rather than a DQ (developmental quotient) was deemed more useful for this 
age cohort. 
 
Figure 2.2  WPPSI-IIIUK - Wechsler Preschool and Primary Scale of Intelligence - 3rd UK Edition. Image 
from Pearson Education Ltd. Available at: https://www.pearsonclinical.com/psychology/products/ 
100000422/wechsler-preschool-and-primary-scale-of-intelligence--third-edition-wppsi-iii.html 
 
2.2.3.2 Administration and Scoring of WPPSI-IIIUK 
The WPPSI-IIIUK is individually administered test of IQ, and a qualified psychologist is required 
for its interpretation. The complete battery with supplemental tests takes approximately 90 
minutes to complete and includes a mixture of verbally presented and visually presented 
materials. Answers are given orally, through pointing, or the fine motor manipulation of 
blocks and pencil and paper tasks. The standard subtest administration order was used. It 
was scored by transferring raw scores to the summary score sheet (see Appendix K) and hand 
scored to calculate scaled and standardised scores from the reference group tables provided 
in the manual. 
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Table 2.4 Domains and subtests of the WPPSI-IIIUK 
Domain (bold) and 
Subtest 
Type Description and how assessed 
Verbal (VIQ) 
Information* Core Learn and remember general factual knowledge. Child 
answers questions that tap wide general knowledge 
Vocabulary* Core Word knowledge and verbal concept formation. Child 
provides definitions for words read aloud 
Word Reasoning* Core Verbal reasoning. The child asked to identify the common 
concept being described in a set of clues. 
Comprehension Supl. Verbal reasoning and ability to use past information and 
demonstrate practical behaviour; verbal comprehension and 
expression. The child answers questions based on knowledge 
of general knowledge and social principles. 
Similarities Supl. Verbal reasoning and concept formation. Child is asked how 2 
concepts are similar or share a common characteristic. Ability 
to categorise. 
Performance (Visual/non-verbal) (PIQ) 
Block Design* Core Analyse and synthesise abstract visual stimuli. The child uses 
blocks to recreate designs presented first in 3D and then 2D. 
Matrix Reasoning* Core A matrix analogy test measuring fluid intelligence. The child is 
asked to complete various pattern matrixes. 
Picture Concepts* Core Abstracts, categorical reasoning ability. The child chooses a 
picture from each row of pictures which share a common 
characteristic. 
Picture Completion Supl. Visual perception and organisation; attention. The child views 
a picture and then points to or names the missing part. 
Object Assembly Supl. Visual-perceptual organisation. The child is presented with 
puzzle pieces, and is timed to assemble the whole. 
Processing Speed (PSQ) 
Coding* Core Processing speed, short-term memory, visual perception, 
visual-motor coordination. The child, in a timed task, copies 
symbols that are paired with geometric shapes.  
Symbol Search Core 
for 
PSQ 
Processing speed, short-term visual memory, visual-motor 
coordination, cognitive flexibility, visual discrimination. The 
child scans a search group and marks whether a target symbol 
is represented in the search group. 
General Language Composite (GLC) – optional 
Receptive Vocabulary Opt. Comprehend verbal directives, auditory discrimination and 
processing. The child looks at group of four pictures and 
points to the one presented aurally. 
Picture Naming Opt. Expressive language ability, word retrieval from memory and 
visual association. The child is asked to name a sequence of 
pictures. 
*subtests used to calculate the full-scale IQ (FSIQ) score. Supl = supplemental; Opt = optional. Table 
adapted from WPPSI-IIIUK Administration Manual Table 1.2 p. 3 (194) and WPPSI-IIIUK Technical 
Manual pp. 25-30 (195). 
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2.2.3.3 Psychometric Properties of WPPSI-IIIUK 
 The WPPSI-III was normed on a United States sample of 1,700 children, the ‘UK’ version 
normed on a representative sample of 805 children, which closely approximated the UK 2001 
Census data on similar demographic variables. Reliability and validity information is outlined 
extensively in the WPPSI-III Technical and Interpretative Manual (195). The average internal 
consistency values for individual coefficients are .95 for VIQ, .93 for PIQ, .89 for PSQ, and .96 
for FSIQ (196). Test-retest reliability is fairly stable (VIQ 0.91; PIQ 0.86; FSIQ 0.92; PSQ 0.86; 
GLC 0.91). Construct validity is supported by factor-analytic studies and with comparisons 
with other assessments of cognitive functioning.  One criticism of the test is that it doesn’t 
include a robust measure of working memory for young children (197). 
2.2.4 The NEPSY II 
 
 
Figure 2.3 The NEPSY-II neuropsychological assessment tool. Image from Pearson Education Ltd. 
Available from: https://www.pearsonclinical.co.uk/Psychology/ChildCognitionNeuropsychologyand 
Language/ChildGeneralAbilities/NEPSY-SecondEdition(NEPSY-II)/NEPSY-SecondEdition(NEPSY-II).aspx 
 
2.2.4.1 Introduction to the NEPSY-II 
The NEPSY-II assesses neuropsychological development in children aged 3 to 16 years (198). 
It originated in the 1980s in Finland and evolved throughout the 1980s and 1990s leading to 
the publication of the NEPS in Finland and the NEPSY in America in 1998. This assessed 
children aged 3-12 years on a broad range of tasks assessing five neuropsychological 
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domains, namely, attention and executive functioning, language, memory and learning, 
sensorimotor and visuospatial processing (182). What distinguishes it from other children’s 
neuropsychological assessment batteries is that it was designed exclusively for children, 
rather than depending on downward extensions of adult-based tasks (182). Based on Lurian 
theory, it uses a process-oriented approach to explain cognitive development (178). 
Cognitive areas are viewed as complex capacities mediated by interacting functional 
systems. When one subcomponent is impaired then complex functions can be impacted 
upon and sometimes performance can be affected across functional domains. 
It was designed to detect subtle difficulties both across and within subtest domains; to track 
effects of congenital and acquired brain damage, and the lower age limit allows the study of 
development in preschool aged children (199). 
The NEPSY-II was published in 2007 and constitutes a major revision of the NEPSY. It covers 
a broader age range of 3-16 years. It includes a new domain – social perception - in addition 
to the original theoretically derived five domains outlined above. There are 32 subtests in 
total. Subtests with lower psychometric properties have been replaced by subtests with 
greater clinical sensitivity and construct validity. Primary, combined, process and contrast 
scores can be calculated, depending on the selection of subtests chosen for administration. 
The rationale for including the NEPSY-II, was that in addition to its sound psychometric 
properties it was created within a child developmental context. It allows for cross 
comparison with other longitudinal studies that have used NEPSY and NEPSY-II including the 
NICHD and Toby TH trials (16, 139). A large set of subtests are included in this study (see 
Section 2.2.4.2 below) representative of the Attention & Executive Functioning, Language, 
Memory & Learning, Sensorimotor and Visuospatial Processing domains to provide a 
detailed age-specific NP profile of children at age five years. It was important to include not 
only neuropsychological processes previously shown to be associated with HIE, such as 
memory (see Chapter 1 for review), but equally to include less well understood areas for this 
age group to provide a cross-domain profile. These detailed profiles are necessary at 
different ages to improve our understanding of the emerging nature of these skills across 
childhood, and to build knowledge of potential phenotypes following HIE. Currently, the 
knowledge base is reliant on a mere handful of well-designed studies in this area. 
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2.2.4.2 Administration and Scoring of NEPSY-II 
The NEPSY-II is individually administered test, and a qualified psychologist is required for its 
interpretation. There is a core battery of subtests, and also specific batteries recommended 
for a variety of referral queries, for example suspected dyslexia or attention difficulties. The 
subtests administered in this study are described in Table 2.5, which include all subtests of 
the core battery and additional subtests with the highest clinical sensitivity. Due to a lack of 
published data on the social perception scale it’s subtests were excluded. 
It was scored by transferring the raw scores from the record form (see Appendix L) to the 
NEPSY-II scoring assistant software (see Appendix M). 
Table 2.5 NEPSY-II domains and subtests 
Domain (bold) 
and Subtest 
Abbr. Description and how assessed 
Attention and Executive Functioning 
Auditory 
Attention 
AA Selective auditory attention and the ability to sustain it (vigilance). The 
child listens to a series of words and touches the appropriate circle 
when he/she hears the target word. 
Design Fluency DF Behavioural productivity in the child’s ability to generate unique 
designs by connecting up to five dots, presented in 2 arrays: structured 
and random. The child draws as many designs as he/she can on each 
array within a specified time limit. 
Inhibition IN inhibit automatic responses in favour of novel responses and the 
ability to switch between response types. The child looks at a series of 
shapes or arrows and names either the shape or direction or an 
alternate response, depending on the colour of the shape or arrow. 
Statue ST Motor persistence and inhibition. The child is asked to maintain a body 
position with eyes closed during a 75-second period and to inhibit the 
impulse to respond to sound distractors. 
Language 
Comprehension 
of Instructions 
CI Receive, process, and execute oral instructions of increasing syntactic 
complexity. The child points to appropriate stimuli in response to oral 
instructions. 
Phonological 
Processing 
PH Phonemic awareness such as identifying words from word segments; 
Phonological Segmentation - phonological processing at the level of 
word segments (syllables) and letter sounds (phonemes). The child is 
asked to repeat a word and then to create a new word by omitting a 
syllable or a phoneme, or by substituting one phoneme in a word for 
another. 
Repetition of 
Nonsense 
Words 
RN Phonological encoding and decoding. The child repeats nonsense 
words presented aloud. 
Speeded 
Naming 
SN Rapid semantic access to and production of names of colours, shapes, 
and sizes. The child is shown an array of colours and shapes; and 
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colours, shapes, and sizes. He/she names them in order as quickly as 
possible. 
Word 
Generation 
WG Verbal productivity - ability to generate words within specific semantic 
and initial letter categories. The child is given a semantic category and 
asked to produce as many words as possible in a limited time. 
Memory and Learning 
Memory for 
Designs 
Memory for 
Designs 
Delayed 
MD 
MDD 
Spatial memory for novel visual material. The child is shown a grid with 
four to eight designs on a page, which is then removed from view. The 
child selects the designs from a set of cards and places the cards on a 
grid in the same location as previously shown. A delayed task assesses 
long-term visuospatial memory. 
Memory for 
Faces 
Memory for 
Faces Delayed 
MF 
MFD 
Encoding of facial features, face discrimination and recognition. The 
child looks at a series of faces and then is shown three photographs at 
a time from which he/she selects a face previously seen. A delayed 
task assesses long term memory for faces. 
Memory for 
Names 
Memory for 
Names Delayed  
MN 
MND 
Learn the names of children over 3 trials. The child is shown six cards 
with drawings of children on them while being read the child’s name. 
The cards are shown again, and the child is asked to recall the name of 
the child on the card. A delayed task assesses long term memory for 
names. 
Narrative 
Memory 
NM Memory for organised verbal material under free recall, cued recall 
and recognition conditions. The child listens to a story and is then 
asked to repeat the story. The child is then asked questions to elicit 
missing details from his or her recall of the story. 
Sentence 
Repetition 
SR Repeat sentences of increasing complexity and length. The child is read 
a series of sentences and asked to recall each sentence immediately 
after it is presented. 
Sensorimotor 
Fingertip 
Tapping 
FT Finger dexterity and motor speed. The second part assesses rapid 
motor programming. The child copies a series of finger motions 
demonstrated by the examiner as quickly as possible. 
Imitating Hand 
Positions 
IH Imitate hand/finger positions. The child imitates various hand positions 
demonstrated by the examiner. 
Manual Motor 
Sequences 
MM Imitate a series of rhythmic movement sequences using one or both 
hands. The child repeats a series of hand movements demonstrated by 
the examiner until the required number of movements is completed. 
Visuomotor 
Precision 
VP Graphomotor speed and accuracy. The child uses his/her preferred 
hand to draw lines inside of tracks as quickly as possible. 
Visuospatial Processing 
Design Copying DC Motor and visual-perceptual skills associated with the ability to copy 
two-dimensional geometric figures. The child copies figures displayed 
in the Response Booklet. 
Geometric 
Puzzles 
GP Mental rotation, visuospatial analysis, and attention to detail. The child 
is presented with a picture of a large grid containing several shapes. 
For each item, the child matches 2 shapes outside of the grid to two 
shapes within the grid. 
Amended version of Table 2.1 in NEPSY-II Clinical and Interpretive Manual pp 21-23 (200). 
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2.2.4.3 Psychometric Properties of NEPSY-II 
 The NEPSY-II aimed to improve and expand the cognitive domains, enhance the clinical 
utility, improve the psychometric properties, and simplify its administration (201). It was 
standardised on a single, well-stratified sample of 1,200 U.S. citizens with exclusion criteria 
including neurological disorders (200). A Finnish standardisation has also been completed. 
Most, but not all subtests underwent re-standardisation for the 2nd version. Separate clinical 
samples were also investigated for the revision. Its principal strength being one of the only 
paediatric neuropsychological tests with wide domain coverage using subtests that are co-
normed and can be cross-compared (201). 
The internal reliability overall is very good. Across the age groups they range from adequate 
to very high (200). In the 5-6 year group, six subtests have very high reliability. One subtest 
– memory for faces – was low for this age. For children of this age with a clinical diagnosis, 
reliability coefficients of r= 0.80 and higher are given (201). Test-retest correlations range 
from adequate to high. Concurrent validity has more evidence with comparisons with 
intelligence (WISC-IV), and neuropsychological tests (CMS and D-KEFs), and enhanced 
evidenced for discriminant validity with its analysis of clinical samples (202). 
2.2.5 Children’s Memory Scale (CMS)  
The Children’s Memory Scale (203) was published in 1997 and was developed as a downward 
extension of the adult Wechsler Memory Scale (WMS). It assesses learning and memory in 
those aged 5 – 16 years. It evaluates the processes of the learning and subsequent retention 
of information in different modalities. There are nine subtests which assess functioning in 
three domains: (i) auditory/verbal learning and memory (verbal), (ii) visual/nonverbal 
learning and memory (visual), and (iii) attention/concentration. It covers short-term 
memory, working memory and long-term memory which include immediate and delayed 
recall and recognition tasks. It acknowledges the central importance of attention to this 
process. The working memory model assumed in this test is that of Baddeley and Hitch 
(1995) which postulates a short-term memory system which allows for the temporary 
retention and manipulation of a limited amount of information, in order to complete a 
cognitive task (204).  
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Recent research related to children’s intellectual functioning has acknowledged the 
important role ‘working memory’ in children’s development. Despite the many strengths of 
the choice of WPPSI-IIIUK as the intellectual abilities measure for this research, some have 
commented on the removal of subtests from the previous edition that assessed working 
memory (‘arithmetic’ and ‘sentences’), resulting in no assessment of working memory in the 
WPPSI-IIIUK as a weakness of this tool (196). To redress this, the ‘numbers’ subtest from the 
attention/concentration domain of the CMS was administered as a replacement. This subtest 
in addition to the memory and learning subtests of the NEPSY-II provide a comprehensive 
assessment of memory. 
The numbers subtest assesses the ability to repeat random digit sequences of graduated 
length. In the ‘Forwards’ portion, the child repeats the digits in the same sequences as heard. 
In the ‘Backward’ portion, the child repeats the digits in the reverse order of that presented 
(203) (See Appendix O). The subtest measures verbal short-term and working memory. 
The CMS was standardised on a stratified U.S.A. nationwide sample of 1,000 ‘normally 
functioning’ children using the 1995 US Census information. The CMS has been linked to the 
Wechsler intelligence scales using a sample of 300 children. This allows for discrepancy 
analysis between intellectual and memory needs and abilities (195). The reliability coefficient 
for the Numbers total score is 0.79 (forwards 0.74 and backwards 0.82). Test retest stability 
coefficients were only provided for indexes. In this case attention/concentration corrected 
for variability was 0.85. In comparison/discrimination studies with other psychometric tools, 
the attention/concentration index correlated highly with other measures of complex 
attention, moderately with measures of general cognitive ability, and a strong relationship 
to academic achievement more so than the verbal and visual long-term memory tasks.  
Convergent validity was demonstrated in the studies using other childhood memory tests on 
equivalent subtests (203). 
Special group studies carried out with clinical samples suggest that the CMS is very sensitive 
to dysfunction caused by brain anomalies. The attention/concentration index unsurprisingly 
was most affected by epilepsy, ADHD and specific language impairment.  
The CMS Numbers raw score is converted to an age-related standard scaled score of 10(3). 
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2.2.6 Interpretative Features of Psychometric Tests 
When using psychometric tools - such as the use of WPPSI-IIIUK, NEPSY-II and CMS in this 
study - it is important to remain cognizant of the issue of test purity. Standardised tests 
measure constructs (such as memory) by developing tasks that typically require input (e.g. 
the instructions), ‘thinking’, and output (‘the answer’) by the examinee. Although tests with 
high validity seek to measure constructs in a pure sense, all tests are burdened with 
measurement error and pure assessment of a mental construct in isolation to other 
constructs is nigh on impossible (e.g. in order to remember something it must first be 
attended to). A second feature of test content is to include a set of items that spans a full 
range of age-related performance in order to achieve satisfactory floor and ceiling levels. 
This often necessitates a set of items that differ in some way in their task demands. For 
example, the vocabulary subtest of the WPPSI-IIIUK includes picture items and verbal items. 
Finally, scaled and standardised scores are comprised of raw scores accrued from different 
tasks. For example, the CMS Numbers scaled score represents the scores of two tasks, 
namely, digit forwards (a short-term memory task) and digit backwards (a working memory 
task). Thus, the Numbers scaled score masks the individual contributions made by the 
underlying tasks, which may include individual areas of impairment. An awareness of these 
issues is important for the understanding of the limitations of test interpretation, and an 
acknowledgement of which underlying skills are influencing subtest or domain level 
performance. 
2.2.7 Neurological Assessment 
The neurological assessment was undertaken by one of three consultant paediatricians (Dr. 
Deirdre Murray, Dr. Evonne Low, Dr. Louise Gibson). They assessed muscle tone, power and 
deep tendon reflexes. A GMFCS (Gross Motor Function Classification System) score (205), 
was assigned to children with cerebral palsy. 
2.2.8 Vision Assessments 
Vision assessments were undertaken by a consultant ophthalmologist (Dr. Mark James) and 
demographic, clinical, visual, orthoptic, biometric and refractive data was measured. See 
Information Letter in Appendix P. 
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Clinical data additional to that already described included: family history of ocular disorders; 
and anterior segment and fundal findings on slit lamp biomicroscopy. Visual data included: 
visual acuity from a Sheridan-Gardner or Snellen chart, and logMAR chart if appropriate; and 
confrontation visual fields assessment using a target gradually moved in from the periphery 
until detected by the child, while maintaining fixation on a central target. Orthoptic data was 
assessed by an experienced paediatric orthoptist (Beatrix Haskins), and included: ocular 
alignment on cover testing; angle of squint as determined by prism cover testing; ocular 
motility, including convergence; and presence or absence of stereopsis as determined by the 
Lang II stereo test, scored out of four. 
All biometric and refractive measurements were performed by Dr. James. Cycloplegic 
autorefraction was performed 30 minutes following instillation of a drop of cyclopentolate 
1% to each eye, with the use of one of three autorefractors available at different times during 
the study. These were (i) the NIDEK Auto Refractometer AR-630A (Nidek CO., Japan), (ii) the 
Topcon RM-A3000 Auto Refractometer (Topcon, Tokyo, Japan), or (iii) the NIDEK Auto 
Refractometer AR-800 (Nidek CO., Japan). Data reliability was checked by performing 
cycloplegic streak retinoscopy using a Welch Allyn retinoscope (Welch Allyn Medical 
Products, Skaneateles Falls, New York). Results recorded in sphero-cylindrical form, including 
axis, were used to calculate the spherical equivalent (SE) refractive error for each eye. Ocular 
biometry using the IOLMaster (Carl Zeiss Meditec, Jena, Germany) recorded the average of 
10 valid readings of axial length and 15 keratometry readings for each child. Keratometric 
values were the mean of the steepest and flattest meridian in dioptres (D) in each eye.  
Visual impairment was defined as a presenting vision (i.e. unaided or with glasses if worn) of 
less than 6/12 in the better seeing eye. Ametropia was defined as the presence of one or 
more of the following in either eye: myopia if SE refraction ≤ -0.5 D; hyperopia if SE refraction 
≥ +2.0 D; and astigmatism if cylinder power ≥ 1.5 D. Anisometropia was defined as an 
interocular difference in SE of ≥ 1.0 D. 
2.3 Experimental Design 
This quantitative follow-up study employed a prospective cohort observational design. 
Children were followed longitudinally from birth to 5 years. For temporal reasons, the 
researcher was aware of the group membership (i.e. HIE vs comparison) of each child, but 
importantly was blinded to ALL other data collected from previous studies except for the 
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child’s name, parent(s)’ name, contact details, and date of birth. The current study assessed 
neurological status, intellectual ability, neuropsychological functioning, visual function and 
behavioural and executive functioning carer ratings of the HIE and comparison groups at age 
five.  
This researcher was responsible for all aspects of the five-year assessment protocol, chose 
the neurodevelopmental assessment tools, designed the parent questionnaires, recruited 
the children and families at age five and assessed, scored and interpreted all assessments 
with the exception of the orthoptic/ophthalmic and neurological assessments. 
2.4 Proposed Data Analysis 
Quantitative descriptive and inferential statistics, and clinical prediction measures will be the 
principal forms of data analysis employed in this thesis. Statistical analysis was completed 
using IBM SPSS Statistics V12.0, 20.0, 22.0 for MS Windows (IBM Corporation, NY, USA)s and 
VassarStats: Website for Computational Statistics (Lowry, R 1998-2018, Vassar College, NY, 
USA). Some of the ocular data in Chapter 7 was analysed using Stata package V8.0 (StataCorp. 
2005; Stata Statistical Software: Release 9.0; College Station, TX, USA). 
The relationship between repeated administrations of the ATNAT (ordinal) in the first three 
days of life, neonatal discharge exam and time to oral feeding with 24 months GMDS-R 
outcome (continuous) and with overall outcome (ordinal) will be examined using Spearman’s 
rank order correlation. 
The relationship between repeated administrations of the GMDS-R at 6, 12 and 24 months 
(continuous) with 5-year WPPSI-IIIUK outcome (continuous) and with overall outcome 
(ordinal) will be examined using Spearman’s rank order correlations. 
Between-group differences in scores of outcome dependent variables at age five years across 
categorical independent variables assigned in the neonatal period will be analysed using the 
non-parametric Kruskal-Wallis H Test. These include:  
i. WPPSI-IIIUK domain scores, NEPSY-II subtest scores and the CMS Numbers subtest 
scores at five years across Sarnat grades assigned at 24 hours of age; 
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ii. WPPSI-IIIUK domain scores, NEPSY-II subtest scores and the CMS Numbers subtest 
score at five years across EEG grades assigned at 6 and 24 hours of age. 
Pair-wise post hoc comparisons of the significant results will be analysed using Mann-
Whitney U Tests. All p values are 2-tailed with statistical significance level set at p<.05 except 
for the NEPSY-II subtest scores. To reduce the chance of Type 1 error caused by multiple 
comparisons (potentially 25), a Bonferroni correction for post hoc testing is made for the 
subset of subtests within each NEPSY-II domain (Attention and Executive Functioning: 
.05/5=.01; Language: .05/5=.01; Visuospatial Processing (.05/2=.025); Memory and Learning: 
.05/8=.006); Sensorimotor: (.05/5=.01). 
Mann-Whitney U Tests were additionally used for the investigation of differences between: 
NEPSY-II subtest scores in the HIE and Comparison cohorts; NEPSY-II subtest scores in the 
HIE intact-at-five-years group and Comparison cohort; Griffiths and WPPSI-III scores in the 
HIE group with normal and abnormal 5 year ophthalmic outcome. 
Clinical utility of prediction will be analysed firstly by creating a set of binary 
‘normal/abnormal’ variables, by collapsing the scores by cut-off range (see Table 2.6). Next, 
ATNAT classification, and neonatal discharge exam for predicting 2-year outcome, and 
Sarnat, EEG Grade, and GMDS-R scores for predicting 5-year outcome will be calculated using 
PPVs (Positive Predictive Values), NPVs (Negative Predictive Values), sensitivity, specificity, 
and AUROC (area under the receiver operated characteristic curve) with 95% confidence 
intervals. (IMPORTANT NOTE: In Chapters 3 and 5 these clinical utility measures are used in 
the conventional fashion, i.e. PPV to analyse proportions of children with an abnormal early 
score that have an abnormal later score (206). However, in Chapter 4 these measures are 
inverted, i.e. to determine the value of an early normal score for later normal score. To 
reduce confusion this will be highlighted again for the reader in Chapter 4). 
Table 2.6 Definitions of normal and abnormal cut-off levels for each test used and for the overall 
outcome variable. 
Assessment ‘Normal’ category ‘Abnormal’ category 
ATNAT = 0 = 1 or 2 
Sarnat = 0 = 1-3 
EEG Grade = 0-1 = 2-4 
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Assessment ‘Normal’ category ‘Abnormal’ category 
Neonatal discharge 
exam 
= 0 = 1-2 
GMDS-R DQ ≥ 88 DQ < 88  
WPPSI-IIIUK FSIQ ≥ 85 FSIQ <85 
Overall 5yr outcome None of: death, CP, IQ<85, 
sensory impairment NDD, 
EI multidisciplinary team 
At least one of: death, CP, IQ<85, 
sensory impairment NDD, EI 
multidisciplinary team 
ATNAT = Amiel-Tison Test of Neurological Assessment at Term, GMDS-R = Griffiths Scale of Mental 
Development – Revised, WPPSI-IIIUK = Wechsler Preschool and Primary Scale of Intelligence 3rd UK 
version, CP = cerebral palsy, FSIQ = Full-scale IQ, DQ = Griffiths developmental quotient, NDD = 
neurodevelopmental disorder, EI = early intervention. 
 
The birth data (e.g. birthweight, mode of delivery) and demographic data gathered at age 
five for the HIE and Comparison cohorts will be described using means and standard 
deviations for continuous variables and frequencies for categorical variables. Differences 
between these cohorts will be explored using parametric pairwise comparisons using 
independent t-tests for continuous variables and Chi-square test for independence for 
categorical variables. One-sample t-tests are used to compare observed WPPSI-IIIUK scores 
to the test norms. 
Fisher’s exact (and Freeman Halton extension) statistics will be used when minimum cell 
frequency is violated in any of the Chi-square calculations. Effect sizes in this study are 
calculated as follows: Cohen’s d for independent Samples T-Test, Phi coefficient and 
Cramer’s V for Chi-square, r = z /√N where N = no. of cases for Mann-Whitney U tests (207). 
2.5 Procedure 
2.5.1 Funding and Ethical Approval 
The previous researcher (Deirdre Murray) had identified the potential importance of the 
follow-up of this HIE cohort of children beyond 24 months. It provided a unique opportunity 
to investigate the long-term emerging subtle neurological sequelae of this group as identified 
in other long-term follow up studies (71, 75, 117). A submission was made, and funding 
granted from the Health Research Board of Ireland (HRB), grant number: RP/2008/238. The 
research protocol, entitled “Ability of early continuous EEG to predict long-term neurological 
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outcome at 4.5 years in infants following neonatal hypoxic-ischaemic encephalopathy” was 
produced and submitted to the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals, University College Cork. Ethical approval was granted in January 2008 (reference: 
ECM4 (hhh) 05/02/08, see Appendix A). When the current researcher was recruited to the 
study an ethics amendment was submitted in November 2008 (see Appendix B) due to 
changes I made to the tests to be used in the five-year protocol (namely the addition of 
WPPSI-IIIUK and NEPSY-II). In 2010, an ethics amendment submission was made to a separate 
birth cohort study (protocol title: “Sleep patterns of full-term babies in the early postnatal 
period” - related to EEG, sleep-wake cycles in the ‘normal’ neonate) to seek permission to 
recruit these children at age five as a comparison sample (see ethics proposal Appendix E, 
and approval (reference ECM 3 (bb) 06/12/11), Appendix F). 
Confidentiality of the participants was assured by anonymising identifying data through the 
use of a numeric unique identifier for each participant. Hard copies of record forms were 
stored in locked filing cabinets within a secure office at UCC accessible only by secure ID 
cards. The electronic SPSS database file was similarly pseudonymised and stored on an 
encrypted drive. 
2.5.2 Recruitment for 5-year follow-up 
In the HIE cohort, there were 65 children recruited to the original study. Of those, 6 died and 
2 were excluded, with 6 lost to follow-up by age 24 months (see Figure 2.4 which provides a 
flowchart of cohorts from birth). The remainder of the cohort of 51 infants with HIE were 
invited to participate in the current study by letter updating parents/carers about the status 
of the study and explaining that funding had been received to continue the follow-up. All 
families had been previously informed at 24 months follow-up that there was a possibility 
that the study would be continued pending appropriate funding (see letter in Appendix C). It 
explained that vision assessments would be offered in the forthcoming weeks and that 
neurodevelopmental and neurological assessments would be offered when the child turned 
five years. A follow-up telephone call was then made by this researcher to each of the 51 
families. In cases where parents reported that they had changed residence, a copy of the 
information was sent to the new address. In cases where telephone numbers were obsolete, 
the child’s hospital number was used to contact the family’s general practitioner for current 
contact details. 
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Figure 2.4 Flowchart for the HIE and Comparison cohorts from birth to five-year outcome 
assessment. LTFU=lost to follow-up. 
The comparison birth cohort (see Figure 2.4) comprised 80 infants. A subset received a 
separate letter (from the original researcher to protect anonymity) describing the purpose 
of the HIE study and outlining the function and importance of a comparison group for 
longitudinal research. A summary of the proposed commitment and assessment details were 
included with an invitation for inclusion of the child (see Appendix G). 
For both groups, parents were asked whether the child had been assessed by a psychologist 
in the preceding year. If this was the case, the researcher sought permission to contact the 
child’s psychologist to ascertain which if any standardised measures had been used with the 
child. In cases where the WPPSI-IIIUK/other IQ assessment (n=6) or NEPSY-II (n=0) had been 
administered the researcher used the results from the previous assessment to avoid the 
practice effects of re-administration (see Appendix N). 
Once verbal consent was received, two initial appointments were made at a suitable time 
with a third organised if required. Each family was given the choice to have the assessment 
carried out in a clinical room in the health sciences building at University College Cork or at 
the child’s home. Funding was made available to support transport and parking costs. 
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2.5.3 Assessment Process  
At the initial appointment, the researcher read the written consent form to the parent, and 
time was given to clarify information and answer questions. Once informed consent was 
agreed, and researcher signed two copies of the consent form, one for the parent to keep. 
The parent was then invited to complete the parent questionnaire with the researcher. 
Parallel to this process, the researcher sought to engage the child in order to build rapport. 
The focus then turned to the child and time was spent building rapport and asking social 
questions including whether the child was in preschool/school. A brief description of the 
expected activities was described. Although no formal informed assent was collected from 
the child, the current researcher asked the child if he/she wished to be involved and was 
assured that they could stop at any time. The current researcher only continued if she felt 
the child was comfortable based on her many years working as a psychologist assessing 
young children. The parent(s) were encouraged to leave the room for the process of the 
assessment. However, as is typical for this young age group, many parents remained in the 
room for some, or all of the testing. In these cases, it was explained that due to the nature 
of the way in which standardised tests are structured that no assistance from the parent 
could be given to the child.  
During session one, the complete WPPSI-IIIUK was administered in strict accordance with the 
administration guidelines in the WPPSI-III administration manual (194). The subtests were 
administered in the order in which they appeared in the assessment form, as recommended 
by the authors. The ‘Numbers’ subtest from the CMS was then administered. At the end of 
the session brief verbal feedback was given to the parent to describe a subjective evaluation 
of the child’s test behaviours, and a rough estimate of the child’s intellectual performance 
on the assessment. 
During session two, verbal feedback from the first session was given to the parent re the 
WPPSI-IIIUK and CMS scores. Selected subtests from the NEPSY-II were then administered to 
the child. The following order was used: (i) Memory for Names (immediate), (ii) Auditory 
Attention, (iii) Repetition of Nonsense Words, (iv) Memory for Designs (immediate), (v) 
Memory for Names (delayed), (vi) Comprehension of Instructions (vii) Design Copying, (viii) 
Visuomotor Precision, (ix) Memory for Designs (Delayed,) (x) Memory for Faces (immediate), 
(xi) Fingertip Tapping, (xii) Geometric Puzzles, (xiii) Imitating Hand Positions, (xiv) Memory 
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for Faces (Delayed), (xv) Inhibition, (xvi) Manual Motor Sequencing, (xvii) Narrative Memory, 
(xviii) Speeded Naming, (xix) Statue, (xx) Sentence Repetition, (xxi) Phonological Processing, 
(xxii) Design Fluency, (xxiii) Word Generation. 
The Memory & Learning subtests that contained an immediate and a later administered 
delayed component (typically 15-25 minute interval) were administered early to ensure 
successful administration of the delayed subtests in cases where the session finished early.  
In cases where the child began to lose interest or tired of the verbal or longer activities the 
administration order was altered to maintain rapport. When required, a third session was 
organised to complete NEPSY-II administration. The NEPSY-II technical manual reports on 
subtest order studies that demonstrate that the administration order has no significant 
association with the NEPSY-II results (200). 
At the end of session two, the research paediatrician completed a neurological assessment 
with the child. At the final session, the parent and child were thanked for their time and 
contribution, and the parent was provided with feedback or informed that a future 
telephone feedback session would be completed, with a written copy to follow in the post 
where requested. The parent was encouraged to contact the researcher by telephone at any 
time in the future if further queries arose. In cases where there were areas of difficulty 
assessed for the child, a one-to-one feedback appointment was arranged with information 
about and referral to an appropriate clinical and/or educational follow-up service.  
To minimize the effect of fatigue in the children, sessions were broken up (e.g. time for a 
snack) to suit the children to ensure maximum chance of achieving the best performance of 
a child without compromising the standardised administration procedures. An important 
factor in the project was the ample time afforded to the researcher to organise additional 
appointments and times that suited the families and the option of doing home-based 
assessments. 
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3.1 Abstract 
Aim: 
The clinical and electrographic signs of hypoxic-ischaemic encephalopathy evolve over the 
first days of life. We examined the evolution of neurological signs over the first 3 days of life, 
and determined whether serial administration of the Amiel-Tison neurological assessment 
at term (ATNAT) would predict neurodevelopmental outcome at 24 months. Associations 
between Individual ATNAT items on day 3 and five-year IQ outcome were also explored.  
Methods: 
Term neonates born with suspected HIE between May 2003 and May 2005 in a Cork 
maternity unit were recruited prospectively. Modified Sarnat grading was assigned. The 
ATNAT was administered on days 1, 2 and 3 of life and a discharge neurological examination. 
Time to oral feeding and demographic variables were recorded. Developmental status was 
assessed using the Griffiths Mental Development Scales-Revised at 6, 12, and 24 months. IQ 
was assessed at five years using the WPPSI-IIIUK scales. 
Results: 
From a birth cohort of sixty five children, n=57 infants who had reached 24 months, were 
invited for follow-up. Of these, 4 were lost to follow up and 2 excluded. Thus, 51 (31 male 
and 20 female) were included. Of these 6 had died, resulting in 76% (45/59) assessed that 
had survived from the birth cohort. Neurological examination evolved and normalised over 
the first three days of life in many cases. At 24 months, 41% (21/51) children had an adverse 
outcome, (i.e. developmental delay, CP or death). Examination at all time points correlated 
significantly with neurological outcome at 24 months. The best correlations were found to 
be (i) neurological examination at discharge (r=0.65, p<0.001), (ii) Sarnat grading (r=0.64, 
p<0.001) and (iii) ATNAT on day 3 (r=0.46, p<0.001). The best predictive value was seen with 
neurological examination at discharge (PPV and NPV of 72% and 86%) for 24-month 
outcome. Day 3 ATNAT correlated with five-year IQ (r=-0.47, p<0.01) as did 9 of the individual 
items, the highest being palmar grasp and crying. 
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Interpretation: 
Persistence of abnormal neurological signs correlates significantly with adverse outcome. 
The later a neonatal neurological examination was performed, the better its predictive 
ability. Four ATNAT items correlated as well or better than the overall ATNAT score for five-
year IQ outcome. This study demonstrates that neurological symptoms quickly evolve in the 
neonatal period, with the requirement for repeated measurement and a future focus for 
research to better understand which early neurological test items remain constant and which 
evolve in the first hours and days of life.  
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COMMENT: It is important to note that this chapter is partially based on the previous original 
work of Dr. Deirdre Murray for her PhD thesis. Dr. Murray undertook the analysis at 24 
months and these findings were previously included in chapter 7 of her thesis (187). 
Additionally, Ms. Claire Thompson, Medical Student UCC supported the preparation of the 
individual item ATNAT scores and the preliminary statistics including the preparation of the 
scatterplot diagrams. My role in the production of this chapter was as follows: I prepared the 
manuscript for publication and wrote-up the content of Dr. Murray’s chapter for article 
submission, double-scored all Griffiths results, and expanded some of the statistical 
interpretation and presentation of the results at 24 months. I recruited and assessed all of 
the infants at age five years, and summarised and interpreted all of the five-year outcome 
data outlined later in the chapter. 
This is described in further detail in Chapter 8, Section 8.1: Summary and Impact of the Thesis 
Findings. 
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3.2 Introduction 
HIE affects 3-5 per 1000 live births. In the severe form, it remains one of the leading causes 
of neonatal death, and approximately 25% will experience severe neurological disability 
including cerebral palsy, epilepsy, intellectual disability, and sensory loss  (208). Outcome can 
be difficult to predict and is traditionally described using the clinical Sarnat score assigned at 
24 hours post-delivery (14). Whilst the Sarnat score is useful at the extremes (mild and severe 
grades), it is more difficult to predict outcome in those infants with a moderate Sarnat grade 
of encephalopathy. Although the Sarnat grade provides a single summary score, the 
neurological signs observed in HIE continue to evolve over the first 72 hours of life.  
The Amiel-Tison Neurologic Assessment at Term (ATNAT) (60) has been developed to provide 
a framework for observing the development of cortical control in the infant at term and has 
been shown to predict the occurrence of cerebral palsy following birth asphyxia (61, 62). 
Previous studies have not examined repeated measurements over the first days of life. The 
central tenet of the Amiel-Tison is that the stage of maturation of the two motor control 
systems (subcorticospinal and corticospinal) can be clinically evaluated in the term infant 
(63). Amiel-Tison, author of the ATNAT, recommends serial assessments for two reasons: (i) 
to reduce the confounder of transient clinical signs caused by medical treatments, and 
metabolic processes; (64), (ii) to discriminate between a ‘static’ neurological profile more 
usually seen in infants with prenatal damage, and an ‘evolving’ profile more commonly seen 
in HIE and ‘normal’ babies (65). 
In a NICU setting, the clinician requires quick, reliable and valid tools to assess the sick infant. 
The ATNAT takes approximately 15 minutes to complete and contains 35 individual items. 
Interobserver reliability values from two separate studies suggest excellent agreement for 
16 items (209, 210), with one study reporting good agreement for the remaining items also 
(209), whilst the second report the majority of the remaining items with fair to good 
reliability with lower reliability on two final items (210). Amiel-Tison reported that three 
items – called the ‘triad’ may be particularly useful for prediction because they may mark 
lower cognition in later childhood (69). In a study of babies following preterm birth, those 
children with abnormalities in the AT triad displayed poorer IQ scores at age five (211). 
The aims of this study were (i) to examine the evolution of neurological signs in term infants 
with HIE over the first three days of life, (ii) to investigate the ability of these repeated serial 
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assessments to predict neurodevelopmental outcome at 2 years, and (iii) to analyse the 
relative importance of items of the ATNAT for outcome at five years.  
3.3 Method 
This prospective study was carried out in a large maternity service with approximately 6000 
deliveries per annum as part of a study into early continuous video-EEG monitoring (212). 
Ethical approval was obtained from the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals. Between May 2003 and May 2005, term infants (> 37 weeks gestation) 
with HIE were recruited if they fulfilled 2 or more of the following criteria: initial capillary or 
arterial pH < 7.1, Apgar score < 5 at 5 minutes, initial capillary or arterial lactate > 7 mmol/L 
or abnormal neurology/clinical seizures. Neurology was assessed by dedicated research 
paediatricians not involved in the clinical care of the infant. The parents of infants fulfilling 
the criteria were approached and written informed consent was obtained. Infants were 
typically recruited within 6 hours of birth, with the remainder recruited at the onset of clinical 
seizures. Participants were excluded if they had co-existing congenital anomaly, or significant 
co-morbidity.  
Initial neurological assessment was administered using the Amiel-Tison Neurologic 
Assessment at Term (ATNAT) (60). Early neurological status continued to be monitored with 
repeated administration of the ATNAT daily for three consecutive days. The ATNAT consists 
of examination of 35 items (see Table 3.1) describing cranial characteristics, alertness, 
behaviour and spontaneous activity, passive tone in the limbs and axis, active tone, and 
primary reflexes (see Appendix J for a copy of the ATNAT assessment form). Scores are 
assigned for each item as follows: 0 = ‘within normal range’, 1 = ‘a moderately abnormal 
result’, 2 = ‘a definitely abnormal result’, and are assigned each time the ATNAT is 
administered. The scores are not used in a quantitative way, but rather are designed to 
develop an opinion of the infant’s neurological status based on the most commonly observed 
scores. The final synthesis is described as normal in the absence of neurological signs, or 
presence of minor abnormalities (without CNS depression), moderate (with CNS depression) 
or severe (deep CNS depression and repeated seizures for > 30mins) for the term infant (64). 
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Table 3.1 Amiel-Tison Neurological Assessment at term (ATNAT): List of items for assessment (64). 
Domain Item for measurement 
 
Cranial Assessment Head circumference 
Anterior fontanelle 
Squamous sutures 
Other sutures 
Neurosensory Function and 
Spontaneous Motor 
Activity 
Fix and track 
Ocular signs 
Response to voice 
Social interaction 
Crying 
Excitability 
Convulsions 
Spontaneous motor activity 
Spontaneous thumb abduction 
Passive Muscle Tone Upper Limbs:  
 
Lower Limbs: 
 
Right-left 
comparisons: 
Body axis: 
Recoil 
Scarf 
Recoil 
Popliteal angle 
Asymmetry 
Ventral incurvation (flexion) 
Dorsal incurvation (extension) 
Comparison of curvatures 
Axial Motor Activity 
(active tone) 
Righting reaction (lower limbs and trunk) 
Raise to sit (neck flexor muscles – head forward) 
Reverse manoeuvre (neck extensor muscles – head 
backward) 
Primitive Reflexes Non-nutritive sucking 
Palmar grasp 
Automatic walking 
Moro reflex (only used when other reflexes 
asymmetrical/absent) 
Asymmetric tonic neck reflex (ATNR) 
Palate and Tongue High arched palate 
Fasciculations of tongue (peripheral, at rest) 
Adaptedness to 
Manipulations During 
Assessment 
Stability 
Feeding Autonomy Term newborn 
Medical Status at the Time 
of Assessment 
Assisted ventilation 
Anticonvulsant drugs 
Phototherapy 
Other 
The majority of the ATNAT assessments were undertaken by the research Paediatrician (Dr. 
Deirdre Murray), with the remainder completed by a designated experienced neonatal 
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paediatric registrar (Dr. Pronab Bala). In the event that some of the items could not be 
administered (e.g. sucking, Moro reflex, axial tone assessment) due to endotracheal 
intubation, difficulties were recorded, and the assessment attempted again at a later stage.  
Additional neurological assessment consisted of a designation of a modified Sarnat score 
assigned at 24 hours (Table 3.2) (188, 213).  
Table 3.2 Modified Sarnat Score. 
Grade I 
(mild) 
Grade II 
(moderate) 
Grade III 
(severe) 
Irritability 
‘hyperalert’ 
Mild hypotonia 
Poor sucking 
Lethargic 
Seizures 
Marked abnormalities of tone 
Requires tube feeding 
Comatose 
Prolonged seizures 
Severe hypotonia 
Failure to maintain 
spontaneous respiration 
Source: Levene et al. (1985) (188). 
 
Each infant underwent a final neurological examination by the neonatal staff at discharge 
from the neonatal intensive care unit (NICU). The examination was graded as ‘0’ for normal 
if there were no abnormalities seen, ‘1’ for moderate if there were any suspect findings, such 
as mild head lag, or ‘2’ for severe if there were significant neurological abnormalities 
(increased peripheral tone, poor suck, marked head lag). The date that oral feeding was fully 
established was also recorded.  
3.3.1 Long-term neurodevelopmental follow-up 
Neurodevelopmental follow up was carried out at 6, 12, and 24 months using the Griffiths 
Mental Development Scales – Revised (GMDS-R) (172) for children aged 0-2 years. The scales 
were administered by the Griffiths’ trained paediatricians (DM, and some by PB), either at 
the outpatients’ clinic, or in the participant’s home, in addition to a neurological examination 
assessing peripheral, axial tone and deep tendon reflexes.  Maternal educational level and 
socio-economic status were recorded. At five years, children were invited back for 
neurocognitive assessment including IQ testing using the WPPSI-IIIUK. This tool measures 
overall IQ (FSIQ), Verbal IQ, Performance IQ, Processing Speed quotient (PSQ) and General 
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Language Composite (GLC). A more comprehensive description of the five-year outcome 
assessments is described in Chapters 2 (methodology) and Chapter 5 (main 5-year outcome 
chapter).  
For this study, an abnormal outcome at 24 months was defined as developmental delay 
(GDQ<=87, (mean score minus 1SD), cerebral palsy or death.  
3.3.2 Statistical Analysis 
Statistical analysis was completed using IBM SPSS Statistics V12.0 and V20.0 for MS Windows 
(IBM Corporation, NY, USA) and VassarStats: Website for Computational Statistics (Lowry, R 
1998-2009, Vassar College, NY, USA). Descriptive statistics (means and standard deviations, 
or frequencies) were calculated for birth weight, gestation, and mode of delivery. Evolution 
of ATNAT scores across the first 3 days was presented in stacked bar charts. Correlations 
between neonatal signs and 24-month outcome were assessed using non-parametric 
Spearman’s rho rank correlation in preference to Chi-square test for independence, to 
analyse the ordinal nature of the categories. Their predictive utility were assessed using the 
area under the receiver operator characteristic curve (AUROC), positive predictive value 
(PPV), negative predictive value (NPV), specificity and sensitivity of binary values. For 
associations between ATNAT items and five-year IQ, Pearson’s Product Moment correlation 
was used. Statistical significance was taken as p < 0.05.  
3.4 Results 
From a birth cohort of 65, n=57 infants who had reached 24 months of age at the time of the 
study, were included. Of these, 4 were lost to follow up, giving a two year follow up rate of 
82%. In addition, two infants were excluded due to uncertainty regarding diagnosis of HIE. 
One had concurrent congenital diaphragmatic hernia repaired and one was investigated for 
dysmorphic features and hypotonia. Figure 2.4 in Chapter Two provides a flowchart of the 
cohorts over time. 
The remaining 51 infants consisted of 31 males and 20 females, with a mean (SD) birth weight 
of 3,416 (634) grammes, and a mean (SD) gestation of 40.1 (1.5) weeks. The mode of delivery 
was normal vaginal delivery in 12 (23.5%), forceps in 5 (9.8%), vacuum in 10 (19.6%), 
combined vacuum and forceps in 5 (9.8%), and emergency caesarean section in 19 (37%). 
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Their assigned Sarnat grades were I (mild) in 24 cases, II (moderate) in 18 cases and III 
(severe) in 9 cases. 
3.4.1 Early neurological examination and 24-month outcome. 
The results of the early neurological examinations, observed for each participant and his/her 
diagnostic and developmental outcome at 24 months, are displayed in Table 3.3 (children 
following an abnormal NICU discharge exam) and Table 3.4 (children following a normal NICU 
discharge exam).  
Table 3.3 Neurological examination and outcome details of participants who died or obtained an 
abnormal discharge examination (Case 1-22). 
Case 
no 
ATNAT 
Day 1 
ATNAT 
Day 2 
ATNAT 
Day 3 
Oral 
Feed 
Discharge 
exam  
Sarnat 
Grade  
GDQ - 
24mth Outcome 
1 2 1 n/a 2 n/a 3 86 LD 
2 2 died died No Died died died Died 
3 2 died died No Died died died Died 
4 2 2 2 No Died 3 died Died 
5 2 2 2 No 2 3 50 SQ 
6 1 0 0 3 2 1 95 MD 
7 1 2 2 11 2 3 68 hemi/GDD 
8 1 1 1  2 2 68 hemi/GDD 
9 2 2 1 7 2 2 102 Hemi 
10 2 2 1 6 2 2 52 GDD 
11 2 1 1 8 2 2 84 GDD 
12 1 1 1 4 2 2 99 Diplegia 
13 2 2 2 No 2 3 died Died 
14 2 2 2 No 2 3 died Died 
15 2 2 2 No 2 3 died Died 
16 NMB NMB 1 5 2 2 113 0 
17 2 2 1 7 2 2 116 0 
18 2 2 2 6 1 2 103 Hemi 
19 1 1 1 5 1 2 50 GDD 
20 2 2 1 3 1 2 102 0 
21 1 1 1 2 1 1 112 0 
22 1 1 1 2 1 1 121 0 
ATNAT = Amiel-Tison Neurologic Examination at Term, GDQ = Griffiths Developmental Quotient, 
NMB = neuromuscular blockade, n/a = not available, oral feed = days from birth to establishment of 
oral feeding, SQ = spastic quadriplegia, MD = motor delay, GDD = global developmental delay, LD = 
language delay, hemi = hemiplegia, 0 = normal result/outcome. 
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Table 3.4 Neurological examination and outcome details of participants who obtained a normal 
discharge examination (Case 23-51). 
Case 
no 
ATNAT 
Day 1 
ATNAT 
Day 2 
ATNAT 
Day 3 
Oral 
Feed 
Discharge 
exam  
Sarnat 
Grade  
GDQ - 
24mth Outcome 
23 2 2 2 3 0 2 71 GDD 
24 2 2 1 11 0 2 83 GDD 
25 1 0 0 6 0 1 74 GDD 
26 1 0 0 2 0 1 87 GDD 
27 2 2 1 5 0 2 119 0 
28 2 2 0 5 0 2 117 0 
29 2 1 0 3 0 2 98 0 
30 2 1 0 3 0 1 113 0 
31 2 1 0 2 0 2 101 0 
32 1 1 1 6 0 2 120 0 
33 1 1 1 4 0 2 109 0 
34 1 1 1 4 0 1 109 0 
35 1 1 1 1 0 1 112 0 
36 1 1 0 5 0 1 103 0 
37 1 1 0 4 0 1 109 0 
38 1 1 0 4 0 1 111 0 
39 1 1 0 3 0 1 109 0 
40 1 1 0 3 0 1 100 0 
41 1 0 0 5 0 1 110 0 
42 1 0 0 3 0 1 113 0 
43 1 0 0 3 0 1 119 0 
44 1 0 0 3 0 1 112 0 
45 1 0 0 2 0 1 102 0 
46 1 0 0 2 0 1 113 0 
47 1 0 0 2 0 1 113 0 
48 0 1 0 3 0 1 113 0 
49 0 0 0 3 0 1 108 0 
50 0 0 0 1 0 1 117 0 
51 0 0 0 1 0 1 110 0 
ATNAT = Amiel-Tison Neurologic Examination at Term, GDQ = Griffiths Developmental Quotient, oral 
feed = days from birth to establishment of oral feeding, GDD = global developmental delay, 0 = 
normal result/outcome. 
In the first day of life, 21/51 (41%) had a ‘severely abnormal’ ATNAT score of 2. Of this group, 
by day 2 of life, 2/21 had died, and of the surviving infants, 14/19 continued with a score of 
2, whilst 5/19 had improved to a score of 1. By day 3, only 7/19 continued with a score of 2, 
and all of these experienced a poor outcome (4 deaths, 3 with cerebral palsy, and 1 with 
global developmental delay). These findings are summarised in Figure 3.1. An additional child 
who had an ATNAT score of 1 on day 1 had deteriorated to a score of 2 for day 2 and 3. This 
child was later diagnosed with CP and developmental delay. 
 [102] 
 
On day 1, 25/51(49%) had a ‘moderately abnormal’ ATNAT score of 1. By day 2, of these, 
14/25 remained with ATNAT = 1, and by day 3, 9/25 continued to have an ATNAT = 1. These 
findings are summarised in Figure 3.2. By day 3 for the whole group, 17 infants had ATNAT = 
1 (9 from the Day 1 ATNAT=1 group and 7 from the Day 1 ATNAT=2 group and 1 without a 
day 1 ATNAT score). Of these, 7/17 had abnormal outcomes at 24 months; 4 children with 
global developmental delay, 1 with hemiplegia and developmental delay, 1 with diplegia and 
1 with an isolated hemiplegia. 
 
Figure 3.1 The evolution of infants with a severe neurological abnormality on Day 1, assessed using 
the ATNAT. ATNAT1, ATNAT2, ATNAT3 = Amiel-Tison neurological assessment at Term day 1, 2 and 3 
respectively. Normal = ATNAT score = 0, moderate = ATNAT score = 1, Severe = ATNAT score = 2. 
Discharge exam = neurological examination at discharge from the NICU. 
N/A 
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Figure 3.2: The evolution of infants with a moderate grade neurological abnormality on Day 1, 
assessed by ATNAT. ATNAT1, ATNAT2, ATNAT3 = Amiel-Tison neurological assessment at Term day 1, 
2 and 3 respectively. Normal = ATNAT score = 0, moderate = ATNAT score = 1, Severe = ATNAT score 
of 2. Discharge = neurological examination at discharge from NICU. 
 
A small group of infants, 4/51 (8%) had normal ATNAT assessments on day 1, all with normal 
24 month outcomes. 
In the whole series, by day 3 of life, 23/49 (47%) of the surviving infants had normal ATNAT 
neurological assessments. Of this group, 3/23 had mild developmental delay at 24 months.  
Examination at discharge was performed on the final day of the infant’s stay in NICU by 
research or medical staff. This assessment did not use the structured ATNAT and each baby 
was assigned a grade of normal, moderate or severe based on their clinical findings. The age 
of the infants varied from 2 to 27 days, with the sicker infants remaining hospitalized longer. 
Data was missing for one infant, and three infants died prior to NICU discharge. Of the 
remaining 47, discharge neurological examination was entirely normal in 29/47 (62%), in 
5/47 (11%) moderate abnormalities were seen. The remaining 13 infants (28%) continued to 
have severely abnormal examinations on discharge from NICU.  
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There was a significant correlation (p < 0.01) between neurological outcome at two years 
and ATNAT on days 1, 2 and 3 of life. In addition, outcome correlated with Sarnat score, and 
examination at discharge (Table 3.5). The best correlation was seen between outcome and 
examination at discharge, followed by Sarnat score assigned, and finally ATNAT on day 3. 
GDQ scores at 24 months differed significantly depending on ATNAT score on day 3. The 
mean (SD) GDQ scores were 106.4 (10.5) in the normal ATNAT day3 group, 98.3 (22.9) in the 
moderately abnormal ATNAT day3 group, and 61.5 (18.96) in the severely abnormal ATNAT 
day3 group. 
 
Table 3.5 Correlation between early neurological assessment and 24 month outcome. 
Examination 
Correlation with 
Outcome Status* 
Correlation with 
GMDSR Dev. Quotient 
AUROC for Outcome Status 
 
ρ value 
(n=47) 
p-value 
ρ value 
(n=44) 
p-value (95% CI) p-value 
ATNAT day 1 0.45 0.001 0.43 0.002 
0.652 
(0.47-0.84) 
0.132 
ATNAT day 2 0.42 0.003 0.40 0.004 
0.652 
(0.45-0.86) 
0.132 
ATNAT day 3 0.46 0.001 0.59 0.001 
0.754 
(0.58-0.93) 
0.012 
Sarnat grade 0.64 0.001 0.61 0.001 
0.744 
(0.57-0.92) 
0.016 
Discharge 
exam 
0.65 0.001 0.50 0.001 
0.786 
(0.64-0.96) 
0.005 
*Outcome status = Normal or abnormal 24 month outcome, ρ = rho value = correlation coefficient 
using Spearman’s Rank correlation, GDQ = general quotient of GMDS-R at 24 months, ATNAT day 1 = 
Amiel-Tison Test of Neurological Assessment at Term on day 1 of life, ATNAT day 2 = ATNAT score on 
day 2 of life, ATNAT day 3 = ATNAT score on day 3 of life. AUROC = area under the receiver operated 
characteristic curve. 
AUROC curves were statistically significant for ATNAT day 3, Sarnat score, and highest for 
discharge examination. In summary, the later that a neurological assessment was performed, 
the more reliable was its prediction of outcome.  
To determine whether differences existed between the correlation coefficients of the 
neonatal tests (that had significant AUROC values) and the 24 month GDQ and overall 
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outcomes, the t-statistic was used as the comparison between dependent coefficients (214). 
No differences were found in the correlation strengths between the neonatal tests and 24-
month GDQ scores, however, Sarnat grade (z=3.52, p<.01) and the discharge exam (z=2.26, 
p=.012) had stronger correlations than ATNAT day 3 for 24-month outcome.  Within each of 
the individual neonatal tests, only ATNAT day 3 had a stronger correlation for one of the 2 
year outcomes, suggesting a better ability to correlation with GDQ than with overall 24-
month outcome (z=2.53, p<.01).  
Neurological outcomes at 24 months correlated with discharge examination (ρ = 0.65, p < 
0.001). Of the 13 severely abnormal participants, 11/13 had abnormal outcomes at follow 
up. Of the 5 moderately abnormal, 2/5 had abnormal outcomes. Of the 29 infants with 
normal examinations at discharge, 25/29 (86%) were normal at 24 months. This gave a 
positive predictive value (PPV) of an abnormal examination at discharge of 72% (95% C.I.: 
0.46-0.89), and a negative predictive value (NPV) of 86% (95% C.I.: 0.67-0.95). Sensitivity was 
calculated at 77%, and specificity at 83%. 
Within the subgroup of 18 infants with Sarnat Grade II, or moderate encephalopathy, 
examination at discharge was still moderate or severely abnormal in 10/18. An abnormal 
examination at discharge predicted an abnormal outcome with a PPV and NPV of 70% (95% 
C.I.: 0.35-0.92) (7/10) and 75% (95% C.I.: 0.36-0.92) (6/8) respectively.  
3.4.1.1 Oral feeding and 24-month neurological outcome 
Time to establishment of oral feeding (days from birth) correlated significantly with 
neurological outcome (ρ=0.40, p=0.008).  In 7/51 (14%) infants oral feeding was never 
established; 3/7 died in the first week of life, prior to NICU discharge. The 4 surviving infants 
were discharged with nasogastric feeding tubes. Of these 4 children, 3 have died and the sole 
survivor has severe cerebral palsy (spastic quadriplegia). Three further children took more 
than 7 days to establish feeding, and all of these infants had abnormal outcomes; 1 with 
isolated hemiplegia, and 2 with global developmental delay.  
3.4.2 ATNAT items and five-year outcome 
We were interested to further analyse the ATNAT day 3 findings, and to examine whether 
they were related to five-year cognitive outcome in our HIE cohort. The outcome 
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measurement used was the Full-Scale IQ (FSIQ) from the WPPSI-IIIUK. From the cohort, at the 
time of preliminary analysis, 34 were included in this arm of the study.  
Each of the individual 35 items of the ATNAT were analysed using Pearson’s Product Moment 
correlation statistics to assess associations between ATNAT items and five-year FSIQ score. 
Of these, only nine items correlated significantly (p<0.05) with FSIQ. Table 3.6 provides a 
summary of these findings. 
Table 3.6 ATNAT total score and items that correlate significantly with 5-year WPPSI-IIIUK Full Scale IQ 
ATNAT vs. FSIQ Pearson coefficient 
(r) 
Level of significance 
(p-value) 
Shared variance 
r2 
ATNAT Total -0.47 <0.01 0.22 
Palmar Grasp -0.65 <0.01 0.42 
Crying -0.63 <0.01 0.40 
Lower Limb Recoil -0.49 <0.01 0.24 
Upper Limb Recoil -0.47 <0.01 0.22 
Upper Limb Scarf -0.45 <0.01 0.20 
Fix and Track -0.43 <0.05 0.18 
Response -0.40 <0.05 0.16 
Social Interaction -0.40 <0.05 0.16 
Lower Limb Angle -0.35 <0.05 0.12 
 
For the ATNAT total, and the individual items that had a shared variance of at least 20%, the 
results are displayed graphically in Figure 3.3 and Figure 3.4. 
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Figure 3.3 Correlation between the global ATNAT score measured on day 3 of life in the HIE cohort and 
global IQ outcome at age five years. 
 
Figure 3.4 Correlation between ATNAT individual items (palmar grasp, crying, lower limb recoil, 
upper limb recoil, upper limb scarf) measured on day 3 of life in the HIE cohort and global IQ outcome 
at age five years. 
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With respect to the ATNAT scores, the ‘palmar grasp’ item had the highest shared variance 
for all but one (PIQ) of the WPPSI-IIIUK domains – (r2 values were 0.42 for FSIQ, 0.33 for VIQ, 
0.40 for PIQ, 0.40 for PSQ, 0.37 for GLC). With respect to the FSIQ and the other IQ domains, 
Performance IQ had the highest shared variance for all but one (palmar grasp) of the nine 
significant ATNAT items. 
 
3.5 Discussion  
This study demonstrates the pattern of neurological evolution in infants with hypoxic-
ischaemic encephalopathy over the first three days of life. Neurological examination 
normalised in many infants with 47% having a normal examination by day three. A normal 
early assessment predicted a normal outcome at 24 months. Those infants with persistent 
neurological abnormality on day three were more likely to progress to neurodevelopmental 
disability. This risk was 100% in those with severely abnormal ATNAT rating, and 41% in those 
with a moderately abnormal rating 
With respect to five-year outcome, the ATNAT total score and nine of the individual items 
measured on day 3 of life correlated negatively with IQ at five years. 
A number of methods to assess neonatal neurological status have been described (56, 57, 
215). The Amiel-Tison method was chosen because it is quickly and easily administered, 
examines forebrain function and has been previously shown to correlate with outcome at 
12-15 months, in particular to outcome following perinatal asphyxia (62, 65). A further 
strength of the ATNAT, is the inclusion of items that assess early observations of infant 
behaviour such as sucking. Neonatal examination used in combination with a modified 
Sarnat score at 6 hours of age with amplitude integrated EEG (aEEG) has been found to 
enhance aEEG’s ability to predict neurological outcome at one year (66). Amess et al. also 
found that neonatal neurological assessment was a useful adjunct to magnetic resonance 
spectroscopy, with late examinations (> 7 days) having superior predictive sensitivity of 12-
month outcome than early examinations (< 48 hours) (62). 
The current study found that the later that a neurological examination was performed, the 
greater the correlation with neurological status at 24 months. In terms of correlation 
strength, the ATNAT day 3 was on a par with Sarnat and the discharge exam for mental 
 [109] 
 
development at 24 months.  An abnormal examination at the time of discharge placed the 
infant in a high-risk group, with 72% progressing to developmental delay. In the moderate 
subgroup, the discharge examination was particularly useful. In infants with moderate Sarnat 
scores, the overall rate of abnormal outcome was 50%. However, this was 25% in those with 
a normal discharge examination, and 70% in those with an abnormal discharge examination. 
Thus, a clinician may find the neurological status at discharge useful in counselling parents 
and guiding long-term follow-up. Sarnat scoring, or ATNAT assessment at 24 hours combined 
with a detailed examination at discharge could provide outcome indicators to physicians who 
do not have access to more sophisticated methods of prognostication. The utility of detailed 
neonatal neurological assessment in these situations has been previously demonstrated in 
the developing world (81, 216). Our data confirms the importance of structured neonatal 
neurological examination and its ability to aid prognostication.  
Why does the discharge examination appear to be more reliable in predicting outcome? A 
number of factors may interfere with accurate neurological assessment in the first few days 
of life. Sicker infants may be intubated, and/or sedated. Hypotension, shock and multi-organ 
failure may lead to abnormalities of tone and movement (217). Many of our infants received 
anticonvulsants and sedatives. One infant who had meconium aspiration syndrome was 
ventilated and received neuromuscular blockers for the first 2 days of life, making 
neurological assessment impossible. By discharge most of these confounders will have 
abated, helping to explain the increased sensitivity (77%) of the abnormal examination at 
discharge, compared with earlier examinations. Notably, one limitation was that the 
discharge examination was performed and recorded by different medical staff. These 
examinations were also performed at different ages. This highlights the importance of a 
detailed, consistent discharge examination of the neurological status of these high-risk 
infants.  
The individual contribution of each item of the ATNAT for the prediction of outcome deserves 
further scrutiny. The nine items found to be significant in this study were related to passive 
muscle tone (upper and lower limb recoil, upper limb scarf and lower limb angle), 
neurosensory elements (crying, visual fix and track, response and social interaction) and the 
palmar grasp primitive reflex. The cranial items were not significant, and this is consistent 
with the finding from others that it is too early to detect cranial dysmorphisms or a head 
which may not grow as expected postnatally (218). As outlined earlier, NICU care and 
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sedation can affect the manifestation of reflexes, however palmar grasp was more easily 
elicited and significantly associated with five-year IQ outcome. The set of items with the 
greatest correlation were for passive muscle tone and neurosensation (crying, fix and track, 
response to voice and social interaction). Hypotonia is a central feature of neurological 
assessment and differences in severity between upper and lower limbs can aide diagnosis 
and prognostication (127). The infants’ alertness indicated by the neurosensory observations 
also correlated with five year IQ and may reflect intact cortical control (64). In this study 
upper and lower limb recoil scores had similar if not higher correlation than the ATNAT global 
score for five-year outcome. Active tone, Gosselin et al. argue is a better marker for higher 
control (basal ganglia and hemispheres) and descends with time, than for lower motor 
control of the brain stem and cerebellum. These axial motor activities were not significant 
with IQ outcome, however axial tone can be affected by transient abnormal posture (64). 
A limitation of the administration of the ATNAT exclusively in the neonatal period is that it 
precludes access to later-elicited responses (e.g. postural reactions) which may possess 
superior predictive qualities (67). Further analysis of the individual items of the ATNAT may 
reveal markers for later outcome, because it includes behavioural and communication items, 
which share construct validity with later developmental assessments (68). The ‘Amiel-Tison 
triad’ of signs, administered in the first 18 months, for example, can suggest damage due to 
a focal lesion. There have been promising observations in relation to premature infants and 
clusters of ATNAT signs that may predict subtle neurological outcome (219). Detailed analysis 
of early clinical signs is dependent on what can be elicited in a neurological examination. At 
birth this is limited by the level of maturation of the baby at that time, and what their nervous 
system can display. A recent study of low risk infants assessed serially at 3, 6, and 48 hours 
of age, differentiated items that remained stable over time, and those which marked 
maturity in the infant (e.g. visual tracking) in this short period (220). Future study will be 
required to replicate these findings and especially to isolate those items most likely to be 
transiently affected by the birth process in the first hours of life. 
Similar to the argument made for the importance of detailed follow-up in premature babies 
(210), the clinical criteria for neurodevelopmental follow-up in the HIE population deserves 
attention. Earlier studies have demonstrated neuropsychological deficits in older children, 
(75, 121) and our cohort are currently being followed up into the school years. This study has 
highlighted eight children at age 2 with developmental delay with no motor disability. It is 
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this group of children, if not appropriately screened, who are at risk of not being identified 
for early interventions. Fortunately, interesting models of serial developmental screening in 
young children are being developed, for example, the ‘developmental pathways study’ (221), 
which may go some way towards resolving this issue. 
In conclusion, we have shown that neurological signs evolve rapidly over the first three days 
following perinatal asphyxia. Persistence of abnormal neurological signs correlates 
significantly with adverse outcome. The later a neonatal neurological examination was 
performed, the better its predictive ability, with examination at discharge having a PPV and 
NPV of 72% and 86% respectively. 
  
 [112] 
 
 
 
 [113] 
 
CHAPTER 4 
4 The Ability of Early Serial Developmental Assessment to 
Predict Outcome at 5 Years Following Neonatal Hypoxic-
Ischaemic Encephalopathy. 
 
Catherine M O’Connor, C Anthony Ryan, Geraldine B Boylan, 
Deirdre M Murray. 
 
 
 
 
 
 
 
 
 
 
 
 
Published: Early Human Development (2017) 110: 1-8.  
 [114] 
 
4.1 Abstract 
Background: 
Neurodevelopmental difficulties in children following hypoxic-ischaemic encephalopathy 
(HIE) may not emerge until school age. 
Aims: 
To evaluate the value and stability of early serial developmental assessments in predicting 
long-term outcome. 
Study Design:  
Prospective study of 65 infants with neonatal HIE and early continuous EEG at birth. 
Participants: Term infants with HIE were recruited at birth. Development was measured at 
6, 12 and 24 months using the Revised Griffiths’ Scales (GMDS-R). Outcome Measures: 
Intellectual abilities at age five were measured using the Wechsler Preschool & Primary Scale 
of Intelligence (WPPSI-IIIUK) and the ‘numbers’ subtest from the Children’s Memory Scale. 
Overall five-year outcome was also reported. 
Results: 
IQ outcome was available in forty-seven surviving children (28 male, 19 female: mean (SD) 
age 64.0(5.7) months). Mean processing speed (p=0.01) and short-term verbal memory 
(p=0.005) were below the norm. Global development (GDQ) at 6, 12 and 24 months 
correlated (p<0.01) with five-year global, verbal and performance IQ with improved 
correlation over time. Normal GDQ throughout early childhood predicted normal IQ at 5 
years (24-month AUROC value=0.941, p=0.001). All children who had an abnormal 6-month 
or 12-month GDQ had an overall abnormal outcome at age five, as did 80% of abnormal GDQ 
at 24mths. GDQ predictions were superior to neonatal Sarnat and EEG grading for abnormal 
outcome at age five. 
Conclusions: 
Normal early development predicts normal 5-year IQ with prediction increasing over time.  
Repeated measurement is warranted due to instability of findings across the first two years. 
Follow-up for children with abnormal early development is warranted given high sensitivity 
for school-age global abnormal outcome.  
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4.2 Introduction 
Hypoxic-ischaemic encephalopathy (HIE) occurs following approximately 3 per 1000 term 
births. It remains one of the leading causes of neonatal death, with survivors at risk of 
significant neurological disability including cerebral palsy, epilepsy, intellectual disability, and 
sensory loss (127). Longer term outcome studies have reported more specific 
neurodevelopmental sequelae that may not emerge until after 24 months (71, 74, 75). These 
include delayed educational attainment and specific deficits in language, sensorimotor and 
selected memory domains (130, 222). In particular, working memory, long-term episodic and 
specifically verbal learning and retention are lower in children with moderate and severe HIE 
(124, 223).  
The challenge lies in the early identification of children for whom later-emerging deficits are 
more likely to occur. Research studies have outlined the importance of follow up of affected 
children into their school years to capture the full impact of early injury (224). 
The ability of early standardised developmental assessment to predict later cognitive 
outcome is clear at the extremes of developmental progress because a severe insult has a 
suppressor effect across multiple development domains (225). However, the prediction of 
more subtle deficits, most amenable to intervention, poses a greater challenge. Prediction 
studies observing clinical samples of infants tend to report low sensitivity and high specificity 
for later intellectual difficulties (226-228). Development progresses rapidly in the first years 
of life and the range of “normal development” is wide. Little information is available 
regarding the temporal stability of repeated early developmental assessments (229). 
Stability is likely to depend upon the patterns of development in the underlying domains of 
motor skills, language and cognition. The optimal time to assess these domains in early 
childhood remains unclear and the importance of serial assessment is acknowledged (230). 
The use of the Bayley Scales (231), predominates in this field, and knowledge of predictive 
properties of other standardised development assessments such as the Griffiths scales is less 
well understood, especially for infants following neonatal HIE. 
This study sought to record the temporal stability of serial developmental assessment in 
children following HIE at 6, 12 and 24 months and to determine the role of age at assessment 
for the prediction of (i) cognitive abilities and (ii) overall outcome at five years. 
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4.3 Materials and methods 
4.3.1 Participants 
Infants with hypoxic-ischaemic encephalopathy (HIE) were prospectively recruited between 
May 2003 and December 2005, from a maternity service with approximately 6,000 deliveries 
per annum (212). Children were recruited prior to the introduction of therapeutic 
hypothermia and were therefore not cooled. Ethical approval was granted from the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals, Cork, Ireland. Inclusion criteria 
were infants of >=37 weeks gestation who met at least two of the following: (i) initial capillary 
or arterial pH <7.1, (ii) Apgar score <5 at 5 minutes, (iii) initial arterial or capillary lactate >7 
mmol/L, (iv) abnormal neurology or clinical seizures. Infants were excluded if they had co-
existing congenital anomalies, or significant co-morbidity. Written informed consent was 
obtained from the parent(s) within 6 hours of birth, or where relevant, with the onset of 
clinical seizures. Serial administration of neurological assessments, and continuous EEG 
monitoring was performed for 24-72 hours duration. The EEGs were graded according to 
background activity, as follows: Grade 0 (normal) - continuous background pattern with 
normal physiologic features; Grade 1 (normal/mild abnormalities) - continuous background 
pattern with slightly abnormal activity (mild asymmetry, mild voltage depression, or poorly 
defined sleep wake cycle (SWC); Grade 2 (moderate abnormalities) – discontinuous activity 
with inter-burst interval (IBI) of <10s, no clear SWC, or clear asymmetry or asynchrony; Grade 
3 (major abnormalities) – discontinuous activity with IBI of 10-60s, severe attenuation of 
background patterns or no SWC; Grade 4 (inactive EEG findings) – background activity of < 
10µV or severe discontinuity with IBI of >60s. A modified Sarnat encephalopathy grade was 
assigned at 24 hours (14, 188). These methods have been described previously (232). 
4.3.1.1 Outcome data 
The Griffiths Mental Development Scales (0–2), 1996 revision (GMDS-R) (172), was used to 
obtain standardised developmental assessments. Children were seen at 6, 12 and 24 months 
by a Griffiths’ certified trained paediatrician (Dr. Deirdre Murray) either at home or at the 
outpatients’ clinic. A neurological examination assessing peripheral tone, axial tone and deep 
tendon reflexes was completed.  
The Griffiths is a standardised assessment of infant and child development and was chosen 
for its clinical utility, psychometric properties and ecological validity. The scales were 
scientifically constructed based on item analysis and developmental theory. Items are 
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categorised into five subscales, ‘Locomotor’, ‘Hearing and Language’, ‘Personal-Social’, ‘Eye-
Hand Co-ordination’ and ‘Performance’, with standardised subscale means ranging 100.2–
101.1 (15.9–16.3) for the standardisation sample(172). The overall Griffiths’ developmental 
quotient (GDQ) mean is 100.5 (11.8). An ‘abnormal’ score in this study was considered a GDQ 
≤88. 
At age five years, participants were contacted, and those that provided written consent for 
inclusion in the research study, were seen either at home or at a research facility, for 
intellectual assessment by a clinical psychologist (the current researcher) blinded to the 
neonatal data and early Griffiths’ assessments. Neurological assessment was undertaken by 
a research paediatrician who assessed muscle tone, power and deep tendon reflexes. A 
GMFCS (Gross Motor Function Classification System) score (205), was assigned to children 
with cerebral palsy. Medical and demographic information was included in a parent 
questionnaire. Intellectual ability was assessed using the Wechsler Preschool and Primary 
Scales of Intelligence – 3rd UK Edition (WPPSI-IIIUK) (194). Scaled scores for subtests and Full-
Scale IQ (FSIQ), Verbal IQ (VIQ), Performance (non-verbal) IQ (PIQ), Processing Speed 
Quotient (PSQ), and General Language Composite (GLC) were calculated. All composite 
scores are standardised with a mean of 100(15). An ‘abnormal’ IQ was defined in this study 
as <=84. The ‘Numbers’ subtest of the Children’s Memory Scale (CMS) (203), was also 
administered to include a measure of verbal working memory, and scaled scores calculated. 
An ‘abnormal’ outcome at age five was defined as death, cerebral palsy (CP), significant 
hearing/vision loss, FSIQ >= 1SD below the mean (i.e. IQ <=84), a DSM-IV diagnosed 
neurodevelopmental disorder (autistic spectrum disorder (ASD), developmental co-
ordination disorder (DCD), attention deficit hyperactivity disorder (ADHD), Language 
Disorder (Lang D/O)) and/or requirement for multidisciplinary early intervention (MD EI) 
team. Referrals to relevant individual health professionals were also noted. 
4.3.2 Statistical Analysis 
Statistical analysis was completed using IBM SPSS Statistics 20.0 for MS Windows (IBM 
Corporation, NY, USA) and VassarStats: Website for Computational Statistics (Lowry, R 1998-
2012, Vassar College, NY, USA). Mann-Whitney (continuous) and Chi-square (categorical) 
correlations were used to explore normal/abnormal 5-year outcome data with birth and 
social data. Fisher’s exact (and the Freeman Halton extension) statistics were used when the 
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minimum expected cell frequency assumption was violated, i.e. cell numbers less than 5. 
Spearman’s rank correlation coefficients were analysed for all IQ quotients. One sample t-
tests were used to compare observed scores to the WPPSI-IIIUK test norms. PPV, NPV, 
sensitivity, specificity, and AUROC curves with confidence intervals were calculated. It is 
important to note that in this chapter the use of prediction statistics (PPV, NPV, sensitivity 
and sensitivity, AUROCS) were not used in the conventional way, but rather to predict 
normality rather than diagnosis. Consequently, ‘PPV’ refers to the predictive value of a 
NORMAL early score for later NORMAL score, and ‘NPV’ refers to the predictive value of an 
early abnormal score to predict later abnormal score. All p values were two-tailed with 
statistical significance cut-off set at < 0.05. 
4.4 Results 
In total, 65 children were recruited to the study. The modified Sarnat grades assigned at 24 
hours were: 27 mild, 21 moderate, and 12 severe. Of these, by 24 months, 6 (all severe) had 
died, 6 (4 mild, 2 moderate) were lost to follow-up and two had been excluded due to 
confounding medical conditions – one (mild) with a repaired congenital diaphragmatic 
hernia and the other (moderate) with a suspected genetic syndrome due to dysmorphic 
features and generalised hypotonia. The remaining 51 children were contacted at age five. 
Of these, 1 (moderate) was lost to follow up and 3 (2 mild, 1 moderate) withdrew from the 
study. See Figure 4.1 for flowchart. 
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Figure 4.1 Flowchart of HIE Birth Cohort to Five Year Assessment. 
 
At five years 47/59 (79.6%) surviving children (28 male, 19 female) attended for IQ 
assessment. Mean(SD) age at assessment was 64.0(5.7) months. To avoid practice effect, the 
IQ data for six of these children already enrolled in local health/disability services was taken 
from assessments completed within the previous six months by external psychologists. Three 
children were unable to complete the WPPSI-IIIUK due to severe physical disability. Of these, 
two were assigned basal IQ outcomes at age five, and one was inconclusive. Therefore, IQ 
scores were available for 46 children. 
The relevant birth, clinical and demographic data for the children who attended at age five 
years is presented in Table 4.1. 
 
65 recruited from cohort at 
birth
41 attended 6 month follow-up
42 attended 12 months follow-up
45 attended 24 month follow-up
51 contacted at five years
47 attended cognitive 
assessment  at five years
3 withdrew
1 lost to follow-up
6 died (5 in neonatal period; 1 before 24mths)
2 excluded (query chromosomal anomoly and hernia)
6 lost to follow-up
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Table 4.1 Clinical and Demographic Characteristics of the Children who attended for five-year 
outcome. 
PERINATAL DATA n=47 
Birth weight (mean(SD)) g 3431.02 (618.26) 
Gestational age (mean(SD)) weeks 40.15 (1.48)* 
First Born n(%) 36 (78)* 
Mode of delivery n(%) 
NVD 
Instrumental 
Emergency CS 
 
8 (17) 
22 (47) 
17 (36) 
Apgar Score at 1 min 3.70 (2.28) 
Apgar Score at 5 mins 6.00 (1.91) 
Male Gender n(%) 28 (60) 
First documented pH (venous) mean(SD) 6.99 (0.18) 
First documented BD (venous) mean(SD) -13.8 (4.9) 
Sarnat Grade n(%) 
Mild 
Moderate 
Severe 
 
22 (47) 
19 (40) 
6 (13) 
EEG at 24 hours n(%) 
Grade 0 (normal) 
Grade 1 (normal/mild abnormalities) 
Grade 2 (moderate abnormalities) 
Grade 3 (major abnormalities) 
Grade 4 (inactive) 
** 
5 (11) 
26 (55) 
7 (15) 
6 (13) 
1 (2) 
DEMOGRAPHICS 
 
n=47 
Age assessed (Mean(SD)) months 64.00 (5.74) 
Has sibling(s) n(%) 32 (73) † 
Commenced Primary Schooling n(%) 36 (78)* 
Maternal Education Level‡ n (%) 
Primary or Lower Secondary 
Secondary School Completed 
Third Level Qualification 
† 
9 (21) 
19 (43) 
16 (36) 
Household Occupation‡ n(%)  
Professional/Managerial/Technical 
Non-manual 
Skilled/Semi-skilled/Unskilled Manual 
* 
18 (39) 
9 (20) 
19 (41) 
Race:     White n(%) 43 (92) 
 
Region: n(%) 
Urban 
Small Town 
Rural 
 
15 (32) 
20 (43) 
12 (26) 
 [121] 
 
SD = standard deviation, NVD= normal vaginal delivery, CS=Caesarean Section, BD= base deficit, n/a 
= not available. *1 missing value; **2 missing values; †3 missing values; ‡ Category definitions 
modelled on Irish Census (2006) data. 
4.4.1 HIE Birth Cohort - Outcome at Five Years 
Of the original cohort of 65 children born with HIE, the outcome of 53 children was known 
at 5 years, with 47.2% (25/53) having an abnormal outcome. Six died (5 in the neonatal 
period and 1 before 24 months), eight had cerebral palsy (3 with intellectual disability), one 
had hearing impairment, four had an IQ>1SD below the mean (3 with concurrent diagnoses: 
1 ADHD, 2 Lang D/O) four further diagnosed neurodevelopmental disorders (1 ASD, 1 ADHD, 
1 DCD, 1 Lang D/O) and two attending MD EI teams. Categorised by Sarnat grade, the rates 
of abnormal outcome were: mild - 6/22 (27.3%); moderate - 9/19 (47.4%); severe - 10/12 
(83.3%).  
Intellectual abilities assessed at five years revealed mean scores in keeping with the mean 
standardised test norm of 100(15) for Full-Scale (FSIQ) 99.2(18.0), Verbal (VIQ) 100(17.9), 
Performance (PIQ) 101.3(17.1) and Language (GLC) 97.7(16.3) domains. However, Processing 
Speed (PSQ) was significantly reduced at 92.5(18.3) (t=-2.69, p=0.010), due to lower than 
expected scores on the ‘Coding’ subtest (one of two subtests used to calculate PSQ). The 
mean scaled score of 8.11(3.41) and median score of ‘8’ were significantly below the 
expected norm of 10(3), (t=-3.68, p=0.001). 
To display further the influence of the underlying individual WPPSI-IIIUK subtests for each of 
the quotients, Table 4.2 provides outcome subtest-level scores for the HIE cohort as a whole, 
and for those with no diagnosis of CP. The patterns of central tendency and dispersion are 
broadly similar within the sets for the Verbal IQ and General Language Composite. However, 
within the Performance IQ subtests, the mean Picture Concepts scaled score is higher than 
the Block Design and Matrix Reasoning subtests. 
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Table 4.2 Mean WPPSI-IIIUK and CMS subtest scaled scores for (i) the HIE cohort at age 5 (ii) the HIE 
cohort without cerebral palsy. 
Subtest scaled scores 
HIE Cohort: All 
(n=42) 
HIE Cohort: No CP 
(n=38) 
WPPSI-IIIUK Mean S.D. Mean S.D. 
Verbal IQ     
Information 10.31 2.67 10.32 2.65 
Vocabulary 11.20 2.22 11.27 2.16 
Word Reasoning 11.00 2.68 11.0 2.62 
Performance IQ     
Block Design 10.48 2.97 10.66 2.84 
Matrix Reasoning 10.36 2.02 10.37 1.99 
Picture Concepts 11.71 2.23 11.73 2.17 
Processing Speed Quotient     
Coding 8.11 3.41 8.70 3.04 
Symbol Search 9.33 3.46 10.00 2.92 
General Language Composite     
Receptive Vocabulary 9.59 2.45 9.54 2.48 
Picture Naming 10.49 2.47 10.51 2.50 
CHILDREN’s MEMORY SCALE     
Verbal Working Memory 8.45 4.02 8.74 3.72 
Digit Span Forwards 8.21 3.78 8.53 3.47 
Digit Span Backwards 9.97 3.56 10.03 3.50 
CP = cerebral palsy, WPPSI-IIIUK = Wechsler Preschool and Primary Scale of Intelligence 3rd UK 
version, IQ = intelligence quotient; S.D. = standard deviation. 
The impact of Sarnat grade of HIE on IQ scores is presented in Table 4.3. The effect of a 
cerebral palsy diagnosis is also displayed. As expected, the infants with severe HIE had the 
worst outcomes, with the mean FSIQ = 73.8(33.3). However, the two children with severe 
HIE and no cerebral palsy at follow-up had normal IQs, compared to three children with CP 
(IQs - 68, 43, 43). 
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Table 4.3 Means and standard deviations of WPPSI-IIIUK Full-Scale and domain quotients for all 
children at five years, and subdivided by Sarnat Grade (mild, moderate, severe) and/or diagnosis of 
cerebral palsy. 
WPPSI-IIIUK 
scores 
All Children No cerebral palsy Cerebral palsy 
 N Min Max Mean S.D.  N mean S.D. N mean S.D. 
FSIQ total 46 43 125 99.2 18.0 39 102.9 12.4 7 78.6 29.3 
FSIQ mild 22 84 125 102.8 11.2 22 102.8 11.2 0 NA NA 
FSIQ mod 19 75 123 101.7 14.5 15 102.4 14.5 4 99.0 16.6 
FSIQ severe 5 43 118 73.8 33.3 2 107.5 14.8 3 51.3 14.4 
VIQ total 46 48 131 100.0 17.9 39 103.0 13.6 7 82.9 28.8 
VIQ mild 22 83 131 104.2 11.1 22 104.2 11.1 0 NA NA 
VIQ mod 19 67 127 100.8 16.5 15 100.3 16.8 4 102.8 17.6 
VIQ severe 5 48 121 78.0 32.1 2 110.5 14.8 3 56.3 13.6 
PIQ total 46 49 131 101.3 17.1 39 105.0 11.2 7 80.6 28.5 
PIQ mild 22 81 131 104.1 11.5 22 104.1 11.5 0 NA NA 
PIQ mod 19 79 127 104.7 13.0 15 106.0 11.3 4 100.0 19.6 
PIQ severe 5 49 116 75.6 30.2 2 107.0 12.7 3 54.7 9.8 
PSQ total 43 49 137 92.5 18.3 37 95.8 15.6 6 71.8 21.2 
PSQ mild 21 71 125 95.4 13.3 21 95.4 13.3 0 NA NA 
PSQ mod 17 60 137 94.8 19.0 14 96.1 20.0 3 88.7 14.6 
PSQ severe 5 49 104 72.6 25.0 2 99.0 7.1 3 55.0 7.9 
GLC total 42 45 128 97.7 16.3 36 100.2 11.9 6 82.5 29.2 
GLC mild 21 83 128 102.5 12.6 21 102.5 12.6 0 NA NA 
GLC mod 17 78 113 98.5 10.1 13 98.0 9.8 4 100.3 12.7 
GLC severe 4 45 103 68.8 27.2 2 90.5 17.7 2 47.0 2.8 
WPPSI-IIIUK: Wechsler Preschool and Primary Scale of Intelligence – 3rd UK Edition. FSIQ: Full Scale 
Intelligence Quotient. VIQ: Verbal Intelligence Quotient. PIQ: Performance Intelligence Quotient. 
PSQ: Processing Speed Quotient. GLC: General Language Composite. Mild: mild Sarnat grade. Mod: 
moderate Sarnat grade. Severe: severe Sarnat Grade. N: number of children. S.D.: standard 
deviation 
The mean FSIQ outcome scores for mild (102.8(11.2)) and moderate (101.7(14.5)) HIE grade, 
were similar and did not differ significantly from expected norms. In addition, scores for mild 
and moderate VIQ (104.2(11.1), 100.8(16.5)), PIQ (104.1(11.5), 104.7(13.0)), PSQ (95.4(13.3), 
94.8(19.0)) and GLC (102.5(12.6), (98.5(10.1)) were similar in both groups. The greatest 
difference was seen in processing speed (PSQ) across all grades.  
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Verbal short-term memory (‘digit-span forwards’ task) scores for all Sarnat grades were 
lower than the normative values. For the sample, the Numbers Forward task was 8.33(3.85); 
significantly below the expected norm of 10(3) (t=-2.85, p=0.007). Furthermore, we were 
unable to assign verbal working memory scores, as an insufficient number of children met 
the baseline criteria for the ‘Numbers backwards’ task on the Children’s Memory Scale.  
4.4.2 Correlation between early developmental assessment and five-
year outcome. 
We next examined the strength of association between the Griffiths’ developmental 
assessments undertaken at 6, 12 and 24 months with IQ outcome at five years. GDQ at 6, 12 
and 24 months correlated significantly with FSIQ, VIQ and PIQ at five years (Table 4.4), and 
the strength of correlation increased over time. The highest correlation was found between 
the composite Griffiths DQ at 24 months and FSIQ at 5 years (ρ=0.64, p<0.001), explaining 
41% of the shared variance. 
Table 4.4 Correlation between developmental quotients at 6, 12 and 24 months and intellectual 
outcome at five years. 
WPPSI-IIIUK 
at 5 years 
Griffiths DQ at 6 
months 
Griffiths DQ at 12 
months 
Griffiths DQ at 24 
months 
 ρ-
value 
p value N ρ-
value 
p value N ρ-
value 
p value N 
Full Scale IQ 0.45 0.006 36 0.58 <0.001 37 0.64 <0.001 40 
Verbal IQ 0.48 0.003 36 0.52 0.001 37 0.58 <0.001 40 
Performance IQ 0.42 0.010 36 0.51 0.001 37 0.51 0.001 40 
Proc. Speed Q 0.20 0.263 33 0.52 0.002 34 0.53 0.001 37 
Gen. Lang. Com 0.57 0.001 33 0.30 0.081 34 0.42 0.011 36 
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WPPSI-IIIUK 
at 5 years 
Griffiths DQ at 6 
months 
Griffiths DQ at 12 
months 
Griffiths DQ at 24 
months 
ST Verbal Mem 0.34 0.05 33 0.16 0.371 34 0.27 0.106 37 
WPPSI-IIIUK: Wechsler Preschool & Primary Scale of Intelligence (3rd Edition); Griffiths DQ: Griffiths 
Mental Development Scales (0-2)-Revised Developmental Quotient; IQ: intelligence quotient; Proc 
Speed Q: processing speed quotient; Gen Lang Com: General Language Composite; ST Verbal Mem: 
short-term verbal memory ρ-value: Spearman’s rho correlation coefficient. 
Given that processing speed (PSQ) was reduced at 5 years in this group, the Griffiths five 
domain level subscales at 24 months and association with 5-year PSQ was considered. 
Although the five domains correlated with overall GDQ, only Locomotor (ρ=0.50, p=0.002), 
Eye-Hand Coordination (ρ=0.54, p=0.001), and Performance (ρ=0.60, p<0.001) subscales 
were significant for PSQ. Additionally, all children with abnormal Eye-Hand Coordination 
(n=4) and Locomotor subscale scores (n=6) at 24 months, had abnormal WPPSI-IIIUK coding 
scaled scores at age five years. Locomotor and Eye-hand Coordination subscales did not 
correlate with the other WPPSI-IIIUK subquotients. 
4.4.3 Temporal stability of early developmental assessments 
The stability of Griffiths developmental quotients (GDQ) gathered at 6, 12 and 24 months for 
each infant were tracked across time. The mean (SD) developmental scores achieved at 6, 12 
and 24 months are presented in Table 4.5. There were 27 children who attended on all of 
the three occasions. The total number of children who attended at each time point are also 
included. 
For the 27 children who attended for assessment on all 3 occasions, there was a dip in the 
Locomotor subscale at 12 months (mean=82.97, 1SD below test norms), which had 
recovered to within the normal range by 24 months, albeit with a wider dispersion 
(SD=27.41) than expected. This trend was mirrored when all of the cohort who attended at 
each time point were included. A similar dip at 12 months was observed for the Personal-
Social domain, however scores remained within the normal range at all time points. Hearing 
& Language subscale dropped approximately 12 points between 6 and 24 months of age. The 
Performance subscale was the lowest of the domains tested at 24 months (Table 4.5). 
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Table 4.5 Mean Griffiths Mental Development Scale (0-2) Revised’s Global and Subscale scores achieved at 6, 12 and 24 months of age for (i) the 27 children (with 5-year 
outcome) who attended on all three occasions and (ii) the total set of children (with 5-year outcome) who attended at each time point. 
 Children who attended at all ages (n=27) Children who attended at each age 
Griffiths Mental 
Development Scales 
(0-2) Revised. 
6 months 12 months 24 months 6 months 
(n=37) 
12 months 
(n=37) 
24 months 
(n=40) 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Griffiths DQ 99.89 14.13 94.26 18.05 96.59 19.95 98.38 17.45 94.78 16.61 98.05 19.21 
Locomotor 95.78 16.80 82.07 20.78 99.59 27.41 94.31 18.07 83.03 20.67 102.15 24.58 
Personal-Social 101.63 16.02 95.22 20.65 102.78 24.51 101.43 17.43 97.51 20.15 109.11 15.70 
Hearing & Language 107.37 16.46 98.48 18.56 95.52 20.95 109.11 15.70 100.00 17.11 97.23 20.22 
Eye & Hand Coord. 97.63 17.15 99.96 22.28 97.56 18.94 98.26 17.93 100.22 21.62 100.95 17.32 
Performance 95.11 18.77 97.93 18.00 92.56 20.67 94.97 19.49 98.05 18.21 91.73 20.88 
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Overall, twenty-nine children tested ‘normal’ on the Griffiths - either on all three occasions 
(n=16) or on all of the occasions that they attended (n=13) in early childhood. This was 100% 
predictive of a normal cognitive (IQ) outcome. However, despite a normal FSIQ, 3/29 (10.3%) 
of these had an overall abnormal outcome: one had mild ataxic CP, one had ADHD and one 
had significant hearing impairment.  
Nineteen children in the cohort were assigned an abnormal Griffiths GDQ score on at least 
one of the early developmental assessments. Of these, 17/19 (89.5%) had an overall 
abnormal outcome at 5 years, including 6/19 (31.6%) with an abnormal IQ. Of those, 5/19 
children achieved an abnormal GDQ on all occasions that they attended, and all had an 
abnormal outcome at 5 years. Notably, all children whose Griffiths score was abnormal at 6 
or 12 months, and all children whose Griffiths score was >=2SD below the mean at any time 
point from 6-24 months had an abnormal five-year outcome (Table 4.6). 
Table 4.6 Profile of children assessed at 6, 12, or 24 months and five-year outcome. 
Age assessed 
(n)  
Griffiths GDQ Total No. 
of children 
No. with 
Normal 5yr 
O/C 
No. with 
Abnormal 
5yr O/C 
Abn 5yr 
O/C with 
Abnormal 
IQ 
6 months 
(n=38) 
Normal 32 21 11 3 
1SD below 2 0 2 1 
2SD-4SD below 4 0 4* 2 
12 months 
(n=38) 
Normal 26 21 5 2 
1 SD below 6 0 6 1 
2SD-4SD below 6 0 6* 3 
24 months 
(n=40) 
Normal 30 22 8 0 
1 SD below 4 2 2 0 
2SD-4SD below 6 0 6 6 
*1 death before 24mths. GDQ = Griffiths Global Developmental Quotient, No. = number, O/C = 
outcome, Abn = abnormal. 
 
4.4.4 Predictive Power of normal early childhood assessment at each 
time point for normal 5-year IQ 
We examined the predictive power of a normal GDQ score for a normal five-year IQ at each 
time point (Table 4.7). As expected, the best prediction was seen at 24 months with an 
AUROC = 0.941 (p=0.001). The 24-month normal GDQ was 100% predictive of normal 5-year 
IQ. At all time-points the early GDQ scores displayed moderate to high AUROC accuracy 
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values (see Figure 4.2), with higher sensitivity and lower false negative rates. A higher 
proportion of children with a normal five-year IQ, had normal early Griffiths scores, than had 
mild Sarnat or normal Early EEG at 24 hours. All children with an abnormal IQ at five years 
had an abnormal 24mth GDQ. When we examined all perinatal and demographic factors 
listed in Table 4.1, it was found that in addition to early GDQ scores, Sarnat grade was the 
only characteristic that differed significantly between those children with and without 
normal five-year IQ (ρ=0.46, p=0.02). 
 
Figure 4.2 AUROC values for the prediction of normal 5 year IQ from normal development scores at 6, 
12 & 24 months, and from a mild Sarnat grade, or from an EEG Grade 0-1. AUROC, area under the 
receiver operated curve; mth, month; GDQ, Griffiths Global Development Quotient. 
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Table 4.7 The ability of normal early serial assessments to predict a normal WPPSI-IIIUK FSIQ at age five years. 
GDQ PPV 
(95% CI) 
NPV 
(95% CI) 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
AUROC 
(95% CI) 
p value 
6 MTH (n=36) 90.63 
(73.83-97.55) 
75.00 
(21.94–98.68) 
96.67 
(80.95-99.83) 
50.00 
(13.95-86.05) 
0.733 
(0.469–0.998) 
0.075 
12 MTH (n=37) 92.31 
(73.40–98.66) 
36.36 
(12.37–68.39) 
77.42 
(58.46–89.72) 
66.67 
(24.11–94.00) 
0.720 
(0.482–0.959) 
0.091 
24 MTH (n=40) 100.00 
(85.87–100.00) 
60.00 
(27.37–86.31) 
88.24 
(71.61–96.16) 
100.00 
(51.68–100.00) 
0.941 
(0.870–1.00) 
0.001** 
Sarnat grade I (n=46) 95.46 
(75.12-99.76) 
25.00 
(10.60-47.05) 
53.85 
(37.38-69.57) 
85.71 
(42.01-99.25) 
0.698 
(0.505-0.890) 
0.099 
EEG Grade 0-1 (n=44) 90.32 
(73.10–97.48) 
30.77 
(10.36–61.12) 
75.68 
(58.45–87.63) 
57.14 
(20.24–88.19) 
0.664 
0.431–0.897 
0.173 
GDQ: Griffiths Developmental Quotient; PPV: Positive Predictive Value; NPV: Negative Predictive Value; AUROC: Area Under the Receiver Operated Curve; MTH: months. 
Sarnat grade I: Mild Sarnat grade. EEG Grade 0-1: Normal/mildly abnormal EEG grade at 24 hours. 
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4.4.5 Predictive Power of early childhood assessment at each time point 
for overall outcome 
For overall outcome, all children with a normal five-year outcome had normal 6 and 12-
month GDQ. Furthermore, an abnormal 6- and 12-month GDQ score was 100% predictive of 
abnormal outcome. Surprisingly GDQ at 12 months was most closely related to overall 
outcome suggesting that this was a more global measure of injury (see Figure 4.3 and Table 
4.8), whilst the 24-month assessment was more closely linked to 5-year IQ. 
 
 
Figure 4.3 AUROC values for the prediction of normal overall 5 year outcome from a normal Griffiths 
score at 6, 12, or 24 months, from a mild Sarnat Grade, or from an EEG Grade 0-1. (AUROC, area 
under the receiver operated curve; mth, month; GDQ, Griffiths Global Developmental Quotient. 
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Table 4.8 The ability of normal early serial assessments to predict a normal overall outcome at age five years. 
GDQ PPV 
(95% CI) 
NPV 
(95% CI) 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
AUROC 
(95% CI) 
p value 
6 MTH (n=38) 65.63 
(46.78–80.83) 
100.00 
(51.68–100.00) 
100.00 
(80.76- 100.00) 
35.29 
(15.2-61.38) 
0.676 
(0.50-0.86) 
0.064 
12 MTH (n=37) 80.78 
(60.02–92.70) 
100.00 
(69.88–100.00) 
100.00 
(80.76–100.00) 
70.59 
(44.05–88.62) 
0.853 
(0.72-0.99) 
<0.001** 
24 MTH (n=40) 73.33 
(53.83–87.03) 
80.00 
(44.22–96.46) 
91.67 
(71.53–98.54) 
50.00 
(25.51-74.49) 
0.708 
(0.53-0.88) 
0.027* 
Sarnat* grade (n=48) 72.73 
49.56-88.39 
53.85 
(33.75-72.86) 
57.14 
37.43-74.97 
70.00 
45.67-87.16 
0.636 
(0.48-0.80) 
0.112 
EEG* grade 0-1 (n=46) 67.74 
(48.54–82.68) 
66.67 
(38.69–87.01) 
80.77 
(60.02–92.69) 
50.00 
(27.85–72.15) 
0.654 
(0.490-0.818) 
0.076 
GDQ: Griffiths Developmental Quotient; PPV: Positive Predictive Value; NPV: Negative Predictive Value; AUROC: Area Under the Receiver Operated Curve; MTH: months. 
Sarnat grade I=mild Sarnat grade. EEG Grade 0-1: Normal/mildly abnormal EEG grade at 24 hours. *only children who survived the neonatal period were included in the 
analysis. 
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4.5 Discussion  
We have described the five-year IQ and overall outcome in a cohort of children following 
neonatal HIE. We confirmed the importance of undertaking repeated developmental 
assessments in the early years since one-third of children with HIE in our cohort had unstable 
development scores across early childhood. We have also confirmed the utility of early 
developmental assessment in the prediction of overall outcome at five years, and the 
importance of long-term monitoring for those with abnormal early development scores.  
At five years, similar to findings for other populations of children with perinatal injury such 
as stroke  (233), the Processing Speed quotient was the lowest score, and was depressed for 
all grades due to poor performance on a ‘coding’ pencil task, even in those with no motor 
impairment. Therefore, this reduction may be due to either poor fine motor coordination or 
actual poor processing speed. The motor data collected in the early Griffiths assessments 
and the observation that 100% of children with lower than average locomotor and eye-hand 
coordination at 24 months had lower coding scores at age five suggests a motor coordination 
explanation. 
Verbal working memory is an important skill to assess at school-going age, and the ‘Numbers’ 
subtest from the CMS was included to measure this construct. The CMS verbal working 
memory subtest comprises two tasks – an aggregate of digit-span forwards and digit-span 
backwards. However, it transpired that for the HIE cohort, the floor items were set too high 
on the digit-span backwards task for accurate interpretation. This meant that a child (aged 
5) with a raw score of 0 achieved a scaled score of 7 (16th percentile), thus risking the inflation 
of the verbal memory score. Consequently, only digit forwards was interpreted, which 
yielded instead a short-term memory score which was significantly below the expected level. 
This finding raises the psychometric issue of testing children at the extreme ends of the age 
range for a test, (the CMS is aimed at 5 to 12 years) and also to have a sufficient range of 
tasks at the lower end to allow for a spread of low scaled score results at this level. Executive 
functions such as processing speed and working memory are critical for effective thinking 
and educational attainment. In our cohort, lower than expected scores in these areas were 
not easily predicted by early assessment and were often seen in children with normal IQ at 
five years. Similarly, we have shown that infants with mild grade HIE do not survive 
unscathed, and follow-up at 6 months of age with a structured developmental assessment 
may be useful in detecting those with potential future difficulties.  
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Although previous studies have reported the ability of the GMDS-R to predict outcome 
assessed using the previous WPPSI-R version,  this is the first study to examine the prediction 
of serial GMDS-R in early childhood to predict outcome assessed using the third edition of 
the WPPSI (122, 234). In this HIE population, early developmental assessment correlated 
with later IQ outcome. GMDS-R scores at all time-points correlated with Full-Scale, Verbal 
and Performance IQs, with the relationship strengthening over time. Although our cohort 
was recruited before the introduction of therapeutic hypothermia, the high sensitivity values 
of an early normal development score for school-age normal outcome is commensurate with 
those reported from randomised controlled trials of therapeutic hypothermia (18, 137, 139). 
In the current study, the importance of assessing children serially in the first two years was 
observed, as different children demonstrated abnormal development patterns at different 
ages. The developmental stage of the child at the time of measurement may affect the ability 
of an assessment tool to detect delay (171). Milne et al., suggest that changes in score 
stability over time may represent natural developmental trajectories rather than any 
inconsistency in the developmental tool itself (170). At twelve months, in our study, children 
were more likely to obtain an abnormal GMDS-R score, typically due to low attainments on 
the Locomotor subscale, which often normalised by 24 months. This provides an example of 
the differential role of specific domain areas, and how the age at assessment plays an 
important role in their predictive ability (235). Consistent with our findings, Barnett et al., in 
a previous neonatal encephalopathy cohort, demonstrated higher prediction of a Griffiths 
score at 12 months for later motor competence than for IQ, with IQ prediction improving by 
24 months (122). Similarly, we found the 12-month assessment to be a poor predictor of IQ, 
although it did correlate well with overall outcome. This may be a reflection of the test 
battery used at this time point, with the 12-month battery more heavily influenced by the 
global function (fine motor, gross motor, behavioural function) of the child at that 
developmental stage. Motor milestones vary considerably at this stage due to the influence 
of the musculoskeletal system, rather than cerebral function alone (236). Some children, 
particular those who “bottom shuffle” may not crawl, or walk unaided until up to 18 months 
despite normal cognitive outcome. By 24 months the range of motor skills seen is less and 
so motor function is less likely to sway the reliability of the test.  
Previous studies reporting the ability of abnormal early development assessments to predict 
abnormal cognitive outcome consistently show a pattern of low sensitivity and high 
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specificity. This has led some researchers to question the cost-effectiveness of the continued 
use of developmental assessment tools by clinicians. However, these studies have been 
constrained by limiting their focus to outcome based on IQ tests. Our study suggests that 
early developmental assessments are helpful to predict later IQ but perhaps more interesting 
is their greater predictive value for overall outcome. Seventeen of the nineteen (89.5%) 
children who experienced at least one abnormal Griffiths score in early childhood had an 
abnormal overall outcome at five years of age. 
In our research, we were interested to determine whether serial early assessment provided 
added value when compared with other markers for outcome. The only other variable 
included in our analysis that proved to be significantly different for children who had a 
normal compared to an abnormal five-year cognitive outcome was Sarnat grade. The 
predictive properties of neonatal Sarnat and EEG grades were lower than Griffiths with 
poorer sensitivity, and higher false negative rates. Thus, assignation of a mild vs. a moderate 
or severe Sarnat or a Grade 0-1 vs. a higher grade EEG was not reassuring for predicting 
outcome. Recently, Tusor et al. similarly found that the Thompson scoring grade for 
encephalopathy was a poor predictor (237). Findings from the current study indicate the 
need for repeated assessment in the early years to increase the sensitivity for both later IQ 
outcome and overall outcome. Assessment at six months, allows for the early identification 
of abnormal development, which is likely to remain severe and persistent, whilst assessment 
at 12 and 24 months, tracks those children who initially do well but show variable results 
over time. Serial assessment may help to control for the wide normal variability seen in the 
acquisition of developmental milestones, and to reduce the dependence on sensory-motor 
tasks as children grow. It allows us to plot trajectories of developmental change over time, 
and to highlight emerging cognitive deficits.  
A significant limitation of this study is the small sample size, however, this cohort remains 
one of the largest prospectively recruited with clearly defined HIE of all grades; mild, 
moderate and severe.  This cohort was recruited immediately prior to the era of therapeutic 
hypothermia and so the overall rate of long-term disability will differ from contemporary 
cohorts. However, the validity of early neurological assessments and the high rate of subtle 
disability found in the group with mild HIE (not currently cooled) will remain unchanged. In 
terms of interpretation a further limitation of this study is the unconventional way in which 
predictive testing was used in this study. PPV was developed to investigate the accuracy of 
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diagnostic tests, i.e. the extent to which a positive diagnostic test, in fact predicts a diagnosis. 
NPV predicts the accuracy of a negative test score for absence of disease. In this study, the 
PPV was used to examine the prediction of normal early developmental tests for normal 5-
year outcomes, with NPV examining the prediction of abnormal score for later abnormal 
outcome. The current researcher had sought to define these clearly, but because the use of 
PPV and NPV was inverted in this study, the threat of causing confusion to the reader is 
regrettable. On a separate point, our conclusions are limited by the low numbers of children 
who had abnormal early and five-year outcomes which reduced the accuracy of our NPV 
rates, with wide confidence intervals noted. 
To conclude, in the first two years of life, early developmental assessment using the GMDS, 
even at 6 months can accurately identify those children at risk of later difficulties, although 
they are poor predictors of exact IQ score at 5 years. A 24-month developmental assessment 
is the best time to predict later intellectual outcome in a population of children with HIE. 
Measures of early development are inconsistent in the first two years and merit repeated 
administration. 
COMMENT: My contribution to this chapter is described in further detail in Chapter 8 Section 
8.1: Summary and Impact of the Thesis Findings. 
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4.6 Appendix 4.A 
Summary of HIE Cohort data including assigned Sarnat and EEG grade at 24 hours of age, 
global development scores at age 6, 12 and 24months, IQ and overall outcome at five years 
of age.  
Table 4.9 Summary of HIE cohort data including assigned Sarnat and EEG grade at 24 hours of age, 
global scores at 6, 12 and 24months, IQ and overall outcome at five years. 
Case 
No. 
Sarnat 
Grade 
EEG 
Grade 
GDQ–
6mth 
GDQ-
12mth 
GDQ–
24mth 
WPPSI-IIIUK – 
FSIQ at Age 
Five 
Outcome at Age Five 
01 1 1 Normal Normal Normal Normal* Normal 
02 2 1 Normal* Normal* Normal Normal* CP Ataxic: GMFCS Level 
I 
03 2 2 Normal Normal Normal* Normal* Hearing impairment 
04 1 2  Normal Normal* Normal* Normal 
05 1 1 Normal Normal Normal Normal* Normal 
06 3 1 Normal   Normal* Normal 
07 1 1 Normal Normal Normal Normal* Normal 
08 2 1 Normal* Normal* Normal* Normal* Normal 
09 2 3 Normal*   Normal* Normal 
10 1 1 Normal Normal Normal* Normal Normal 
11 2 1  Normal Normal* Normal Normal 
12 2 1 Normal  Normal Normal Normal 
13 1 0 Normal 1SD 
Below 
Normal Normal DCD; (SLT, OT, Psy) 
14 1 0 Normal Normal Normal* Normal Normal 
15 1 1 Normal* Normal Normal Normal Normal 
16 2 1 Normal Normal Normal Normal Normal 
17 2 1 Normal* Normal Normal* Normal Normal 
18 2 0 Normal* Normal Normal Normal Normal 
19 1 1 Normal Normal Normal Normal Normal 
20 2 1 Normal Normal  Normal Normal 
21 1 1 Normal* Normal Normal Normal Normal 
22 1 0  Normal Normal Normal Normal 
23 1 1  1SD 
Below 
1SD 
Below 
Normal MD EI Team (SLT, OT, 
Psy): Referred to 
CAMHS, Paed Neuro 
24 1 1 Normal Normal Normal* Normal Normal 
25 1 1 Normal 1SD 
Below 
Normal Normal ASD 
26 1 1  Normal Normal Normal Normal 
27 1 0 Normal Normal* Normal Normal Normal (SLT) 
28 2 2   Normal Normal Normal (OT) 
29 2 3 Normal Normal 1SD 
Below 
Normal S/L D/O. MD EI Team: 
(SLT, OT, Psy) 
30 2 3 Normal 2SD 
Below 
 Normal CP Dyskinetic: GMFCS 
Level 3 
31 3 2 Normal Normal 1SD 
Below 
Normal Normal 
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Case 
No. 
Sarnat 
Grade 
EEG 
Grade 
GDQ–
6mth 
GDQ-
12mth 
GDQ–
24mth 
WPPSI-IIIUK – 
FSIQ at Age 
Five 
Outcome at Age Five 
32 1 1 Normal 3SD 
Below 
Normal Normal MD EI Team: (SLT, Psy, 
PT) 
33 1 N/A  Normal Normal Normal Normal 
34 1 N/A   Normal Normal Normal 
35 1 1 Normal*   Normal Normal (OT) 
36 2 2 Normal  1SD 
Below 
Normal Normal (OT) 
37 2 1 1SD 
Below 
1SD 
Below 
Normal Normal CP Sp Unilateral (left): 
GMFCS Level 1 
38 1 1   Normal Normal ADHD 
39 2 2 Normal 1SD 
Below 
Normal Normal CP Sp Unilateral (right): 
GMFCS Level 1 
40 1 1 Normal 1SD 
Below 
2SD 
Below 
1SD Below IQ 1SD Below; MD EI 
Team (SLT, OT, Psy) LST. 
41 2 1 1SD 
Below 
Normal 2SD 
Below 
1SD Below IQ 1SD Below; Severe SL 
D/O, SpLC (SLT) 
42 2 1 Normal 3SD 
Below 
4SD 
Below 
1SD Below IQ 1SD Below; SL D/O: 
(SLT, Psy) 
43 2 2  Normal 3SD 
Below 
1SD Below IQ 1SD Below; ADHD 
44 3 3 Normal 2SD 
Below 
2SD 
Below 
2SD Below CP Sp Unilateral (left): 
GMFCS Level I; I.D. 
45 3 3 4SD 
Below 
4SD 
Below 
4SD 
Below 
Assigned 4SD 
Below 
CP Sp Bilateral (quad): 
GMFCS Level V; I.D. 
46 3 4 4SD 
Below 
  Assigned 4SD 
Below 
CP Sp Bilateral (quad): 
GMFCS Level V. I.D. 
47 1 1 Normal* LTFU LTFU LTFU LTFU 
48 1 0  Normal Normal* Withdrew Normal at 24mths 
49 1 2 Normal Normal*  Withdrew Normal at 12 mths 
50 1 2  1SD 
Below 
Normal LTFU Normal at 24mths 
51 2 1 Normal* Normal* Normal* Withdrew Normal at 24mths 
52 3 4 4SD 
Below 
4SD 
Below 
Died  Died 
53 3 3 Died    Died 
54 3 3 Died    Died 
55 3 N/A Died    Died 
56 3 4 Died    Died 
57 3 3 Died    Died 
58 3 3 4SD 
Below 
  Test 
inconclusive 
CP Dyskinetic. GMFCS 
Level V 
59 2 2     Excluded – dysmorphic 
features 
60 1 N/A     Excluded – congenital 
diaphragmatic hernia 
61 1 2 LTFU LTFU LTFU LTFU LTFU 
62 1 1 LTFU LTFU LTFU LTFU LTFU 
63 2 N/A LTFU LTFU LTFU LTFU LTFU 
64 2 N/A LTFU LTFU LTFU LTFU LTFU 
65 1 N/A LTFU LTFU LTFU LTFU LTFU 
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No.=number; GDQ=Griffiths Mental Development Scales–Revised developmental quotient; 6mth= 
six months of age; 12mth= twelve months of age; 24mth=twenty four months of age; WPPSI-
IIIUK=Wechsler Preschool and Primary Scale of Intelligence 3rd UK version; FSIQ=full scale intelligence 
quotient; N/A=Not Available; SD=Standard Deviation; Normal*=IQ score 1SD above the mean; 
CP=cerebral palsy; GMFCS=gross motor functioning classification system; DCD=developmental 
coordination disorder; SLT=speech & language therapy; OT=occupational therapy; Psy=psychology; 
MD EI Team=multi-disciplinary early intervention team; CAMHS=child/adolescent mental health 
service; paed neuro=paediatric neurology; ASD=autistic spectrum disorder; PT=physiotherapy; 
ADHD=attention deficit hyperactivity disorder; Sp=spastic; LST=learning support teaching; SL 
D/O=speech/language disorder; SpLC=special language class; I.D.=intellectual disability; LTFU=lost to 
follow up; mths=months 
. 
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5.1 Abstract 
Objective: 
More than half of all infants with neonatal hypoxic ischaemic encephalopathy (HIE) are 
graded as mild and do not meet current criteria for therapeutic hypothermia (TH).  These 
infants are often not enrolled in follow up and hence our knowledge of their long-term 
outcome is sparse. We wished to compare 5-year outcomes in a group of infants with mild, 
moderate, and severe HIE, graded with both early EEG and clinical assessment, none of 
whom were treated with TH. 
Methods: 
Term infants with HIE and a healthy comparison group were recruited at birth. Both groups 
had early continuous EEG recordings. Cognitive and motor outcome was assessed at 5 years. 
Results: 
Outcome was available in 53/65 infants with HIE and 30/42 infants in the comparison group 
at 5 years. Infants with mild HIE at birth (n=22) had significantly lower full-scale IQ, verbal IQ, 
and performance IQ than comparison infants (n=30) at 5 years (p=0.001, 0.001 and 0.004 
respectively). No difference in cognitive measures was seen between infants with mild and 
moderate grades HIE. Intact survival – with no requirement for early intervention at 5 years 
- varied across EEG grade HIE at 6 hours after birth; 75% in mild, 46% in moderate, 43% in 
major abnormalities and 0% with inactive EEGs, compared to 97% in the comparison group. 
Conclusion: 
Survivors of mild HIE, graded clinically or by early EEG have higher rates of non-intact 
outcome than a non-HIE comparison group with neonatal normal EEG, and they have 
cognitive outcomes similar to that of children with moderate encephalopathy in an uncooled 
HIE cohort. 
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5.2 Introduction: 
Neonatal hypoxic ischaemic encephalopathy (HIE) remains a leading cause of newborn death 
and long-term neurodisability. It causes 23% of global neonatal deaths, totalling 1 million 
annually. Twenty-five percent of surviving children, are left with significant long-term 
neurological disability (127), placing HIE in the top ten diseases with the highest lifelong 
global burden (13). The significance of non-motor disability is increasingly recognized, with 
reported rates of learning and neuropsychological difficulties, autism, epilepsy, and sensory 
loss contributing to adverse long-term quality of life. The more subtle disabilities may not be 
apparent in early childhood where assessment is focused on developmental milestones.  
Outcome is generally aligned with clinical grading, with moderate and severe grades having 
the highest rates of motor deficit and mortality (127). The outcome in mild HIE is generally 
considered to be normal. Due to a fear of serious adverse events, prior to the establishment 
of the safety profile of induced hypothermia, infants with mild HIE were not enrolled in trials 
of therapeutic hypothermia (TH), and therefore do not meet current criteria for therapeutic 
intervention (139).  Few prospective cohorts have included infants with mild 
encephalopathy, and have focused instead on moderate and severe grades. We wished to 
determine the cognitive and motor outcome of a prospective cohort of infants across all 
grades of HIE, with both clinical and early continuous EEG grading.  
5.3 Participants and Methods: 
5.3.1 Initial recruitment 
This prospective study was conducted in a maternity service with 6000 deliveries per year. 
Ethical approval was obtained from the clinical research ethics committee of the Cork 
Teaching Hospitals. Between May 2003 and December 2005, term infants (≥37 weeks of 
gestation) with HIE were recruited if they fulfilled two of the following criteria: initial capillary 
or arterial pH of <7.1, Apgar score at 5 minutes of <5, initial capillary or arterial lactate level 
of >7 mmol/L, and abnormal neurologic features/clinical seizures. Broad inclusion criteria 
were used to ensure recruitment of all grades (mild, moderate and severe) of HIE. Neurologic 
condition was assessed by a research paediatrician (Dr. Deirdre Murray), not involved in the 
clinical care of the infants within the first 6 hours and was performed using a standardized 
method (60). Infants were excluded if alternative diagnoses were suspected; sepsis, 
intracerebral infarction, congenital abnormalities or metabolic encephalopathy.  
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The parents of infants fulfilling the criteria were approached and written informed consent 
was obtained within 6 hours of birth, or with the onset of clinical seizures. After recruitment, 
silver-chloride EEG electrodes were applied to the scalp at F3, F4, C3, C4, T3, T4, O1, O2, and 
CZ (according to the international 10–20 system of electrode placement, as modified for 
neonates). A Viasys NicoletOne EEG monitor (Viasys International, Madison, WI) was used to 
record continuous video-EEG recording for a 24-72 hours duration. Recordings were 
commenced as soon as possible after birth, generally within 6 hours. Measurements of heart 
rate, respiration, and oxygen saturation were also recorded. A modified Sarnat 
encephalopathy grade was assigned at 24 hours as described by Levene in 1985 (14, 188). All 
EEGs were assigned a grade based on background activity which has been previously 
described (see Table 5.1) (105). All seizures in each EEG recording were annotated visually 
by an experienced neonatal neurophysiologist (Prof. Geraldine Boylan). Electrographic 
seizure was defined as a sudden repetitive, stereotyped discharge of minimum 10 seconds 
duration on one or more EEG channels with evolving frequency, amplitude and morphology. 
Table 5.1 Classification of EEG background activity (105). 
Grade Findings Description 
0 Normal EEG Findings Continuous background pattern with normal physiologic 
features such as anterior slow waves 
1 Normal/mild 
abnormalities 
Continuous background pattern with slightly abnormal activity 
(e.g., mild asymmetry, mild voltage depression, or poorly 
defined SWC) 
2 Moderate abnormalities Discontinuous activity with IBI of < 10s, no clear SWC, or clear 
asymmetry or asynchrony 
3 Major abnormalities Discontinuous activity with IBI of 10-60s, severe attenuation 
of background patterns, or no SWC 
4 Inactive EEG findings Background activity of < 10μV or severe discontinuity with IBI 
of >60s 
EEG = Electroencephalogram; IBI = Inter-burst interval; SWC = Sleep wake cycle 
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5.3.2 Outcome assessment 
Outcome assessment was performed at 6, 12, 24 and 60 months. The 24 month outcome has 
been previously reported (105). Outcome at 5 years was assessed by a clinical psychologist 
(Catherine O’Connor) blinded to the neonatal clinical course, EEG findings and early outcome 
assessments of the HIE group. Attendance at early intervention services (physiotherapy, 
speech therapy, psychology and/or occupational therapy) were also recorded. 
A parental questionnaire was designed to capture relevant medical, clinical and demographic 
information. Intellectual ability was assessed using the Wechsler Preschool and Primary Scale 
of Intelligence – 3rd Edition(UK) (WPPSI-IIIUK) (194). The Full-Scale IQ (FSIQ), Verbal IQ (VIQ), 
Performance IQ (PIQ), Processing Speed Quotient (PSQ), and General Language Composite 
(GLC) were calculated. All quotients are standardized with a mean(SD) of 100(15). The 
children were then administered the ‘Numbers’ subtest from the Children’s Memory Scale 
(CMS) (203), to include an additional measure of short-term auditory memory, due to known 
vulnerability of infants with hippocampal injury (223). The ‘Numbers’ Subtest has a mean(SD) 
of 10(3). The WPPSI-IIIUK was not administered to those children whose IQ had been assessed 
in their clinical setting within the previous six months, and the clinical IQ scores were used 
instead. Neurological assessment of muscle tone, power and deep tendon reflexes was 
completed (Dr. Deirdre Murray). A GMFCS (Gross Motor Function Classification System) 
score was assigned to children with cerebral palsy (205). 
An overall abnormal outcome at age five was defined as follows (at least one present): 
cerebral palsy, Full-Scale IQ >= 1 SD below the mean (IQ < 85) (with intellectual disability 
(Full-Scale IQ > 2SD below the mean, IQ < 70)), other diagnosed neurodevelopmental 
disorder (i.e. attention deficit (hyperactivity) disorder (ADD/ADHD), developmental 
coordination disorder (DCD), autistic spectrum disorder (ASD), specific language disorder 
(SLI)); hearing or vision loss or death.  
5.3.3 Comparison group 
Comparison infants were recruited from an age-relevant subset (n=42) from a prospective 
study examining normal newborn EEG in 80 healthy term infants, born between October 
2005 and August 2007, who were recruited in the first postnatal day following delivery, with 
Apgar scores >8 at 5 minutes and a normal result from standardized neurological exam (60). 
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A baseline EEG was recorded for a maximum of 2 hours in each infant. Seven scalp electrodes 
were positioned over the frontal, central, temporal and parietal areas using the 10-20 system 
of electrode placement, modified for neonates (F4, F3, Cz, T4, T3, P4, P3).  Exclusion criteria 
were: maternal epilepsy or diabetes; birth-weight(BW) <2.5kg; congenital anomalies; 
admission to neonatal unit for special or intensive care (94). Parents/Carers whose children 
were currently aged between 60 and 78 months (n = 42), were sent an information letter 
and a follow-up telephone call to describe the study. 
5.3.4 Statistical Analysis 
Statistical analysis was completed using IBM SPSS Statistics 22.0 for MS Windows (IBM 
Corporation, NY, USA) and VassarStats: Website for Computational Statistics (Lowry, R 1998-
2012, Vassar College, NY, USA). The between-group differences of clinical and demographic 
data for the HIE and Comparison groups were explored using Independent Samples T-Test 
(Cohen’s d for effect size) for continuous variables, and Chi-Square Test for Independence 
(Phi co-ef. and Cramer’s V for effect size) for categorical variables. Kruskal-Wallis and post 
hoc Mann-Whitney U tests, PPVs, NPVs were analyzed to explore differences between 
neonatal clinical HIE and EEG grades and outcome. Effect sizes for Mann-Whitney U tests 
were calculated using the formula ‘r = z /√N’ where N = no. of cases. 
5.4 Results 
In total, 107 children were recruited to the study - 65 children with neonatal HIE, and 42 
comparison infants. Of the 65 children with HIE recruited at birth, 2 were excluded from 
outcome analysis due to co-existing diagnoses; 1 (mild) with congenital diaphragmatic 
hernia, and 1 (moderate) with unexplained dysmorphic features. Of the remaining 63 infants, 
7 (5 mild, 2 moderate) were lost to follow up, and 3 (2 mild, 1 moderate) withdrew from the 
study resulting in outcome data for 53 children at five years of age. Of these, 6 (all severe) 
children had died either in the neonatal period or early childhood. The remaining 47 children 
were assessed at five years. In the comparison group, 42 children were contacted and 6 were 
lost to follow up and 6 withdrew, resulting in n=30 seen at five years. A flowchart depicting 
cohort numbers from birth to five years can be found in Figure 2.4 in Chapter Two. 
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Clinical and demographics characteristics of the HIE and comparison cases seen at five years 
are displayed in Table 5.2. No significant difference in socio-economic status was evident 
between the groups. 
Table 5.2 Clinical and Demographic Characteristics of the Children Included at Five Years. 
Perinatal data HIE Cohort 
(n=47) 
Comparison 
Cohort 
(n=30) 
P 
Value 
R 
Value 
Birth weight (mean(SD)) g 3431.02 
(618.26) 
3567.67 
(423.71) 
0.29 0.12 
Gestational age (mean(SD)) weeks 40.13 (1.48) 40.05 (1.17) 0.82 0.03 
First Born n(%) 36 (78) 11 (37) 0.001* 0.42 
Mode of delivery n(%) 
NVD 
Instrumental 
Elective CS 
Emergency CS 
 
8 (17) 
22 (47) 
0 (0) 
17 (36) 
 
22 (73) 
2 (7) 
2 (7) 
4 (13) 
<0.001* 0.56 
Male Gender n(%) 28 (60) 13 (43) 0.25 0.16 
First documented pH (venous) mean(SD) 6.99 (0.18) n/a n/a  
First documented BD (venous) mean(SD) 
 
-13.8 (4.9) n/a n/a  
Demographics HIE Cohort 
(n=47) 
Comparison 
Cohort 
(n=30) 
P 
Value 
R 
Value 
Age assessed (Mean(SD)) months 64.11 (5.73) 67.57 (6.80) 0.03* 0.30 
Has sibling(s) n(%) 32 (73) 29 (97) 0.02* -0.31 
Commenced Primary Schooling n(%) 36 (78) 20 (69)† 0.53 0.10 
Maternal Education Level (n (%)) 
Primary or Lower Secondary 
Secondary School Completed 
Third Level Qualification 
 
9 (21) 
19 (43) 
16 (36) 
 
5 (17) 
11 (37) 
14 (47) 
0.67 0.10 
Hollingshead occupation criteria* n(%)  
Professional/Managerial 
(Codes 7-9) 
Semi-Professional/Technician/ 
Clerical (Codes 5-6) 
Skilled Manual 
(Code 4) 
Semi-skilled/Unskilled Manual 
(Codes 1-3) 
 
 
15 (34) 
 
8 (18) 
 
8 (18) 
 
13 (30) 
 
12 (40) 
 
8 (27) 
 
5 (17) 
 
5 (17) 
 
0.57 0.17 
Race:     White n(%) 43 (92) 
 
30 (100) 
 
0.15 -0.19 
Region: n(%) 
Urban 
Small Town 
Rural 
 
15 (32) 
20 (43) 
12 (26) 
 
7 (23) 
14 (47) 
9 (30) 
0.71 0.09 
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SD = standard deviation, NVD= normal vaginal delivery, CS=Caesarean Section, BD= base deficit, n/a 
= not available. *Based on Hollingshead Occupational Scale (238)  R value = correlation with Full 
scale IQ at 5 years. 
 
5.4.1 Cognitive Outcome: 
5.4.1.1 Clinical Sarnat Grade 
Of the 47 children with HIE who were assessed at 60 months, three children with severe CP 
were unable to complete the assessment. Based on available psychological, medical and 
educational placement information, two were assigned the basal IQ score, and the third was 
inconclusive. Cognitive assessment was therefore available for 46 children with HIE and in all 
30 comparison children. The median FSIQ, VIQ PIQ, PSQ and GLC scores for each grade of HIE 
are displayed in Figure 5.1 and Table 5.3.  
There were statistically significant differences in all WPPSI-IIIUK cognitive domains across 
Sarnat grades (Comparison, n=30; Mild, n=22; Moderate, n=19; Severe, n=5). For Full Scale 
IQ, 𝜒2  (3, 𝑛 = 76) = 21.93, 𝑝 <  0.001.  Median FSIQ, VIQ, PIQ, PSQ and GLC differed 
significantly between comparison and mild (p<0.001, <0.001, 0.004, 0.048 and 0.01 
respectively) infants. Median FSIQ, VIQ, PIQ, and GLC differed significantly between 
comparison and moderate (p=0.001, <0.001, 0.02, and 0.001 respectively) infants, with PSQ 
at (0.06). No significant difference was seen between mild and moderate HIE infants in any 
of the WPPSI outcome parameters measured. Surviving infants with severe encephalopathy 
who were able to complete assessments had a variable outcome. The three children with CP 
had FSIQ indicating intellectual disability (= 68, 43, 43) and those without CP (n=2) had scores 
in the normal range. Similarly, for the CMS Numbers subtest, children with mild HIE had 
significantly lower scores compared to comparison children (p=0.004). 
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Figure 5.1 Boxplot representations of (A) WPPSI-IIIUK Full Scale IQ and subquotient scores (B=Verbal IQ; 
C=Performance IQ; D=Processing Speed IQ; E=General Language Composite) for the HIE Sarnat grade 
groups and the comparison group. Horizontal lines set at mean(SD) expected = 100(15).
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Table 5.3 Cognitive outcome assessment categorized by Sarnat grade at 24 hours. 
WPPSI-IIIUK Score 
 
Comparison 
N=30 
Mild 
N=22 
Moderate 
N=19 
Severe 
N=5 
Comparison 
vs. Mild 
Comparison 
vs. Moderate 
 Median (Interquartile Range) p-value (effect size (r)) 
Full Scale IQ 
 
117 (110-124) 99 (94-112) 103 (90-112) 68 (43-108) <0.001* (0.51) 0.001* (0.49) 
Verbal IQ  116 (112-125) 105 (99-111) 104 (98-110) 72 (49-111) <0.001* (0.55) <0.001* (0.55) 
 
Performance IQ 115 (107-124) 103 (98-112) 108 (96-114) 66 (49-107) 0.004* 
 
(0.40) 0.02* (0.34) 
Processing Speed Quotient 103 (94-110) 94 (85-105) 94 (80-103) 64 (51-99) 0.048* 
 
(0.28) 0.06 (0.27) 
General Language Composite 110 (104-118) 105 (93-109) 100 (90-107) 64 (46-97) 0.01* 
 
(0.35) 0.001* (0.49) 
CMS Numbers Subtest 11 (9-12) 7 (6-11) 9.5 (7.8-12.5) 5 (1-10.5) 0.004* 
 
(0.42) 0.28 (0.17) 
Q – Quotient, C – Composite, CMS = Children’s Memory Scale. p<0.05=significant difference. r=0.1 -small effect, r=0.3 -medium effect, r=0.5 -large effect. No significant 
difference was seen between mild and moderate in outcome parameters measured. WPPSI-IIIUK Standardized mean (S.D.) = 100(15); Numbers subtest mean(S.D.) = 10(3).
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5.4.1.2 EEG grades at 6 and 24 hours 
In all cases EEG grades either remained constant or improved between 6 and 24 hours. All 
comparison infants had grade 0 baseline EEGs recorded, at a median(IQR) age of 9.00(6.75-
12.25) hours. EEG grades and Sarnat grading is displayed in Figure 5.2. 
 
Figure 5.2 Distribution of EEG grades at age 6 and 24 hours for categorised by the infants Sarnat 
encephalopathy grade. Mod = moderate; Missing = EEG grade not available for infant 
 
The evolution of EEG grades from 6 to 24 hours of age for infants with mild Sarnat grade are 
more closely seen in Figure 5.3 below. 
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Figure 5.3 EEG gradings at 6 and 24 hours of age for infants with a Sarnat grade of mild HIE. 
 
A Kruskal-Wallis Test revealed statistically significant differences in WPPSI domains across 
EEG grades 0-4. For the Full-Scale IQ, 𝜒2  (4, 𝑛 = 68) = 23.32, 𝑝 <  0.001 at 6 hours, and 
𝜒2  (4, 𝑛 = 74) = 18.76, 𝑝 =  0.001 at 24 hours. At both 6 and 24 hours, those infants with 
Grade 0 EEG readings had the highest median IQ scores, and FSIQ scores decreased as EEG 
abnormalities worsened, but did not differ significantly between EEG grades 1-3 (see Table 
5.4 for median(IQR) IQ scores, and Table 5.5 for IQ differences between grades 1-3). Infants 
with Grade 4 EEGs at either time point who survived, had severe to profound developmental 
delay, and due to very low numbers were excluded from further analysis. 
Infants with a normal (Grade 0) EEG reading within the first 24 hours had significantly higher 
Full Scale, Verbal and Performance IQs than infants with abnormal (grades 1 to 3) recordings 
at either 6 or 24 hours.
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 Table 5.4 Five-year cognitive outcome for case and comparison infants with EEG Grades assigned at 24 hours of age. 
WPPSI-IIIUK 
 
EEG Grade 0 
n=35 
EEG Grade 1 
n=26 
EEG Grade 2 
n=7 
EEG Grade 3 
n=9 
EEG Grade 4 
n=3 
EEG Grade 
0 vs.1 
EEG Grade 
0 vs. 2 
EEG Grade 
0 vs. 3 
Median (Interquartile Range) P value (Effect Size (r)) 
Full Scale IQ  117 
(109-124) 
 
104 
(93-114) 
97 
(86-120) 
97 
(56-107) 
43 
(43-43) 
0.002* 
(0.39) 
0.02* 
(0.36) 
0.008* 
(0.42) 
Verbal IQ  114 
(108-124) 
 
106 
(102-112) 
100 
(81-106) 
98 
(60-116) 
49 
(49-49) 
0.001* 
(0.44) 
0.01* 
(0.40) 
0.03* 
(0.34) 
Performance IQ 112 
(105-123) 
 
108 
(98-113) 
98 
(90-108) 
101 
(58-110) 
49 
(49-49) 
0.03* 
(0.29) 
0.03* 
(0.34) 
0.03* 
(0.35) 
Processing Speed Q 102 
(94-110) 
 
97 
(85-104) 
94 
(78-113) 
73 
(58-84) 
49 
(49-49) 
0.08 
(0.23) 
0.41 
(0.13) 
0.001* 
(0.55) 
General Language 
Composite 
110 
(102-117) 
 
105 
(96-110) 
93 
(78-101) 
98 
(57-107) 
49 
(49-49) 
0.08 
(0.23) 
0.006* 
(0.44) 
0.06 
(0.31) 
WPPSI-IIIUK = Wechsler Preschool and Primary Scale of Intelligence 3rd UK Edition, EEG 0 = normal EEG findings, EEG 1 = normal/mild abnormalities, EEG 2 = moderate 
abnormalities, EEG 3 = major abnormalities, EEG 4 = inactive EEG (see table 5.1 for detailed EEG grade descriptions), IQ = Intelligence Quotient, Q = Quotient, p=0.05 
significance level for post hoc Mann-Whitney U Tests, r=effect size where 0.1=small effect; 0.3=medium effect; 0.5=large effect. Interquartile ranges rounded to nearest 
whole number. 
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Table 5.5 : Significance levels and effect sizes of median cognitive score differences at age five years between normal EEG Grade 0 and EEG Grades 1, 2 and 3 assigned at 
age 6 and 24 hours, and between Grades 1 and 2, 1 and 3, and 2 and 3 at age 6 and 24 hours. 
WPPSI-IIIUK 
Quotients at five 
years 
Age at EEG grade 
reading 
Grade 0  
Vs 
Grade 1 
Grade 0 
Vs 
Grade 2 
Grade 0 
Vs 
Grade 3 
Grade 1 
Vs 
Grade 2 
Grade 1 
Vs 
Grade 3 
Grade 2 
Vs 
Grade 3 
  P value (effect size (r)) 
Full Scale IQ 6 Hours 
 
0.001** 
(0.45) 
0.002** 
(0.48) 
0.01* 
(0.43) 
0.18 
(0.24) 
0.11 
(0.32) 
0.65 
(0.11) 
24 hours 
 
0.002** 
(0.39) 
0.02* 
(0.36) 
0.008** 
(0.42) 
0.36 
(0.16) 
0.11 
(0.29) 
0.37 
(0.26) 
Verbal IQ 6 Hours 
 
<0.001** 
(0.56) 
0.001** 
(0.53) 
0.02* 
(0.41) 
0.11 
(0.29) 
0.14 
(0.29) 
0.69 
(0.10) 
24 hours 
 
0.001** 
(0.44) 
0.01* 
(0.40) 
0.03* 
(0.34) 
0.12 
(0.27) 
0.23 
(0.22) 
0.52 
(0.19) 
Performance IQ 6 Hours 
 
0.02* 
(0.34) 
0.01* 
(0.39) 
0.02* 
(0.39) 
0.32 
(0.18) 
0.28 
(0.22) 
0.61 
(0.13) 
24 hours 
 
0.03* 
(0.29) 
0.03* 
(0.34) 
0.03* 
(0.35) 
0.24 
(0.20) 
0.21 
(0.23) 
0.57 
(0.16) 
Processing Speed 
Quotient 
6 Hours 
 
0.37 
(0.13) 
0.40 
(0.13) 
0.02* 
(0.40) 
0.92 
(0.02) 
0.06 
(0.39) 
0.14 
(0.39) 
24 hours 
 
0.08 
(0.23) 
0.41 
(0.13) 
0.001** 
(0.55) 
0.92 
(0.02) 
0.005** 
(0.52) 
0.06 
(0.54) 
General Language 
Composite 
6 Hours 
 
0.001** 
(0.48) 
0.03* 
(0.35) 
0.006** 
(0.49) 
0.78 
(0.05) 
0.06 
(0.39) 
0.25 
(0.32) 
24 hours 0.08 
(0.23) 
0.006** 
(0.44) 
0.06 
(0.31) 
0.02* 
(0.42) 
0.23 
(0.23) 
0.59 
(0.17) 
IQ=Intelligence Quotient, EEG 0 = normal EEG findings, EEG 1 = normal/mild abnormalities, EEG 2 = moderate abnormalities, EEG 3 = major abnormalities, EEG 4 = inactive 
EEG (see Table 5.1 for detailed EEG grade descriptions), p=0.05 significance level for post hoc Mann-Whitney U Tests, r=effect size where 0.1=small effect; 0.3=medium 
effect; 0.5=large effect. *=significance at .05 level; **=significance at .01 level.
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5.4.2 Overall Outcome 
A detailed picture of overall outcome at five years is displayed in Figure 5.4.  When all types 
of disability and/or clinical requirement for multidisciplinary early intervention team support 
are examined, infants with a grade 1 EEG at 6 hours had a 75% chance of intact survival. 
Those with grade 2 EEG abnormalities had a 46% chance of intact survival and those with 
EEG grade 3 or 4 at 6 hours had only 21% intact survival. Overall at 6 hours a 
moderate/major/inactive EEG (grade 2 or more) had a PPV of 68% (95%CI; 0.465-0.843) and 
a NPV of 75% (95%CI; 0.506-0.904), AUROC = 0.712 (95%CI; 0.558-0.867) in predicting an 
abnormal outcome at 5 years. At 24 hours the ability of an EEG grade of 2 or more to predict 
abnormal outcome was PPV= 74% (95%CI; 0.486-0.899), NPV 68% (95%CI; 0.485-0.827) and 
AUROC = 0.696 (95%CI; 0.546-0.845). The improved PPV at 24 hours was due to the natural 
evolution of HIE, with normalization between 6 and 24 hours. Thus, EEG recordings which 
remained abnormal at 24 hours held a worse prognosis (Figure 5.4).  
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Figure 5.4 Detailed outcome data for children with outcome available at 5 years, categorised by EEG 
grade at 6 hours, and 24 hours after delivery. CP = cerebral palsy, OT = occupational therapy, SLT = 
speech & language therapy, EI team = attending multidisciplinary early intervention team, IQ < 1SD 
(<2SD, <3SD) = FSIQ > 1SD (>2SD, >3SD) below the mean at 5 years. ADHD = attention deficit 
hyperactivity disorder, ASD = autistic spectrum disorder, DCD = developmental coordination disorder, 
Language D/O, Lang = Diagnosed language disorder. Single therapy interventions (SLT, OT) are 
displayed in brackets, but did not define disability if child’s outcome was otherwise intact. 
 
5.5 Discussion 
We have shown that whilst median IQ scores were within age-expected average levels, there 
were significant reductions in FSIQ, VIQ, PIQ, PSQ and GLC at five years in children who had 
mild HIE at birth compared to a comparison group. Children with mild HIE had higher rates 
of overall intact survival, but on detailed IQ assessments, children with a history of mild HIE 
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did no better than children with moderate HIE at birth. Greater differences were evident 
between the mild and moderate grades when a detailed analysis of outcome was examined. 
Intact survival following mild EEG abnormalities at 24 hours was 65%, and only 57% with 
moderate HIE. Both groups compared poorly to the comparison groups where 97% had an 
intact survival.  
Current care strategies are based on the premise that outcome in infants with mild 
encephalopathy is normal, with studies reporting good outcome (74). However, a number of 
retrospective studies have recently shown rates of memory and learning impairment to be 
greater than expected, and somewhere closer to that of infants following moderate HIE (77, 
124). In the era of hypothermia, studies have shown that infants classified as mild on clinical 
scoring alone have higher rates of morbidity in the neonatal period (239), but direct 
comparison to uncooled, moderate grade infants is no longer possible due to universal 
introduction of hypothermia in high-income countries. Our finding builds on growing 
evidence that some children with mild HIE do not follow a normal developmental trajectory. 
Significant, subtle disability can become more frequent with age as children ‘grow into’ their 
deficits (77, 124). The FSIQ’s of children from Robertson & Finer’s Canada cohort with mild-
like HIE did not differ from controls at age 5, but did by age 8 (71).  Recent retrospective 
cohorts suggest that up to 70% of adolescents have learning and behavioural difficulties 
which affect their everyday lives (240, 241). Unfortunately, most long-term follow-up studies 
either exclude those with mild HIE, or do not have local contemporary control populations.  
Management of infants with mild HIE remains supportive. Current protocols for TH include 
infants with moderate to severe HIE only (139). These protocols are based on clear data from 
large randomized controlled trials of efficacy in moderate and severe HIE showing improved 
rates of intact survival (16, 18, 139). Even within these grades benefit is not universal with a 
number needed to treat of 7-8 infants for one intact survival (45). In infants with mild HIE, 
the risk:benefit ratio is likely to be even less balanced in favour of aggressive intervention. 
However, although the economic cost of NICU care and cooling is high, it may not be so when 
compared to lost academic achievement. Furthermore, preliminary indications from the roll-
out of hypothermia in clinical settings report that infants with mild HIE are being treated in 
many centres (242). Recent studies highlight the difficulty in assigning HIE grade with many 
infants misclassified based on clinical grading alone (239). We have confirmed the accuracy 
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of our clinical grading at 24 hours by assessing simultaneous EEG recordings. This has allowed 
us to examine the ability of both clinical and EEG grade to predict long term outcome. 
Our data support the need for future clinical trials of neuroprotective agents to include 
infants with mild HIE, both to ascertain the effect of cooling and to examine adjunct low cost 
medical therapies (243, 244). As 50% of infants with HIE have mild grade encephalopathy, 
the burden of disability with loss of academic potential and decreased employment 
prospects may be greater on a global scale, with greater numbers, but similar cognitive 
outcomes to that of moderate HIE (245).  
It remains unclear why such an apparently mild injury may lead to adverse outcome. The 
answer may lie in in vitro and animal studies suggesting that an initial insult permanently 
alters the brain’s ability to repair and develop. This “tertiary brain injury” appears to initiate 
an altered inflammatory or epigenetic response within the brain affecting oligodendrocyte 
development and synaptogenesis, leaving the brain more susceptible to further injury (30).  
Our data shows the heterogenous profile of disability following HIE and the need for 
multidisciplinary early intervention. Additional multi-disciplinary developmental support was 
required in 35% of children with mild EEG abnormalities at 24 hours, compared to 3% in the 
comparison group. Although previous reports have estimated an increased rate of ASD in HIE 
(241), our rates of ASD and ADHD were not higher than expected (246-248).  
Our data confirms the importance of long term follow up to school age, and the use of 
contemporaneous local controls. At our two year outcome assessment these children were 
compared to standardized norms and almost all mild infants scored within normal ranges 
(105). Unfortunately, we did not assess a comparison group at this stage. Longer term follow-
up, with the availability of a comparison group has revealed significant differences at school 
age. Our comparison group performed better than expected on WPPSI-IIIUK assessment, with 
median FSIQ, VIQ and PIQ scores one standard deviation above the mean. Scores 
approaching this level of attainment have been recorded in control groups of children in 
other studies using the WPPSI-III (249). For HIE studies, mean IQ scores in controls of 109 
(Utrecht cohort) and 115 (Canada cohort) in 8-10 year-olds were recorded using the WISC 
(Wechsler Intelligence Scale for Children) scales (see also Chapter 1, Table 1.4 and Table 1.5) 
(77, 131). This may be due to local population differences, the socio-economic profile of the 
group, or the Flynn effect of IQ drift over time, estimated by the  test publishers to be a 0.33 
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score increase per annum (250). This would equate to a 2.3 to 3.6 point increase for our 
study. 
Our comparison group was used because of the availability of neonatal EEG for them and 
were recruited based on an uneventful perinatal course. No significant differences in socio-
economic status (SES) or maternal education existed between our case and comparison 
groups However, this group may be ‘healthier’ than children chosen from the normal 
population. We reviewed a number of our comparison groups’ clinical and demographic 
variables to an Irish national cohort – the ‘Growing Up in Ireland’ study – which randomly 
recruited a national infant cohort of 11,100 families in 2008 (see Chapter 2 Table 2.3). Data 
from this study suggests that in our comparison group, males are underrepresented (43.3% 
Vs. 51.3%), and that our cohort had more infants born after an unassisted delivery (73% Vs. 
58%). Both of these factors may have contributed to inflated scores. However, rates of 
maternal education were surprisingly consistent (84% Vs. 82%). This points to the critical 
need for further studies which include designs that carefully case-control for demographic 
determinants of lower IQ such as male gender, age and educational level, SES and maternal 
education. 
The major limitation of the study is the small numbers available with outcome at 5 years. 
However, recruitment of infants with HIE is difficult and few cohorts are studied 
prospectively from birth. Fewer still include children with mild HIE. Our cases have been 
carefully categorized using both EEG and Sarnat grading, and our comparison group uniquely 
had early EEG and clinical assessment of their neurological status at birth.  Follow up was 
detailed and blinded to neonatal data in both the cases and the comparison group. Very little 
prospective data on non-cooled cohorts comparing mild to moderate HIE is available. 
Although rates of disability in infants with moderate HIE will now be altered due to 
therapeutic hypothermia, there are no approved and effective therapies for those with mild 
or severe infants. Our data has shown that significant disability occurs within these grades at 
5 years, and supports continued research in these cohorts to develop adjunct therapies 
suitable and effective in all grades of HIE.  
In conclusion, we have shown that cognitive outcome, measured by the WPPSI-IIIUK is age-
expected but significantly reduced following mild, moderate or severe HIE compared to a 
comparison group, whether graded by EEG or clinical Sarnat grade. Although mild HIE had 
the highest rates of intact survival; no difference in cognitive ability was evident between 
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mild and moderate grades of HIE. Our data supports the need for future studies of 
neuroprotection to include infants with mild HIE. 
COMMENT: My contribution to this chapter is described in further detail in Chapter 8 Section 
8.1: Summary and Impact of the Thesis Findings. 
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7.1 Abstract 
Objectives: 
To investigate the functional and structural impact of neonatal hypoxic-ischaemic 
encephalopathy (HIE) on childhood visual development and neurodevelopmental outcomes.  
Methods: 
In a prospective study, the neurocognitive outcomes of 42 children with a history of neonatal 
HIE, graded at birth by clinical Sarnat score and early continuous EEG, were assessed serially 
up to 24 months with the Griffiths’ mental development scale (0-2) revised and at 5 years 
using the WPPSI-IIIUK. Visual, refractive, orthoptic and ocular biometry measurements were 
obtained in 32 children, with axial length measurements estimated using the IOLMaster. 
Results: 
Of the 32 children who completed the ophthalmic section of the study, the severity of HIE 
grade was determined to be mild, moderate, or severe in 18 (56.3%), 13 (40.6%), and 1 (3.1%) 
cases, respectively. One (3.1%) child was classed as visually impaired. Twelve (37.5%) were 
found to have ametropia. Mean (± SD) axial length was 22.09 (± 0.81) mm, within the normal 
range for the age of this cohort. Seven of the 42 (16.7%) children who were involved in the 
larger neurodevelopmental arm of the study had clinical evidence of a squint. There was no 
correlation between the severity of HIE grade at birth and axial length, occurrence of squint, 
or motor outcome. 
Conclusions: 
Ocular biometry measurements were not adversely impacted by HIE, showing no correlation 
with the severity of HIE grade. Neonatal HIE is associated with a higher incidence of squint 
compared with the general paediatric population. This occurred despite normal motor 
outcome and in both mild and moderate to severe HIE grades.  
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7.2 Introduction 
Neonatal hypoxic-ischaemic encephalopathy (HIE) remains one of the commonest causes of 
acquired neonatal brain injury, affecting approximately 3 per 1000 term births in the 
developed world with a rate ten times higher in the developing world (127). It causes 23% of 
all neonatal deaths, and surviving infants remain at risk for significant neurological disability 
including cerebral palsy (CP), epilepsy, intellectual disability and sensory loss. Recent 
research has also reported learning and behavioural difficulties often not detected until 
school age (222).  
Visual loss is frequently associated with neurological disability making perinatal HIE, in term 
and preterm infants, the most common cause of visual disability in developed countries 
(258). While damage to the primary visual cortex, visual associative cortex, optic radiations, 
optic nerves or visual attention pathways can occur (258), the mechanism of injury and 
prognosis for recovery is usually unclear. Cortical occipital lesions do not correlate with the 
degree of visual loss, and recovery of cortical blindness can occur in the first few years of life 
(259-261).  
Head growth in early life can be related to the severity of the initial hypoxic insult, and result 
in suboptimal growth and consequent microcephaly (218). This may have ophthalmic 
implications as generally the growth pattern of the eye mirrors that of the brain (262, 263). 
Most postnatal growth of the eye occurs within the first 3 years of life, with a rapid phase 
acceleration evident from birth to 6 months of age (264-268). It is uncertain whether 
perinatal ischaemic injury has a negative effect on early ocular growth rate similar to the 
restriction in brain growth. There is a correlation between the impact HIE has on early visual 
function and subsequent neuromotor development (269), with increased rates of strabismus 
usually explained in terms of concomitant motor difficulties and/or CP (270). 
Few studies have followed the visual outcome of children with neonatal HIE to school age so 
limited outcome data is available, and, to our knowledge, none have previously reported 
detailed ocular biometry. In this paper we report on the ophthalmic outcomes, including 
visual, refractive, orthoptic and ocular biometry measurements of a carefully defined 
prospective cohort of infants with neonatal HIE and compared this with detailed 
neurocognitive outcome from infancy through to school age.  
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7.3 Methods 
Term infants with suspected HIE were prospectively recruited between May 2003 and 
December 2005 from the regional maternity service. Inclusion criteria for the study were 
term (≥37 weeks) infants who met at least two of the following: (a) initial capillary or arterial 
pH <7.1, (b) Apgar score <5 at 5 minutes, (c) initial arterial or capillary lactate >7 mmol/L, (d) 
abnormal neurology or clinical seizures. The exclusion criteria were evidence of co-existing 
congenital anomaly, or significant co-morbidity. Written informed consent was typically 
granted within 6 hours of birth, but outside this timeframe if later seizures emerged. 
Comprehensive neurological assessments and continuous early EEG was recorded. Each 
infant was assigned a modified Sarnat encephalopathy grade at 24 hours and HIE grade was 
confirmed on serial EEG recordings (14, 188). Early developmental progress was assessed at 
6, 12 and 24 months of age using the Griffiths Mental Development Scales – Revised, (172) 
and administered by a registered user of the test (Dr. DM Murray). This standardized test 
provides an overall development quotient (GDQ) and subdomain quotients for locomotor, 
personal/social, hearing/language, hand/eye co-ordination, and performance. The mean 
GDQ is 100.5 (11.8). An abnormal score is ≤88. This is an ‘uncooled’ cohort due to being 
recruited in the pre-therapeutic hypothermia era (17). The two year and five year 
neurodevelopmental outcome of this cohort has been previously reported (105, 252). 
The current study was part of this longitudinal study which followed the 
neurodevelopmental progress of these children to five years and was approved by the 
Clinical Research Ethics Committee of the Cork Teaching Hospitals. Research protocols were 
in keeping with the tenets of the Declaration of Helsinki. Parents or carers of the children in 
the HIE birth cohort from age three years onwards were contacted by telephone by CM 
O’Connor who explained the nature of the vision tests and to obtain consent to forward 
contact details to the ophthalmic team. Written informed consent for the ophthalmic 
component of the study was obtained from parents/carers by Dr M James at the ophthalmic 
appointment. 
During their ophthalmic assessment, data recorded for each participant was classed as 
demographic, clinical, visual, orthoptic, biometric, and refractive. Clinical data included: 
general medical history; family history of ocular disorders; birth weight (kg); occipito-frontal 
circumference (OFC) (cm); HIE grade; and anterior segment and fundal findings on slit lamp 
biomicroscopy. Visual data included: Snellen, logMAR, or Sheridan-Gardiner visual acuity as 
 [197] 
 
appropriate; and confrontation visual fields assessment by the use of a target gradually 
moved in from the periphery until detected. Orthoptic data was assessed by an experienced 
orthoptist (B Haskins), and included: ocular alignment on cover testing; angle of squint by 
prism cover testing; ocular motility, including convergence; and stereopsis determination by 
the Lang II stereo test. 
All biometric and refractive measurements were performed by a single ophthalmologist (Dr. 
M James). Cycloplegic autorefraction was performed 30 minutes following instillation of a 
drop of cyclopentolate 1% to each eye, with the use of one of three autorefractors which 
were available at different times through-out the duration of the study: the NIDEK Auto 
Refractometer AR-630A (Nidek CO., Japan), the Topcon RM-A3000 Auto Refractometer 
(Topcon, Tokyo, Japan), or the NIDEK Auto Refractometer AR-800 (Nidek CO., Japan). 
Reliability of data was checked by performing cycloplegic streak retinoscopy in all cases using 
a Welch Allyn retinoscope (Welch Allyn Medical Products, Skaneateles Falls, New York). 
Results recorded in sphero-cylindrical form, including axis, were used to calculate the 
spherical equivalent (SE) refractive error for each eye. Ocular biometry using the IOLMaster 
(Carl Zeiss Meditec, Jena, Germany) was used to obtain average axial length (mm) and 
keratometry values (expressed as the mean of the steepest and flattest meridian in dioptres 
(D)).  
Visual impairment was defined as a presenting vision (i.e. unaided or with glasses if worn) of 
less than 6/12 in the better seeing eye. Anisometropia was defined as an interocular 
difference in SE of ≥ 1.0 D. As there were no statistically significant differences between 
refractive and ocular biometry data between right and left eyes, all subsequent analyses 
used data from a single eye in each case following randomization.  
At 5 years of age, the study participants were seen either at home or at the university by a 
clinical psychologist (C O’Connor). Each child’s intellectual abilities were assessed using the 
Wechsler Preschool and Primary Scale of Intelligence - III (UK version) (WPPSI-IIIUK), which 
yields a full-scale IQ score (FSIQ), verbal IQ (VIQ), performance IQ (PIQ), processing speed 
quotient (PSQ) and general language composite (GLC). The mean score is 100 (15). An 
abnormal score is <85. 
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7.3.1 Statistical analysis 
Ocular data were analysed using Stata package ver. 8.0 (StataCorp. 2005; Stata Statistical 
Software: Release 9.0; College Station, TX). The associations between the categorical 
variables were examined using the Chi-square test.  IBM SPSS Statistics (version 22.0.0.1) was 
used to explore differences between normal/abnormal vision outcome and clinical, 
developmental and IQ data using Chi-square test for independence for categorical variables 
and Mann-Whitney U tests for continuous variables as these were not normally distributed. 
Statistical significance was set at p value < 0.05. 
7.4 Results 
The study flow and attrition of the cohort is displayed in Figure 7.1. Of the 42 children 
included in the study group, the parents of 33 children agreed to allow them to participate 
in detailed ophthalmological examinations, while the remaining nine did not wish to return 
for assessment, but agreed to a review of their existing ophthalmology notes. Two (22.2%) 
of these nine children had known ophthalmic issues (both with moderate HIE and previously 
diagnosed squint), while there were no visual concerns reported for the other seven. 
Of the 33 children available for detailed ophthalmological examination, one infant with 
severe HIE at birth and severe CP was unable to co-operate with biometric measurements; 
however, no gross squint or significant refractive error was noted. Thus, complete 
ophthalmological assessments were available in 32 infants. The mean age (± SD) at 
ophthalmic examination was 61.0 (± 9.2) months, (range: 40 to 76 months). The ratio of boys 
(n=21) to girls (n=11) was 1.9:1 (see Table 7.1). Ethnicity of children were Caucasian (31; 
96.9%), and Asian (1; 3.1%). HIE severity, assigned by Sarnat grade, was mild, moderate, or 
severe in 18 (56.3%), 13 (40.6%), and one (3.1%) cases, respectively (a detailed break-down 
of Sarnat grade proportions for each part of the study is displayed in Figure 7.2). Median 
(IQR) birth OFC by Sarnat grade were as follows: mild = 36.0cm (34.0-37.05), moderate = 
36.0cm (34.35-36.3), severe = 36.8cm (n=1), with no significant difference between mild and 
moderate HIE grade (p=0.53). There were 2/32 (6.3%) children with an OFC below the 3rd 
centile, one with mild and one with moderate HIE.  
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Figure 7.1 Flowchart of HIE birth cohort and attrition over time to 5 years. 
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Table 7.1 Details of HIE grade and birth parameters by gender for children who attended for 
ophthalmic examination. 
 Boys 
(n=21) 
Girls 
(n=11) 
Total 
(n=32) 
HIE Grade, n (%) 
Mild 
Moderate 
Severe 
 
13 (61.9) 
7 (33.3) 
1 (4.8) 
 
5 (45.5) 
6 (54.5) 
0 (0.0) 
 
18 (56.3) 
13 (40.6) 
1 (3.1) 
Birth weight (kg) 
Mean (± SD) 
Median (range) 
Low BW* n (%) 
 
3.5 (± 0.46) 
3.59 (2.44 – 4.20) 
1 (4.8) 
 
3.16 (± 0.73) 
3.21 (1.83 – 4.18) 
2 (18.2) 
 
3.38 (± 0.58) 
3.45 (1.83 – 4.20) 
3 (9.4) 
Birth OFC (cm) 
Mean (± SD) 
Median (range) 
 
35.72 (± 1.85) 
36 (31.5 – 40) 
 
35.53 (± 2.31) 
35.5 (32 – 40) 
 
35.65 (± 1.99) 
36 (31.5 – 40) 
*Birth weight less than 2.5kg; OFC=occipito-frontal circumference (head circumference) 
 
 
Figure 7.2 Proportion of children in the HIE cohort with mild, moderate and severe Sarnat grade at 
birth, five year cognitive outcome and for the current study. Ophth Ax – children who attended 
ophthalmology assessment; Ophth Hx – children whose parents consented to obtaining vision history 
but did not attend ophthalmology assessment; Ophth DNA – children who withdrew/did not attend 
ophthalmology assessment. 
46% 47%
56%
33% 33%
35%
40%
41%
56%
17%
18% 13%
3%
11% 50%
30 22
18
3 2
23
19
13
5
1
12 6
1
1
3
Birth 5 Year Outcome Ophth Ax Ophth Hx Ophth DNA
Mild HIE Moderate HIE Severe HIE
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Normal visual fields were found in 27 (84.4%) children, while the remaining five (15.6%) had 
no obvious defect, but had insufficient co-operation to allow reliable assessment. A 
presenting visual acuity in either eye of 6/12 or better was documented in 31 (96.9%) 
children, and 6/6 or better in 29 (90.6%). One (3.1%) child was classed as visually impaired, 
with a visual acuity of 6/18 in each eye in the absence of any significant refractive error or 
ocular pathology. Two (6.3%) children were noted to have an amblyopic eye, with a visual 
acuity of 6/12 or worse, secondary to anisometropia.  
A summary of the abnormal ophthalmic outcomes by HIE grade is displayed in Table 7.2. Five 
(15.6%) children had evidence of a manifest squint: two had accommodative esotropia with 
hyperopia; another three had divergent strabismus with no significant refractive error but 
had a positive family history of squint. There was no statistically significant difference in 
strabismus rates between the HIE grades (Table 7.2).  
Table 7.2 Distribution of visual impairment, refractive error, and squint by severity of HIE grade for 
children who attended for the full ophthalmic examination section of the study. 
HIE Grade† No. of 
children 
Visual acuity of 6/18 or 
worse in better eye 
n (%) 
Ametropia in 
either eye* 
n (%) 
Strabismus** 
n (%) 
Mild 
Moderate 
Severe 
18 
13 
1 
1 (5.6) 
0 (0) 
0 (0) 
9 (50) 
2 (15.4) 
1 (100) 
3 (16.7) 
2 (15.4) 
0 (0) 
Total 32 1 (3.1) 12 (37.5) 5 (15.6) 
*: Spherical equivalent refraction of ≥ +2.0 D or ≤ -0.5 D in either eye, astigmatism of ≥ 1.5 D. 
**: Strabismus defined as the presence of a manifest deviation on cover testing. 
†: There were no statistically significant differences in the ocular parameters by HIE grade. 
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The refractive error, angle of squint, and other notable associations are detailed in Table 7.3. 
This table also shows the neurodevelopmental outcomes of two additional children who had 
a diagnosis of squint documented in their medical/orthoptist notes from the larger cohort of 
42, but did not partake in the full ophthalmic assessment arm of the study. Thus, the total 
number of children with confirmed squint from the whole cohort was seven (16.7%).  
 
  
[2
0
3
] 
Table 7.3 Subgroup characteristics of children who had manifest strabismus. 
No. and 
gender 
Age 
(mths) 
HIE 
grade 
Squint 
type 
Angle of squint 
at 1/3m (prism 
diopters) 
Lang 
stereo 
test 
SE 
refractive 
error (D)* 
Other visual 
findings 
Overall outcome 
1. Female 74 Mild Exo 12 4/4 +1.125 Convergence 
insufficiency 
Early Intervention 
2. Male 76 Mild Eso 20 4/4 +1.875  ADHD; VIQ >1SD below 
mean 
3. Male 47 Mild Exo 45 4/4 +2.375 Saccades 
initiation failure 
ASD; PSQ>1SD below 
mean 
4. Female 61 Mod Exo 20 4/4 +1.75  Normal 
5. Male 60 Mod Eso 12 4/4 +4.625  ADHD; 
FSIQ >1SD below mean 
6. Female**  Mod Exo     Normal; 
PSQ >2SD below mean 
7. Female**  Mod Exo     FSIQ>1SD below mean; 
language disorder 
D = diopters; SE = spherical equivalent; Eso = esotropia; Exo = exotropia; SD = standard deviation; Mod = moderate; ADHD = attention deficit 
hyperactivity disorder; ASD = Autism spectrum disorder; FSIQ = full scale IQ; VIQ = verbal IQ; PSQ = processing speed quotient: Early Intervention = 
receiving multidisciplinary clinical intervention. *: SE refractive error of the eye with the greater refractive error. **: Two additional children with 
confirmed history of squint from orthoptist notes were participants of the main HIE study group, but were not from the 32 who attended for the full 
ophthalmic assessment part of the study. 
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No statistically significant difference between refractive data achieved through 
autorefraction and that from retinoscopy was noted (p > 0.05). The mean (± SD) SE refractive 
error as calculated by cycloplegic autorefraction was +1.82 (± 1.74) D for right and +1.79 (± 
1.44) D for left eyes. The overall range of SE refractive error was -0.625 D to +7.25 D. Mean 
astigmatism was +0.44 (± 0.42) D for right and +0.57 (± 0.69) D for left eyes, with a range in 
either eye from 0 D to 3.75 D. In total, 12/32 (37.5%) children were found to have ametropia; 
one child (3.1% of sample) was classed as myopic, nine (28.1%) as hyperopic, three (9.4%) as 
having astigmatism (of whom one was also hyperopic). Two (6.3%) children were noted to 
have anisometropia (both were also in the hyperopic group).  
Ocular biometry assessment showed the mean (± SD) axial length was 22.04 (± 0.88) mm for 
right and 22.06 (± 0.81) mm for left eyes (overall range, 19.74 – 24.77 mm). The mean (± SD) 
keratometric measurement was 43.18 (± 1.42) D for right and 43.18 (± 1.45) D for left eyes 
(equivalent to a mean corneal radius of curvature of 7.81 mm). All subsequent analyses used 
data from a single eye in each case following randomization, a summary of which is given in 
Table 7.4. There was a positive correlation between axial length and age (rho=0.4919, 
p=0.0042), with children over 60 months of age having statistically significant longer median 
axial length than those under 60 months (p = 0.039). Otherwise, there was no statistically 
significant differences between the ocular biometric parameters (axial length, SER, or K) and 
sex or HIE grade (mild Vs. moderate) on univariate analysis. 
Table 7.4 Mean (± SD) refractive and biometry measurements of the randomized eye by gender, age, 
race, and HIE grade. 
 No. of 
children 
Axial length 
(mm) 
Keratometry 
(D) 
SE refractive error 
(D) 
Gender 
Male 
Female 
 
21 
11 
 
22.20 (± 0.92)  
21.87 (± 0.47) 
 
43.00 (± 1.47) 
43.57 (± 1.39) 
 
+1.74 (± 1.73) 
+1.60 (± 0.97) 
Age (months) 
40-60 
61-76 
 
15 
17 
 
21.74 (± 0.64) 
22.40 (± 0.82)*  
 
43.38 (± 1.29) 
43.04 (± 1.60) 
 
+2.11 (± 1.94) 
+1.32 (± 0.85) 
Race 
Asian 
Caucasian 
 
1 
31 
 
22.04 
22.09 (± 0.82) 
 
43.25 
43.20 (± 1.47) 
 
-0.625 
+1.77 (± 1.46) 
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HIE Grade 
Mild 
Moderate 
Severe 
 
18 
13 
1 
 
22.12 (± 0.99) 
22.05 (± 0.53) 
22.04 
 
43.15 (± 1.66) 
43.26 (± 1.24) 
43.25 
 
+1.99 (± 1.72) 
+1.46 (± 0.97) 
-0.625 
Total 32 22.09 (± 0.81) 43.20 (± 1.45) +1.69 (± 1.50) 
*p = 0.039 with respect to the difference in mean axial length between the age groups. D = 
diopters; SE = spherical equivalent; SD = Standard deviation. 
 
We next analysed the developmental progress of children post-HIE with a normal (assessed 
or reported) versus abnormal ophthalmic outcome (i.e. those with visual impairment, 
strabismus and/or ametropia). We found no significant differences in median Griffiths’ 
development scores obtained at six, 12 or 24 months or five-year WPPSI-IIIUK IQ scores 
between those with normal and abnormal ophthalmic outcomes. At five years, Performance 
IQ, which consists of visually-based tasks, was approaching significance (p=0.06). In addition 
to IQ, there was no significant increase in the proportion of children with an overall abnormal 
five-year neurodevelopmental outcome between those with normal and abnormal 
ophthalmic outcomes. 
Whilst no children in the cohort with confirmed strabismus had a diagnosis of CP, there was 
evidence of delayed early motor development at 12 and 24 months of age. Global 
development quotients (DQs) were significantly lower at 12 months (p = 0.038) and 24 
months (p = 0.025) in children with strabismus. These global differences were influenced at 
a domain level by lower locomotor scores at both ages (See Table 7.5). 
Table 7.5 Comparison of early development scores at 12 and 24 which significantly differed between 
children with and without strabismus. 
Griffiths Score 
Strab. 
Md (IQR) 
Strab. 
‘n’ 
No strab. Md 
(IQR) 
No strab. 
‘n’ 
Z 
score 
P 
value 
Global 
(12m) 
84 (68-91) 4 100 (88-109) 31 -2.08 0.038 
Global 
(24m) 
87 (52-101) 7 109 (99-113) 31 -2.25 0.025 
Locomotor 
(12m) 
63 (51-72) 4 87 (80-100) 31 -2.16 0.031 
Locomotor 
(24m) 
88 (49-102) 7 116 (90-126) 31 -2.40 0.016 
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Personal-Social 
(24m) 
89 (52-106) 7 112 (99-119) 31 -2.07 0.038 
Md = median; IQR = inter-quartile range; Global = Griffiths Mental Development Scales global 
development quotient. 
 
 At five years, there were no significant differences between the children with and without 
strabismus for measured IQ. While the incidence of abnormal overall outcome (defined as at 
least one of the following: CP, vision/hearing loss, neurodevelopmental disorder, need for 
early intervention, or IQ < 85) was higher in the strabismus group compared to children 
without strabismus (five out of seven (71.4%) versus 12 out of the 35 (34.3%), respectively), 
the result was not statistically different (see Table 7.3). 
7.5 Discussion 
We have described the detailed ophthalmic outcomes of a prospective cohort of infants 
following neonatal HIE. The infants were born prior to the introduction of therapeutic 
hypothermia treatment for those with moderate-severe HIE. In a recent Cochrane review of 
the effects of cooling (therapeutic hypothermia) infants with neonatal HIE, seven of the 
clinical trials reported visual outcome rates (45). Fifty-eight of 749 survivors (i.e. 7.74%) were 
legally blind. Meta-analysis across the trials suggested a non-significant reduction in 
blindness in infants who were cooled (typical RR 0.62 (95% CI 0.38 to 1.01). Thus, adverse 
sequelae relating to vision remains a significant outcome for infants in this population. It is 
important to note that these randomized controlled trials have focused on infants with 
moderate to severe encephalopathy only. Our data adds significantly to the limited 
knowledge that is available for outcome following mild HIE.  
HIE causes brain injury through a process of inflammation and cell death involving oxidative 
stress and excitotoxicity, which can result in death or permanent neurologic deficits such as 
cerebral palsy, epilepsy, and learning disorders (271). The ophthalmic effects are 
characterized by restriction of the visual fields and may include severe visual loss, with 
neuroimaging studies suggesting that a greater trend towards visual dysfunction in infancy 
has been shown when lesions involve the basal ganglia (272). The visual impairment noted 
in early life interferes with visual exploration at a critical time of neuronal maturation in the 
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occipital lobes, and has been shown to have a negative impact on visual function at school 
age (79, 273). 
The prevalence rate of visual impairment in Caucasian children of seven years of age in a 
British population-based study was found to be 0.5% (273). While higher than this, the rate 
of visual impairment in our study would still be considered low, with no child having clinically 
observable restriction of their visual fields, and only one (3.1%) child found to have visual 
impairment where acuity was worse than 6/12 in both eyes. This child had mild HIE, but had 
no significant refractive or other ocular cause found for reduced vision, raising the possibility 
of cortical impairment or injuries to the inner retina, where chronic functional and structural 
changes have been found in experimental models of induced HIE (274, 275). The rate of 
adverse visual outcomes in our study was lower than those found by Mercuri et al. which 
involved 39 children affected by HIE of a similar age group, where seven (17.9%) children 
were classed as having severe visual impairment, and a further six (15.4%) found to have 
narrow visual fields (79). This may be due to differences between the cohorts with respect 
to Apgar criteria, classification and severity of HIE grade. Our cohort included those with mild 
HIE who would be expected to have a better outcome. In addition, at 5 years, very few infants 
with severe grade HIE were still alive, or able to co-operate for a complete examination due 
to severe motor or intellectual difficulties.  
Our incidence of manifest squint of 16.7% was similar to that reported by Mercuri et al. (79), 
and exceeds the number that would be expected in a healthy childhood population of 
between 1.5 and 4.0% (273, 276-279). Consistent with our findings, a retrospective 
Norwegian population based study of infants with a combination of low Apgar score (0-3) 
and neonatal signs of encephalopathy found that school-aged children had significantly 
increased risk of strabismus and requirement for glasses (21). One explanatory hypothesis 
proposes that adverse intrauterine and perinatal events during a critical period of brain 
development may disrupt the prenatal programming of coordination and control of eye 
movements (279). Cerebral visual impairment of hypoxic-ischaemic origin is associated with 
higher rates of ocular motility disorders, including saccadic initiation failure, absence of 
pursuit, nystagmus, and variable angle squint (280).  The co-occurrence of strabismus and 
problems with specific areas of early development such as locomotion in premature infants 
(281), and eye-hand coordination and depth perception has been previously recorded (282). 
None of the children with strabismus in our study had CP and yet had significantly lower 
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locomotor skills at 12 and 24 months of age, contributing to significantly lower global 
development scores at these ages. We did not find significant differences for eye-hand 
coordination at these early ages or visuomotor processing speed at age five in our cohort, 
and it remains to be seen whether this was due to the low number of tasks requiring depth 
perception skills on the measures used. The role strabismus plays in the acquisition of these 
developmental tasks is an important focus for future study; for example, motor 
improvements have been observed post-esotropic surgery (283).  
Our cohort  was predominantly white European, whose mean SE refractive error of +1.69 D 
is close to that found in both a Spanish and an American study involving healthy Caucasian 
children of an equivalent age (+1.49 D and +1.53 D, respectively), with ethnicity being an 
important consideration as there are lower rates of myopia reported in Caucasian children 
(284, 285). Additionally, rates of myopia and hyperopia in our study were similar to that 
found in population-based data involving Northern Irish children with a comparable age and 
race profile (3.1% vs. 2.8%, and 28.1% vs. 26% respectively) (286). Therefore, it appears that 
mild and moderate HIE does not confer any additional risk with respect to the development 
of refractive error in early childhood. 
Axial length increases with age in the paediatric population (264-266), so it is unsurprising 
that there was a significant difference in axial length comparing those under and over the 
age of five years. Axial growth rates in infants have been found to be similar between the 
genders (268, 287). In keeping with the findings of previous studies (265-267), we found that 
boys generally had longer axial lengths than girls, but not significantly so. Along with rapid 
growth in the eye that occurs within the first three years of life, there are compensatory 
mechanisms such as flattening of the cornea which can offset refractive errors which would 
otherwise be incurred with increasing axial length (288). Consistent with patterns of axial 
length in our study, mean keratometric measurements were also similar to what would be 
expected in this age group; the mean corneal radius of curvature in our study of 7.81 mm is 
very close to the 7.78 mm found in the study by Ojaimi et al. involving school children in the 
6- to 7-year-old age group (289). 
Mercuri et al. found that a correlation exists between visual impairment in early life and 
subsequent abnormal outcomes with respect to neurological and neurodevelopmental 
evaluation, suggesting that impacts on maturation of visual function may mirror those of the 
brain in general (269). There are also well-established links between biometric 
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measurements of the eye and brain, with respect to size and growth rates (262, 263). 
However, we found no correlation between axial length measurements and severity of HIE 
grade in our cohort of infants with mostly mild and moderate HIE. Indeed, the mean axial 
length in our cohort of 22.09 mm is close to the expected normative value from a published 
algorithm for early eye growth (264), and similar to the 22.22 mm noted in a group of healthy 
Spanish Caucasian children of an equivalent age (285). One of the key drivers of axial growth 
within the first year of life is the degree of initial hypermetropia, in support of an active 
model of emmetropization linked to feedback from a defocused visual input (287). It is 
possible that if early ocular growth rates were retarded in our cohort, the resulting excess 
hypermetropia and visual blur may have acted to reverse this trend and stimulate growth. 
There are other birth parameters such as birth weight, head circumference, and gestational 
age which have an impact on ocular biometry, but these did not have any significant impact 
on our results; only full-term babies were included in our cohort, and the numbers with head 
circumference below the 15th centile (n=3) or having low birth weight (n=3) were small. 
To our knowledge, this article represents the first report which has detailed ocular biometry 
data in early childhood complementing ophthalmic and neurodevelopmental outcomes in a 
cohort who were previously diagnosed with HIE. One of the strengths of the study was the 
inclusion of ocular biometry data measured with the IOLMaster, which is reported to be 
superior to ultrasound, and should be the standard for the precision and repeatability of axial 
length measurements in children (290). A limitation of our study was the absence of serial 
axial length measurements from an earlier age in each child. However, cooperation with 
detailed ocular examinations at a younger age is difficult to achieve and less acceptable to 
parents (267). Therefore, we cannot rule out a delay in early ocular growth rates before 
reaching this end point. 
Another limitation of our study is the relatively small numbers involved in the cohort. This is 
due to difficulties in recruiting and retaining a cohort of children with HIE and the high rate 
of mortality and disability in the severe group. However, this remains, to our knowledge, the 
largest prospective study of ophthalmic outcomes in a HIE cohort, and the only one with 
detailed ocular biometric data. In conclusion, we found no increase in refractory error or 
change in ocular axial length measurements in surviving children with a history of neonatal 
HIE. We have confirmed a higher rate of squint in this cohort, in both mild and moderate HIE. 
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Therefore, we suggest that infants with HIE of any grade should undergo an ophthalmic 
assessment in early childhood as part of their overall neurodevelopmental follow-up. 
COMMENT: Dr. James and I worked closely on this piece of work. I recruited the children to 
the vision arm of the study, Dr. James completed all of the ophthalmic assessments, and I 
completed the neurodevelopmental assessments. We analysed different aspects of the data. 
Dr. James focussed on the vision correlates and I focussed on the outcomes of children with 
strabismus (assessed by Ms. Beatrix Haskins), and investigated whether differences existed 
between children with normal vs abnormal vision outcome at five years. Further detail can 
be found in Chapter 8 Section 8.1: Summary and Impact of the Thesis Findings. 
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CHAPTER 8 
8 Summary, Impact and Conclusions 
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8.1 Summary and Impact of the Thesis Findings 
In this thesis, I have presented detailed five-year outcome data of a birth cohort of infants 
following HIE of all grades. This data included demographic, clinical, intellectual, visual and 
neuropsychological measures that provided an in-depth analysis of each child’s 
neurodevelopment. I have also compared these outcomes to a unique community 
comparison group who experienced a normal neonatal period as measured by neurological 
examination and electrophysiology in the perinatal period. I have calculated the associations 
and predictive value of neonatal neurological assessment, Sarnat grading and background 
EEG patterns, along with 6, 12 and 24-month developmental status for five-year IQ and 
overall outcome. In so doing, this thesis has confirmed the importance of serial tracking of 
children across early childhood to capture the non-linear acquisition of skills, and to 
discriminate those skills that are transient or permanent across early childhood. In addition, 
this thesis has described the pattern of abnormal outcome in a small cohort of infants with 
mild encephalopathy adding a strong clinical rationale for investigating the potential of TH 
for mild HIE to protect later outcome.  
This PhD focussed on five main objectives, the results of which are summarised below. 
Firstly, the capacity of a clinical neurological exam to trace the dynamic nature of neonatal 
hypoxic ischaemic brain injury in the initial hours and days of life remains critical for 
treatment onset, and to understand which items, at which time, may hold predictive value. 
Amiel-Tison recommends that a consensus may not be reached until the end of the first 
week, but clinicians don’t have the luxury of waiting in order to make treatment decisions. 
Previous research shows that some items such as eye tracking show maturation within hours 
(220), whilst others take days and all are interrupted by NICU care (60). Our work on the 
ATNAT and two-year outcome confirms the prognostic value of a persistent abnormal score. 
I prepared this work for publication and have examined correlations of individual ATNAT 
items with 5-year IQ outcome, and demonstrated that early visual and behavioural signs of 
alertness, passive tone, and palmar grasp correlated with five-year IQ. However, cranial 
signs, active tone and the majority of primitive reflexes measured on day 3 of life were not 
helpful for prediction. Observations of patterns such as these in different neonatal cohorts 
may contribute to a better understanding of the neuro-anatomical (127) and neuro-
physiological (291) correlates in the neonate that may lead to the ideal constellation of signs 
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to be assessed in a neonatal neurological battery which could be used in non-specialised 
NICU settings. 
Secondly, longitudinal research designs must consider how best to (i) measure the unfolding 
of developmental pathways beyond infancy into childhood, and (ii) examine how the young 
brain dynamically adapts to early brain insult across developmental time. A robust body of 
knowledge demonstrates that developmental follow up to 24 months will capture principally 
sensori-motor, linguistic, social-emotional and emerging cognitive skills, but continued 
assessment into childhood will identify children who ‘grow into their deficits’, when higher 
order cognitive skills are required for task mastery. This is the first study that we are aware 
of that gathered comprehensive data at birth, 6, 12, 24 and 60 months in a HIE cohort, with 
EEG grading. 
Standardised developmental tests were previously serially administered at 6, 12 and 24 
months of age, and I analysed how these skills were associated with intellectual and overall 
outcome at five years. In addition to 5-year full-scale, verbal and performance (non-verbal) 
IQ domains correlating with development at 6, 12 and 24 months, the data demonstrated 
that a consistent early normal development score from 6 to 24 months lead to a normal IQ 
at five years. Of those with at least one abnormal early development score, 89.5% had an 
abnormal overall outcome at five years. The need for serial assessment is established 
because scores are inconsistent across early childhood (33% in our case) as the qualitative 
differences in difficulties in the underlying domains are realised at different ages. In our 
cohort, delay in the locomotor domain was evident at 12 months but not 6 or 24. I have 
confirmed the importance of access to early intervention for children following HIE with 
abnormal 6 or 12 month Griffiths scores, all of whom presented with at least one of cerebral 
palsy, low IQ, diagnosed neurodevelopmental disability, sensory loss or ongoing need for 
early intervention by school age. 
Thirdly to describe the pattern of five-year outcome across all grades of hypoxic-ischaemic 
encephalopathy diagnosed in the neonatal period, and examine the predictive value of early 
Sarnat and EEG grade assignation in the first day of life for outcome at this age. I 
demonstrated that as a group, these children had significantly lower verbal short-term 
memory and processing speed skills that require visual motor coordination skills, than the 
test norms. Unique to this study, I was able to recruit a comparison sample with EEG 
confirmed normal neurological birth and neonatal period and compare the five-year 
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outcome results with same. I found no difference between the IQ scores of those children 
who experienced mild or moderate neonatal HIE, and although within the average ranges, 
critically these grades of HIE were performing significantly worse than the comparison group. 
I further showed the evolution of background EEGs which remained constant or improved 
between 6 and 24 hours of age. I have described the outcomes at these two ages, and 
investigated the predictive power of an EEG assigned at 24 hours. IQs at five years decreased 
as EEG grade worsened, and all infants with grade 4 EEG died or had profound 
neurodevelopmental disabilities. IQ scores did not differ significantly between grades 1-3 but 
all were significantly lower than those with a normal EEG reading at 24 hours (i.e. all of the 
comparison group and 5 HIE infants). 
In relation to the ability of EEG background pattern to predict outcome at five years there 
was a clear pattern of increased propensity for abnormal outcomes as EEG grade increased. 
At six hours of age an infant with a slightly abnormal EEG background activity (mild 
asymmetry, mild voltage depression, or poorly defined sleep-wake cycle) had a 25% chance 
of experiencing later abnormal outcome. Similar to Sarnat grade, the trend of increased 
burden of pathology as measured by EEG confirms the importance of this measurement tool 
for clinical decision making in the hours immediately after birth. 
The fourth aim was to investigate the neuropsychological processes found in these children 
at 5 years. A consistent finding in the literature is that children following HIE can experience 
educational difficulties despite otherwise intact survival. In this study I used 25 tasks of the 
NEPSY-II, and found that although children had scores within the average range (except for 
fingertip tapping, design fluency and memory for names) the accumulation of low scores 
across the tasks was significant. Per child, 28% of median scores were below average, 
compared with 8% in the comparison sample. For children from the HIE cohort with an 
otherwise intact outcome, scores in over a quarter of the subtests were significantly below 
the comparison group. Similar to IQ, I found that children who had Sarnat and EEG grade 0 
at 24 hours of age had higher scores across all neuropsychological domains, with no 
differences between mild and moderate grades. This pattern of lower scores across domains 
despite normal IQ may determine which child may require additional educational support in 
school, and merits further study. 
Finally, I was fortunate to work closely with an ophthalmologist colleague (Dr. Mark James) 
to describe detailed vision outcome in this HIE cohort. Vision outcomes for children post HIE 
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have reported visual field difficulties and, we found an increased incidence of strabismus 
even in those children without cerebral palsy. Furthermore, of the 7 children with 
strabismus, 5 had abnormal outcomes at age five, and a sixth had a low processing speed 
index score. In addition, this group of children had significantly lower developmental scores 
at 12 and 24 months possibly due to delayed locomotor skills. This is a tentative finding due 
to low numbers. There were no differences found for vision outcome between mild and 
moderate encephalopathy grades, or between children with normal or abnormal five year 
outcome. 
 
8.2 Strengths of the Research 
A significant strength of this study was the availability of two prospectively recruited cohorts 
of infants from previous studies born at the same regional maternity services, both of whom 
had been comprehensively neurologically assessed in the neonatal period. The HIE cohort 
had well-defined clinical and EEG confirmed signs of mild, moderate and severe hypoxic 
ischaemic encephalopathy. The community comparison cohort with normal neonatal EEG 
findings. Demographic analysis demonstrated that the two cohorts had similar distributions 
of clinical and demographic factors including gender, birthweight, gestation, maternal 
education, parent occupation, ethnicity, and rural/urban background. Inter-rater variability 
was minimised by the same clinician recruiting the infants at birth (although different for two 
cohorts), the same specialist neonatal neurophysiologist who graded the EEGs, and the same 
Griffiths registered paediatrician who carried out the majority of the GMDS-R assessments 
at all ages.  
At five years, I assessed all children from both cohorts, including intellectual and 
neuropsychological assessment. Apart from knowing which cohorts the children came from 
I was blind to the neonatal and early developmental status of the infants. In the HIE cohort, 
a high retention rate was achieved, and this was enabled by the flexibility I was given to 
assess the children at times and locations (home or university) that suited families. This 
minimised the loss of children who lived a significant distance from the assessment centre. I 
scored all assessments and an assistant psychologist was available for double scoring to 
ensure minimal errors in the raw data. The use of software for scoring and exporting scores 
to excel and then to SPSS assured minimisation of error in the standardised data for the 
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NEPSY-II test which produced 107 output scores per child. As an experienced clinical 
psychologist with a history of working with children and families in early intervention I was 
familiar with the importance of building rapport and communicating empathically to reduce 
stress in the assessment setting. In addition, although I wasn’t involved in the project for the 
early years assessments, I am a registered user of the Griffiths scales and was very familiar 
with the scoring criteria. I re-scored all Griffiths record forms to ensure cross-study accuracy.  
Much is understood about the motor and intellectual effects of neonatal HIE. There has been 
less focus on other neurodevelopmental disorder categories. In our study, I collated rates of 
clinically diagnosed disorders including autism, ADHD, DCD and language disorders. Our rates 
of all of these were higher than for the comparison group recruited at birth. Some studies 
suggest higher rates of birth asphyxia in population studies of children who develop ADHD 
than those who don’t (292). 
Because this research was undertaken in a multidisciplinary research setting, the availability 
of highly specialised professionals was an important strength, especially in relation to 
neonatal EEG analysis by Prof. Geraldine Boylan. 
The most significant strength of our study was the inclusion of infants with all grades of HIE 
which meant that I could undertake detailed analysis of children with mild HIE at a time when 
emerging literature was suggesting that this level of encephalopathy may not always be 
benign. Our cohort also allowed for the comparison of outcome of mild and uncooled 
moderate HIE which will no longer be possible due to the introduction of TH for moderate 
HIE. 
8.3 Limitations of the Research 
The principal limitations of this study are the small cohort sizes of the HIE and comparison 
groups. This is a common feature of longitudinal research that recruits individuals with rare 
conditions. With an annual birth rate of 6,000, it took 30 months to recruit 65 infants at birth. 
The small numbers limited choices for statistical analysis, especially regression models, and 
the control of co-variates. Potential confounding factors such as gender, maternal education 
level, family income, non-native language status and child IQ have shown to hold predictive 
value in HIE cohorts (58, 124), and were not statistically controlled for in our study. When 
compared with a national Irish cohort of children (national ‘Growing Up in Ireland Study’ 
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(190)), our Comparison group had significantly fewer males and infants following unassisted 
birth. However, there were no differences between maternal education level between our 
cohorts, and coincidentally, all children and their parents were fluent English speakers.   
A second important limitation of this study relate to certain characteristics of the Comparison 
group chosen. Although detailed neonatal data was available including, uniquely, EEG 
recordings, the potential for bias was introduced because (i) caregivers who provide consent 
to allow their healthy newborns to be monitored with EEG, may not be representative of a 
community sample, and (ii) comparison with the national ‘Growing Up in Ireland Study’ (190) 
suggests that male gender and firstborns were underrepresented, and the mothers were 
more likely to have had unassisted deliveries. On a positive note, maternal education level 
and parent occupations appeared equivalent. The inclusion of a matched case control group, 
which could have matched for important demographic factors such as gender and age would 
have mitigated their potential influence on childhood outcome. Consequently, it would have 
enhanced the validity removed the threat of the competing hypothesis that the reason for 
the differences found between our cohorts was not solely due to lower group scores due to 
HIE, but also to inflated scores achieved by our Comparison group. However, achievement 
of mean upper average range IQs in control groups has been previously recorded in other 
well designed longitudinal outcome studies (Utrecht study: (109); Canada study: (74, 77)). 
At a broader level, our cohorts were recruited from one region in Ireland, and to recruit 
greater numbers, and improve generalisability of the findings requires multi-centre 
recruitment to encompass a wider population, different hospital structures and approaches 
to neonatal care. 
A significant challenge in longitudinal research arises from how outcomes are measured. 
New knowledge and the passage of time demand updates to psychometric tools (293). Since 
the commencement of this thesis, revised editions of two of the assessment tools have been 
published. ARICD published a major revision of the GMDS-R/GMDS-ER - the Griffiths III - in 
2016. The latest revision of the WPPSI tool, the WPPSI-IV was published in 2012. This alters 
the underlying definition of domain scores, as different constellations of tasks and factors 
used to calculate them are updated. Some longitudinal studies use a combination of versions 
of tests across time, but we felt it more important to remain consistent with the older tests 
to ensure that cross comparison would remain valid. 
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An important aspect of the study that was insufficiently explored was that of the ecological 
validity of the outcome assessments. It is argued for example that the functional implications 
of IQ measurement, bar the extreme scores, may be limited (294). This could be improved 
by exploring in more detail how the findings relate to adaptive skills in real life. In relation to 
developmental outcomes in the early years, Castro et al., explored a mapping structure for 
items from the Griffiths Mental Development Scale with how they relate to everyday life by 
comparing them to capacity areas of the WHO’s ICF (International Classification of 
Functioning) model of disability (295). This more closely aligns assessment scores to domains 
of quality of life. Many measures have been developed to evaluate these adaptive skills 
relevant to young children (296), and there is a paucity of studies using these outcome 
measures in HIE research. One exception was the CoolCap RCT study, which employed the 
‘WeeFIM’ quality of life measure with parents of children at age 7-8 years. This measures a 
range of skills within self-care, mobility and cognition. Results found predictive value of 
18mth Bayley (BSID-II) scores for outcome on the WeeFIM (18). Measures such as these 
include important contextual and environmental factors which could have more closely 
linked our study to a systems based model as was proposed by Sameroff (140). Furthermore, 
the inclusion of an adaptive behaviour scale such as the Vineland Adaptive Behavior Scales 
(297) would have allowed me to examine whether the children in the cohort with an IQ < 70 
met the ICF and DSM criteria for intellectual disability. 
Educational outcomes for this cohort were not included in this study and reduce the findings’ 
practical implications. The outcomes would have greatly benefitted from the inclusion of 
feedback from early years’ and primary school educators. Additionally, further analysis of 
differences between children who had and had not commenced formal schooling is 
warranted. 
8.4 Focus for Future Research 
8.4.1 The Neonate 
The techniques available to measure and observe the neurology of the neonate continues to 
improve. For the neonate at risk of evolving HIE, the aspiration must be to improve the tool(s) 
that can pinpoint the infants that will benefit from treatments such as TH in the hours after 
birth to prevent secondary and tertiary injury mechanisms. This is a tall order, and will only 
be realised with large well-designed multi-centre studies, that can standardise their clinical 
observation procedures. One focus for research must be on the differential contributions 
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that items in grading systems make to marking the injury, otherwise their predictive worth 
will remain diluted within the umbrella of their grade. This is not to suggest a return to the 
pursuit of the magical ‘single marker’. A set of time-specific markers will still be required, but 
these markers need to be weighted based on the ratio of contribution they make towards a 
valid diagnosis and/or prognosis. Whether these markers should remain within grading 
systems, or on a continuum of severity remains to be seen. 
In the current TH climate, the underlying cut offs for mild and moderate grade are of specific 
importance. Amiel-Tison (60) notes that some mild grading systems show no CNS depression 
whilst other systems allow for some. 
To give one example from our cohort, is the item ‘tone’. The original Sarnat and Sarnat (1976) 
(14) criteria defined tone in mild grade to be ‘normal tone’. In Levene et al’s (1985) (188) 
adaptation of the Sarnat grade used in our study, mild grade allows for ‘mild alterations of 
tone’. Within the category of tone, Volpe (127) among others has observed the poorer 
prognosis for infants with ‘shoulder girdle low tone’ than for low tone in other body regions. 
Future research could observe the individual contributions of tone, and other items for 
prognostic value, similar to our preliminary work on the ATNAT items. This requires further 
scrutiny with larger samples.   
“Researchers agree that to define the limit between optimal central nervous system 
function and mild degree of central nervous system dysfunction is the only real 
difficulty. Moreover, in the early stages of extra-uterine adaptation, it is difficult to 
separate the transient effects of cardiorespiratory and metabolic problems from the 
specific expression of brain damage.” (Amiel-Tison, 2002: p. 198)  
A similar argument can be made for future research in regard to EEG grade to elucidate which 
features of the background EEG hold best predictive value. In our cohort and other post TH 
cohorts recruited in our research centre, detailed analysis of EEG background features and 
seizure burden for machine learning algorithms are being developed to enhance the clinical 
value of EEG to examine the course of neonatal HIE. In relation to this HIE cohort, an EEG 
grading algorithm for HIE to predict 5-year outcome has been initiated by engineering 
colleagues. 
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Measures of neonatal signs have never been more timely now that abnormal MRI findings 
have been reported in mild HIE (251, 254), and surveys of current TH practice (242, 298) 
reflect ‘therapeutic drift’ to include babies with borderline mild HIE for cooling. Furthermore, 
RCTs currently recruiting for the efficacy of TH for mild grade encephalopathy are underway. 
A critical goal for future work will be to agree a consensus definition of what is meant by mild 
HIE as articulated by Prempunpong et al. (254), and its measurement pre 6 hours of life (299). 
8.4.2 The Child 
Distinct patterns of neurocognitive difficulties are emerging in children post neonatal HIE. 
Therefore, the identification of early signs in infants for whom developmental trajectories 
may be impacted is crucial. For example, one neurocognitive difficulty seen in children post-
HIE is in the area of memory (in this thesis, verbal short-term memory, and memory for 
names), and associated damage to the hippocampus has been established. A recent 
comparative study further suggests a specific HIE vulnerability to the expected development 
of connective pathways between prefrontal cortex and the hippocampus at birth in neonatal 
rat models. Brockwood et al. (300) showed that following mild/moderate HIE the neural 
networking was not as sophisticated in young rats between the prefrontal cortex and 
hippocampus. In human infants, a well-designed study presented data on poorer attention 
to faces in the first year of life, as observed by lower preferential looking at faces in 12 month 
old infants following neonatal HIE (301). These potentially exciting research studies require 
replication but demonstrate how future studies could align themselves with new evidence 
from the discipline of developmental cognitive neuroscience. The end goal here would be to 
track early specific injury with early developmental markers that cascade to later ‘domain 
relevant’ (302) difficulties such as the specific memory impairment difficulties seen in later 
childhood. This is similar to the model proposed by Bornstein et al. in relation to infant 
behavioural markers for later cognition (143). One potential trajectory that merits future 
examination is the longitudinal set of observations presented in this thesis that in children 
post-HIE with no diagnosed motor disability, there were indications of compromised 
locomotor signs at 12 months, locomotor and eye-hand coordination skills at 24 months 
which correlated with low visuo-motor processing speed at 5 years, and lower coding and 
finger dexterity at five years. Neuroscience may provide the answer to the perinatal causes 
of this potential phenotype.  
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In terms of optimising the early detection of the developmental impacts of neonatal HIE, the 
major questions remain – when and how often do we bring children in for assessment during 
infancy and childhood? Recent trends in developmental research point  to the importance of 
intervening at specific developmental points with probable treatments to target the 
predicted later pathology (303). Efforts to devise early screening markers for infants with 
early signs of ASD (304) is one example of a community based initiative with this aim. 
Although speculative at this stage, it may be that for HIE, early motor delay that doesn’t merit 
diagnosis may be an important marker. This work needs to continue to develop a profile of 
patterns of difficulty linked to different developmental timepoints to ensure timely early 
intervention. 
Finally, future high-quality prospective studies should include designs that pay greater heed 
to the examination of systems level factors that influence childhood outcomes post-HIE such 
as, for example, family coping and parenting style. Consequently, parent interventions and 
supports could be developed to mitigate the factors other than HIE that may be contributing 
to adverse childhood outcomes. This has been successfully researched with children 
following other conditions such as congenital heart disease and prematurity (305). 
8.5 Conclusion 
We have added to the emerging body of knowledge in relation to infants with mild HIE. We 
were able to undertake a thorough comparison of the natural history and outcome of 
untreated children with mild and moderate HIE, which is no longer possible due to the 
introduction of TH for all children with moderate HIE in high income countries. Our pattern 
of evolution of HIE signs in the first 24 hours supports the notion of a ‘dose response’ burden 
of HIE. A grading system, no matter how sophisticated cannot replace a continuum or 
spectrum model and there will always be infants who are on the borderline grades. Our data 
strongly suggests that infants with mild HIE are heterogenous. At 24 hours of age in infants 
with mild grade encephalopathy, EEG grading demonstrated a group of infants where some 
EEG traces normalised and other which didn’t. Our follow up to 5 years further shows how 
the EEG grades can discriminate between normal and abnormal outcome at five years. 
The intellectual and neuropsychological skills at age five years are similar for children 
following mild vs. moderate neonatal HIE, and display a significant burden of injury in 
comparison to their neurologically normal-at-birth peers. 
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8.6 Academic outputs arising from this PhD thesis  
Peer reviewed publications 
Murray, DM, Bala, P, O’Connor, CM, Ryan CA, Connolly, S, Boylan, GB The predictive value 
of early neurological examination in neonatal HIE and neurodevelopmental outcome at 24 
months. Dev Med Child Neur. 2010;52(2):e55-e59. 
Murray, DM, O’Connor, CM, Ryan, CA, Korotchikova, I, Boylan, GB. Early EEG grade and 
outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy. Pediatrics. 
2016;138(4):e20160659. 
O’Connor, CM, Ryan, CA, Boylan, GB, Murray, DM. The ability of early serial developmental 
assessment to predict outcome at 5 years following neonatal hypoxic-ischaemic 
encephalopathy. Early Hum Dev. 2017;110:1-8. 
James, M, O’Connor, CM, Cullinane, A, Murray, DM, Boylan, GB. Ophthalmic outcomes 
following neonatal hypoxic ischaemic encephalopathy; Oculomotor, biometric and 
refractive data in early childhood. Eye. 2019 Mar 5; [Epub ahead of print]. 
Papers in preparation 
O’Connor, CM, Boylan, GB, Ryan, CA, Korotchikova, I., Wrigley, C., Murray, DM No 
difference between mild and moderate encephalopathy in neuropsychological outcome. 
Conference Platform Presentation 
O’Connor, CM, Boylan, GB, Murray, DM. Correlation between Repeated Early 
Developmental Assessment and Intellectual Abilities at 5 years Following Neonatal Hypoxic-
Ischemic Encephalopathy (HIE). Presented at the Pediatric Academic Societies Annual 
Meeting 4th-7th May 2013, Washington Convention Center, Washington DC, USA. Session 
4330: Developmental/Behavioral Pediatrics: Outcomes. 7th May 2013. 
 
Figure 8.1 Conference logo for Pediatric Academic Societies Annual Meeting 2013. 
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Poster: 
O’Connor, CM, Boylan, GB, Murray, DM Can Standardised Developmental Assessment at 6, 
12 & 24 months predict five year intellectual outcome following neonatal hypoxic-ischaemic 
encephalopathy? Presented at the 3rd UK Paediatric Neuropsychology Symposium 23rd-27th 
April 2012, UCL, ICH, London (2012) Scientific Posters. Sp1. Dev Med Child Neur. 2012;54:9-
36. 
 
Figure 8.2 Scientific poster presented at the 3rd UK Paediatric Neuropsychology Symposium 23rd-27th 
April 2012. 
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Appendix B  
Ethical amendments for HIE long-term outcome study 
 
This submission requested a change of psychometric tests (as recommended by the current 
researcher) to the protocol and the recruitment of the current researcher. 
 
Dept of Paediatrics and Child Health 
University College Cork 
 
 
 
 
Dr Michael Hyland, 
Chairman 
Clinical Research Ethics Committee 
of the Cork Teaching Hospital 
 
24th November, 2008. 
 
 
RE:Ability of early continuous EEG to predict long term neurological outcome at 4. 5 
years in infants following neonatal hypoxic-ischaemic encephalopathy. 
 
Dear Dr Hyland, 
 
We are writing to request an amendment to the above mentioned study which received 
expedited ethical approval on 22nd January 2008. Your reference number is ECM 4 (hhh) 
05/02/08. 
 
We are proposing to amend the assessment tests used to determine neurodevelopmental 
outcome at 4.5 years. Further literature reviews and consultation with research colleagues 
has led us to propose the replacement of the Griffiths Scale of Mental Development with the 
Wechsler Preschool and Primary Scale of Intelligence 3rd Edition (UK version) and selected 
subtests from the NEPSY-II, which is a neuropsychological battery for children aged 3 to 16 
years. Both of these tools have been extensively psychometrically evaluated and contain test 
materials specifically designed for use with preschool aged children. It is hypothesised that 
the use of these tests will provide better predictive value for later cognitive and educational 
outcome, and more clinically sensitive results. They will assess some of the subtle 
underlying cognitive processes, including ‘executive functioning’ which appears particularly 
sensitive to neurological trauma. 
 
The interpretation of these assessments must be completed by a qualified psychologist and 
we have recruited Catherine O’Connor as a co-investigator. She is a senior clinical 
psychologist who has worked in Enable Ireland Cork Services (Lavanagh Centre) for the 
past 14 years. It is proposed that she will assess, interpret and provide feedback on these 
assessments to the children and parents/carers of this cohort. In individual cases where the 
assessments yield below average intellectual performance, she will advise families in 
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consultation with Dr. Deirdre Murray, Consultant Paediatrician, of the most appropriate 
referral pathways to clinical/educational services.  
 
It has also been agreed that the ‘Strengths and Difficulties’ questionnaire is the most 
appropriate general parental questionnaire to use to augment the use of the Behavior Rating 
Inventory of Executive Functioning – Preschool Version. It is quick and easy for parents to 
complete and includes questions about a child’s strengths in addition to areas of difficulty. It 
has been widely used in epidemiological studies. 
 
We would be grateful if you could consider our request for ethical approval for these 
amendments to this project. Included in the submission is ‘Form 2’, and amended versions 
of the original research proposal and letter of informed consent. 
 
 
Yours sincerely, 
 
 
Dr Geraldine Boylan 
 
 
Dr Deirdre Murray 
 
 
encl. 
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Introduction: 
Neonatal hypoxic-ischaemic encephalopathy remains an important neurological process. It is 
a major cause of both acute mortality, and long-term severe neuro-disability. HIE affects 
between 1 and 6 per thousand infants born at full term and is caused by a significant period 
of oxygen deprivation (hypoxia) and/or blood-flow (ischaemia) to the brain. When blood 
flow is restored, further damage to brain tissue can occur as toxins from injured cells are 
circulated. Between 15 and 20% of affected infants die during the newborn period, and a 
further 25% have permanent neurological deficits. Thirteen percent of survivors have 
cerebral palsy, and these children usually have more significant disability than children with 
cerebral palsy due to other causes. 
 
Outcome varies considerably, depending on clinical severity. Clinical signs and symptoms 
allow staging of encephalopathy at 24 hours of age (Sarnat grade I, II or III), as first 
described by Sarnat and Sarnat in the 1970’s. This clinical method of staging and assigning 
prognosis remains the most widely used today. Accurate recognition of these clinical stages 
is therefore vital. Frequently, the disabilities are multiple and can include spastic cerebral 
palsy, severe or profound intellectual disability, blindness, and/or seizure disorder. 
 
Whist most children who suffered grade I (mild) encephalopathy have a good outcome, the 
outcome in grade III(severe) encephalopathy is extremely poor, with all survivors 
progressing to severe neurodisability. The prognosis for those with (grade II) moderate 
encephalopathy is less certain. Twenty to forty percent of those with Grade II 
encephalopathy will have an adverse outcome (death or disability). It is difficult, however to 
accurately predict which of the infants with moderate encephalopathy will fall into this 
category. 
 
Previous retrospective studies have shown that even in children without demonstrable 
cerebral palsy, long-term academic performance may be affected, with significantly more of 
those with moderate encephalopathy having a greater than one year delay in their reading, 
spelling, and/or arithmetic skills. 
 
A more recent retrospective study by Neil Marlow in Nottingham used multiple cognitive 
and neuropsychological tests in 65 “neurologically normal” survivors of moderate and 
severe encephalopathy, using matched controls at 7 years of age. They also evaluated 
behaviour and memory. Children in the severe encephalopathy group had significantly lower 
overall scores and significantly underachieved in educational attainment scores. The children 
with moderate encephalopathy had lower educational attainment scores for spelling and 
reading and a higher prevalence of behavioural problems particularly hyperactivity. In many 
centres these children would not have been followed up and would have been discharged as 
“normal outcomes”. These patients were identified retrospectively using the medical chart 
diagnoses; the response rate was low (56%) as many children were lost to follow-up. Thus 
the results may not fully reflect the full extent of adverse cognitive outcomes in children 
with HIE. However, there is a growing body of evidence which suggests that perinatal 
asphyxia leads to significant cognitive impairment in the absence of cerebral palsy. 
 
Parents, as well as treating clinicians, will want to know the implications of the child’s 
condition as early as possible, and thus an evidence-base for the use of prognostic tools such 
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as electro-encephalograms (EEG) needs to be provided with appropriate prospective cohort 
studies. 
 
The prognostic value of the EEG was first described by Monod and colleagues in 1972 and 
since then it has become an important prognostic tool. A good outcome is generally seen in 
those babies with normal background EEG activity following a hypoxic event. Severely 
abnormal background recordings (inactive or isoelectric) are generally associated with major 
neurological sequelae or death. There is still uncertainty about the predictive value of 
moderately abnormal EEGs. However the predictive ability differs depending on the time of 
the recording, with better reliability seen in those studies performed in the first week 
following birth. Those EEGs which recovered on serial recordings over the first weeks of 
life were associated with an improved prognosis. 
 
However, although the evolution of the EEG appears to be important, very few studies have 
looked at EEG changes in the first days following a hypoxic injury. Most of our knowledge 
base is built on EEG studies performed at 1-3 weeks of age. The evidence suggests that for 
accurate prognosis the initial EEG must be performed as close as possible to the peak of 
symptomatic neurological impairment. No previous study has used continuous early EEG 
data. 
 
The individual features of the EEG which will best correlate with long-term outcome are 
unknown. Previous features which have been linked with outcome are background 
amplitude, discontinuity, interburst interval length, disturbance of sleep-wake cycling and 
the presence of electrographic seizures. The relative importance of these factors is unknown. 
The ideal time to perform the EEG, and the important of EEG recovery are questions yet to 
be answered. 
 
Outcome studies have not been performed on this group of infants in Ireland. Since the 
prevalence and outcome of HIE can vary from country to country, the availability of up-to 
date, locally relevant outcome figures are important to Irish physicians and can directly 
influence treatment. Early detection of at risk children is vital so the appropriate referral to 
early intervention services can be made. 
 
None of the studies already performed have evaluated the early use of continuous EEG 
monitoring and the evolution of the EEG in predicting prognosis. Finally, the predictive 
value of EEG has not been examined in long-term follow-up studies. While good outcome 
data is available for the mild and severe forms of encephalopathy, infants in the moderate 
grade have an uncertain future, and while many have been deemed “normal” in the past 
because no serious neurological sequelae occurred, more subtle cognitive, behavioural and 
motor deficits may be missed. 
 
Methods: 
The infants previously recruited for the EEG study will undergo surveillance until the age of 
4.5, to assess long-term outcomes of neurological and cognitive function, as well as 
behaviour and executive function. The assessments will be done at 4.5 years. At this time a 
consultant paediatrician (Deirdre Murray) will perform a full neurological assessment. A 
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clinical psychologist (Catherine O’Connor) will perform a neurodevelopmental assessment 
using the Wechsler Preschool and Primary Scale of Intelligence – 3rd Edition (UK) (WPPSI-
IIIUK) and parts of the NEPSY. Prior to this assessment the parents will be sent a BRIEF-P 
(Behaviour Rating Inventory of Executive Function – Preschool version) form and the 
‘Strengths and Difficulties’ Questionnaire to complete. Ms. O’Connor will assist the parents 
in completing the form. In cases where parents do not speak English, or having difficulty 
with literacy, the form may be completed by the child’s teachers, or playschool carer, with 
the parents consent. Following these assessments, appointments will be arranged for 
assessment of hearing and visual acuity which will take place on different dates to avoid 
fatigue in the children. Parents will be asked to provide details of occupation residence and 
education for the determination of socio-economic grouping. 
 
Subjects and setting: 
The parents of babies, who have already been enrolled in our initial EEG study up to the age 
of two years, will be invited to participate in further follow-up assessments when they have 
reached the age of 4.5 years. Those who consent to ongoing participation in the follow-up 
study will be contacted by our project officer and appointments for assessment arranged. 
These assessments will be carried out adjacent to the paediatric clinic of Dr. Deirdre Murray, 
Senior Lecturer in Paediatrics and Child Health. An assessment using the WPPSI-IIIUK and 
selected subtests from the NEPSY will be administered by Catherine O’Connor, Senior 
Clinical Psychologist. Following their psychological assessment, each child will have a 
neurological examination to look for specific motor deficits. The neurological assessment 
will be carried out by Dr. Murray. Additional appointments for audiology and assessment of 
visual acuity will be arranged for each child in the Audiology departments of the South 
Infirmary hospital, and ophthalmology departments of the Cork University Hospital. 
 
Wechsler Primary and Preschool Scale of Intelligence (UK version) WPPSI-IIIUK 
The WPPSI-IIIUK is an individually administered clinical instrument for assessing the 
intelligence of children aged 2 years 6 months to 7 years 3 months, and is used worldwide. 
The third version is a major revision of its predecessors, providing updated standardised 
norms and adhering more closely to a hierarchical model of intelligence based on the 
Cattell-Horn-Carroll (CHC) model. There are two age-range bands (2-6 to 3-11, and 4-0 to 
7-3), which use different subtests to obtain composite quotients. The administration of the 
core subtests yields a Verbal IQ, Performance IQ and Full-Scale IQ. An additional 
Processing Speed Quotient can be calculated for the older age band. A general Language 
Composite can be calculated using supplemental/optional subtests. 
The WPPSI-III was normed on a United States sample of 1,700 children, the ‘UK’ version 
was normed on a representative sample of 805 children, which closely approximated the UK 
2001 Census data on similar demographic variables. Reliability and validity information is 
outlined extensively in the WPPSI-III Technical and Interpretative Manual. The average 
internal consistency values for individual coefficients are .95 for V-IQ, .93 for P-IQ, .89 for 
PSQ, and .96 for FS-IQ. Test-retest reliability is fairly stable. Construct validity is supported 
by factor-analytic studies and with comparisons with other assessments of cognitive 
functioning. 
 
NEPSY-II 
The NEPSY-II assesses neuropsychological development in children aged 3 to 16 years. It 
originated in the 1980s in Finland, and evolved throughout the 1980s and 1990s leading to 
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the publication of the NEPS in Finland and the NEPSY in America in 1998. This assessed 
children aged 3-12 years on a broad range of tasks assessing five neuropsychological 
domains, namely, attention and executive functioning, language, memory and learning, 
sensorimotor and visuospatial processing. What distinguished it from other children’s 
neuropsychological assessment batteries was that it was designed exclusively for children, 
rather than depending on downward extensions of adult-based tasks. It is based on Lurian 
theory which uses a process-oriented approach to explain cognitive development. Cognitive 
areas are viewed as complex capacities mediated by interacting functional systems. When 
one subcomponent is impaired then complex functions can be impacted upon and sometimes 
performance can be affected across functional domains. 
It was originally designed to detect subtle deficiencies both across and within subtest 
domains; to increase understanding of effects of congenital and acquired brain damage to 
enhance treatment strategies and to provide long-term follow up; to study development in 
preschool aged children. 
The NEPSY-II was published in 2007 and constitutes a major revision of the NEPSY. It 
covers a broader age range of children aged 3-16 years. It includes a new domain – social 
perception – in addition to the original five domains. Subtests with lower psychometric 
properties have been replaced by subtests with greater clinical sensitivity and construct 
validity. Primary, combined, process and contrast scores can now be calculated, depending 
on the selection of the 32 subtests chosen for administration. It has been standardised on a 
single well stratified sample of U.S. citizens and includes clinical groups and a Finnish 
standardisation sample is currently underway. 
 
The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ is a brief screening tool that asks about the behavioural/emotional symptoms and 
positive attributes for 4-16 year olds. For children, the 25-item questionnaire is completed by 
a parent or teacher. It has been validated against other widely used behavioural rating scales 
and has been normed on a UK representative sample numbering 10,438. It yields five scales 
– emotional symptoms, conduct problems, hyperactivity, peer problems and prosocial. The 
summation of the first four scales yields a ‘total difficulties’ score. It is quickly administered 
and considered more acceptable by informants because of the inclusion of positive attributes. 
The SDQ has been used extensively for research and epidemiological purposes. 
 
Behaviour Rating Inventory of Executive Function- Preschool Version 
The Brief-P is the first standardised measure of executive functioning available for the pre-
school child. It was designed to measure the range of behavioural manifestations of 
executive function in pre-school-aged children. The Brief-P consists of a single Rating form 
used by parents, teachers and day-care providers to rate the child’s executive function within 
the context of their everyday environments. The rating form consists of 63 items that 
measure various aspects of executive functioning: inhibit, shift, emotional control, working 
memory and plan/organise. The clinical scales form three broad indexes (Inhibitory self-
control, Flexibility and Emergent metacognition) and one composite score (Global 
Executive Composite). 
 
This method of assessment has been shown to demonstrate good internal consistency, 
reliability, and high test-retest reliability. The normative data used is based on child ratings 
from 460 parents and 302 teachers from across differing socioeconomic groups, and in 
urban, suburban and rural areas in the United States. Discriminant validity was demonstrated 
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with other measures of inattention, hyperactivity-impulsivity, depression, anxiety and 
somatic complaints. 
EEG 
The EEG of the neonate is best described in terms of the background activity or pattern. This 
is the ongoing activity of the brain at rest during wakefulness or sleep. 
All Neonatal EEG data will be analysed by clinical Scientist, Dr Geraldine Boylan and 
Consultant Clinical Neurophysiologist, Dr Sean Connolly, both of whom will be blind to 
clinical status and 2 year follow up information in each infant.  
The following sub-tasks will be carried out for each neonatal EEG: 
• Characterisation of each multimodal recording in terms of background EEG activity 
(non seizure EEG) 
o       Amplitude 
o       Dominant frequency 
o       Presence of specific features 
o       Continuity 
o       Interburst interval duration 
 
• Distinguishing  the presence or absence of sleep states 
• Identifying and marking of electrographic seizures.  
• Characterisation of seizure in terms of amplitude, duration, frequency, location and 
morphology  
• Representative 1 hour segments of each EEG at 6, 12, 24, 48 and 72 hours will 
exported to an EDF format for quantitative EEG analysis using time and frequency 
domain analysis measures.  
• Our previous research has allowed us to identify the most useful quantitative features 
for EEG analysis in the neonate. We propose to measure Spectral Edge frequency, 
Spectral Entropy, Total Power and dominant frequency measures to quantify the 
neonatal EEG.  
    
In addition full diagnostic audiology assessment will be carried out at 4-5 years of age. This 
will include: 
 
• Tympanometry 
• Pure tone audiometry 
 
In children with learning disability who can not easily comply with these procedures, we 
will perform free field audiometry or test oto-acoustic emissions and speech discrimination 
tests. 
Visual acuity assessment will be performed by a registered optometrist who has experience 
in the assessment of children with neuro-disability. 
 
We will examine associations between measures of cognitive, neurological, and behavioural 
outcome, at 4.5 years, and early EEG findings (visual and quantitative analysis). 
Socioeconomic status will be determined for each family and correlated with outcome. 
Results will be compared using a robust non-parametric analysis to allow for correlations 
between repeated measures. 
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The Potential benefits of the study: 
This is the first study which proposes to prospectively follow the cognitive, neurological and 
behavioural outcome of the survivors of neonatal encephalopathy to age 4.5 years. The 
outcomes of these children will be correlated with their early EEG and neurological 
assessments. Never before has a neonatal cohort of survivors of HIE been followed up 
prospectively in Ireland, so no Irish outcome data is available to clinicians. 
 
New treatments such as head-cooling are showing promising results in the treatment of HIE. 
However without accurate prognostic data, it will be difficult to identify those infants who 
would most benefit from treatment. Accurate follow-up data may help to guide surveillance 
practices in this high risk group and will ensure that referral to specialised centres for early 
intervention will occur in the appropriate groups, to maximise the child’s long-term 
functional outcome. 
 
It will provide parents with important information which will allow them to plan for the future 
for their child and their family as a whole. It may also provide them with evidence to support 
the withdrawal of treatment in the rare cases where the prognosis is hopeless. 
 
 [260] 
 
Appendix C  
Invitation letter for HIE Cohort at Age 5 
 
 
 
Neonatal Research Centre 
University College Cork 
Dear Parents, 
 
Once again we would like to express our gratitude to you for allowing your child to take part 
in the Neonatal Encephalopathy Study when they were born, and for attending their follow 
up assessments. With your help we have been able to gain very important information about 
what happens to babies soon after birth, and what this might mean for their future 
development. This information will help doctors caring for babies in the first few days of life, 
and help their parents by increasing the information that we have to give them at this time. 
This will not only help children in Ireland, but our findings will be helpful to parents and 
children in many different countries. It is very important for us to follow all of the children 
involved, and see how they develop and gain skills over time.  
 
The Health Research Board of Ireland has recognised the importance of this research and has 
recently agreed to fund the Neonatal Research Centre to study the progress of all the 
children involved in the study again at 5 years of age. This funding will allow us, with your 
permission, to carry out detailed assessments of your child’s development, hearing and 
vision. We could not continue this research without your help. 
 
Over the next few days, you will be contacted by one of our research team and asked to take 
part in our ongoing follow up study. We will arrange the assessments to times which suit 
you, and you will be reimbursed for any travel expenses. Some of the assessments can be 
arranged to take place in your home, if this is more convenient for you.  
 
If you have any queries, or need to change the appointment time, please contact Ms 
Brenda O’Flynn on 021 4901628 between the hours of 9am to 1pm or Senior 
psychologist, Ms Catherine O’Connor 087 6435049 after hours. 
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Thank you again for your help. 
 
 
Dr Deirdre Murray, 
Consultant Paediatrician/Senior Lecturer  
Department of Paediatrics and Child Health, 
University College Cork. 
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Appendix D  
HIE Cohort Informed Consent Form 
 
UNIVERSITY COLLEGE CORK 
Clinical Research Ethics Committee Of The Cork Teaching 
Hospitals 
 
CONSENT BY SUBJECT FOR PARTICIPATION IN RESEARCH 
PROTOCOL 
Section A 
 
Protocol Number:               Patient Name:      
    
 
Title of Protocol: Long term follow up of children post neonatal encephalopathy. 
 
Research directed by:  
Prof G. Boylan; Dr D Murray.  
 
You are being asked to participate in a research study.  The doctors at University 
College Cork study the nature of disease and attempt to develop improved methods of 
diagnosis and treatment.  In order to decide whether or not you want to be a part of this 
research study, you should understand enough about its risks and benefits to make an 
informed judgement.  This process is known as informed consent.  This consent form gives 
detailed information about the research study and this will be discussed with you.  Once you 
understand the study, you will be asked to sign this form if you wish to participate. 
 
Section B 
I. NATURE AND DURATION OF PROCEDURE(S): 
 
As you know your child was involved in an important research project which looked at 
brainwaves of babies who required resuscitation at birth. With your consent we were 
able to closely follow your child’s development up to 2 years of age. This study has 
given us very valuable information about what happens to children such as yours. It has 
allowed us to discover the types of brainwave changes that can predict whether a baby is 
likely to have any long term problems. This information is now being published in 
international medical journals and will help other babies and their families in the future, 
both in Ireland and worldwide. 
 
To give us extra information we would now like to see you and your child again at the 
age of 4.5 years. We wish to do a further assessment of your child to see how they are 
developing and learning. This will involve your child being asked to carry out tasks 
such as answering questions, and using pictures and blocks. We will ask you to fill in 
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two questionnaires about how they act when they are at home. We also wish to perform 
eye tests on them to look at their ability to see.  
 
II. POTENTIAL RISKS AND BENEFITS: 
 There are no potential risks. The study will take some of you and your child’s time. We 
will pay for any travel or food costs which you will need to attend the follow up sessions 
in the Cork University Maternity Hospital. The assessments will be reported to you if you 
wish and will give you a detailed picture of how your child is progressing compared to 
other children their age. 
 
III. POSSIBLE ALTERNATIVES: 
 The clinical management of your baby will not be affected if you do not want to 
participate in this research.  
 
Section C  AGREEMENT TO CONSENT 
 
The research project and the treatment procedures associated with it have been fully 
explained to me.  All experimental procedures have been identified and no guarantee has been 
given about the possible results.  I have had the opportunity to ask questions concerning any 
and all aspects of the project and any procedures involved.  I am aware that participation is 
voluntary and that I may withdraw my consent at any time.  I am aware that my decision not 
to participate or to withdraw will not restrict my access to health care services normally 
available to me.  Confidentiality of records concerning my involvement in this project will be 
maintained in an appropriate manner.  When required by law, the records of this research may 
be reviewed by government agencies and sponsors of the research. 
 I understand that the sponsors and investigators have such insurance as is required 
by law in the event of injury resulting from this research. 
 I, the undersigned, hereby consent to participate as a subject in the above described 
project conducted at the Cork Teaching Hospitals.  I have received a copy of this consent form 
for my records.  I understand that if I have any questions concerning this research, I can 
contact the doctor(s) listed above.  If I have further queries concerning my rights in connection 
with the research, I can contact the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals, Clinical Sciences Building, Cork University Hospital, Wilton, Cork. 
 After reading the entire consent form, if you have no further questions about giving 
consent, please sign where indicated. 
 
 
 
Doctor:                                                     
      Signature of Subject, Parent or Guardian 
     (include a separate line for assent of minor, if applicable) 
 
Witness:                                              Date:                  Time:    AM 
         (Circle)  PM 
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Appendix E  
Ethical amendment application for recruitment of 
comparison group at age five years. 
 
 
Dept of Paediatrics and Child Health 
University College Cork 
 
 
 
 
Dr Michael Hyland, 
Clinical Research Ethics Committee of the Cork Teaching Hospitals 
1st Floor, 
Lancaster Hall 
6 Little Hanover Street, 
Cork 
 
 
25th October, 2011 
 
Dear Dr Hyland, 
 
We are requesting extended ethical approval for further neurodevelopmental follow up of 
our original cohort of children recruited to the study: Sleep patterns of full-term babies in 
the early postnatal period. 
 
In October 2005, we commenced a study to describe and quantify normative EEG patterns 
during sleep in healthy term newborns in the first twelve hours after birth(1). A further aim 
was to enhance the normative reference data for use in studies of babies with hypoxic-
ischaemic encephalopathy (HIE). This study had full ethical approval of the clinical research 
ethics committee of the Cork teaching hospitals. 
 
Fifty-nine of the babies are now at least five years of age. We now wish to follow-up this 
unique cohort of healthy babies with documented normal neurological assessments and EEG 
readings, to school age. We hope to invite this cohort to be included in a longitudinal follow-
up study at age 5. Comprehensive assessments of intellectual, neuropsychological, executive 
functioning and behavioural screening data will be provided by a registered clinical 
psychologist, and a screening neurological assessment by a neonatologist. Parents/carers will 
obtain detailed feedback about their child’s profile, and where a child is assessed as 
requiring interventions, relevant feedback and referrals will be made to community services 
by the psychologist. 
 
These results will provide very valuable culturally relevant normative data of a 
representative cross-section of five-year old children in the Cork geographical region who 
experienced a normal neonatal period. This data will provide a vital research tool to control 
for the extraneous variables of birth experience and demographics when compared with 
cohorts of results for at risk children, such as the cohort of 66 infants who experienced 
neonatal HIE who are now being studied to age 5 years in an associated study.  
 
Further investigation of these groups may also elucidate subtle differences between EEG 
readings of neurologically normal neonates and the children in the HIE cohort 
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with ‘mild’ encephalopathy, who have been shown in the research to experience normal 
outcome. 
 
We wish to request the continued ethical approval of the Clinical Ethics Committee of the 
Cork University Teaching Hospitals. The cohort of children will be turning five years from 
October 2010 onwards. We will endeavour to reduce the possibility of causing stress to 
potential families by reviewing the ‘Patient Information Monitoring System’ to remove 
contact details of any children who may have died in the intervening period, and to obtain 
updated contact details for each potential participant. 
 
We would be very grateful if you would consider our request for ethical approval for the 
amendments to this project. Included in the submission are (i) ‘Form 2’; (ii) an amended 
version of the original research proposal outlining the specific aims and detailed information 
about the proposed assessment tools; (iii) amended letter of informed consent. 
 
 
 
Yours sincerely, 
 
 
C Anthony Ryan, MD DCH D Obst FRCPI FRCPCH FRCPC FAAP(Ped Crit Care) 
Consultant Neonatologist, HSE 
Professor in Paediatrics and Child Health, UCC. 
 
 
 
 
encl. 
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Study Proposal 
 
Sleep patterns of full-term babies in the early postnatal period– five 
year follow up. 
 
 
Introduction 
EEG is one of the most important investigations in the neurologically compromised newborn 
baby and is the only investigation currently available for accurate seizure diagnosis. The EEG 
excels in the early diagnosis and prognosis of neonatal encephalopathy and recent studies 
suggest that the evolution of changes in the neonatal EEG soon after a hypoxic ischaemic 
insult can provide information on timing of injury (1).  More recently, neonatal EEG data 
obtained within 6 hours of birth has been used to identify babies with hypoxia-ischaemia that 
could benefit from neuroprotective therapies, in particular brain cooling (2). There is very 
little data available on the neonatal EEG in hypoxia-ischaemia early in the newborn period i.e. 
between 0-12 hours of birth and virtually nothing is known about the EEG of the normal 
neonate during this time period. 
   
The influence of factors such as labour, delivery method and maternal anaesthesia have been 
measured in this research. This information is essential to accurately identify the severity of 
hypoxia ischaemia early in the newborn period, provide accurate prognosis in this period and 
correctly identify those babies that will benefit most from neuroprotective therapies. 
 
The normal neonatal EEG in the early newborn period needs to be studied in sufficiently large 
numbers, in order to ensure that EEG information from so very early in life can be used for 
more accurate diagnosis and prognosis. The current study recruited and has accrued normal 
EEG and sleep pattern data and recorded the effects of labour, delivery methods and maternal 
anaesthesia on EEG readings in a cohort of 92 healthy full-term neonates born in the Cork 
region from October 2005. This large cohort ensures inclusion of normal variation. These 
patterns provide a valuable template of ‘normal’ neonatal patterns and can be compared and 
contrasted with EEG patterns of babies with hypoxic-ischaemic encephalopathy and other 
anomaly cohorts. 
 
In the normal newborn babies, continuous Video-EEG data was recorded using the Viasys 
NicOne video-EEG system for two hours. Data was collected as soon as possible, preferably 
within 6 hours post delivery but any data collected up to 12 hours was valuable. A modified 
system of electrode placement limited to 8 scalp electrodes was used. ECG leads recorded a 
single channel heart rate signal. Respiratory movements were measured using a thoracic 
respiratory band. Simultaneous video was collected for the assessment of sleep patterns and 
artefact elimination. 
 
This study availed of the specialist expertise of our Neurophysiologist, Prof. Geraldine Boylan 
in addition to a collaboration with the digital signal processing departments of University 
College Cork and University College Dublin, who have developed quantitative analysis 
techniques for the interpretation of neonatal EEG. This has allowed specific analysis of small 
changes in the EEG that may not be quantifiable visually, and may identify common patterns 
or trends in the data. Results for 30 babies has recently been published (3). 
 
Work which has led up to this project: 
Accurate assessment of the neurological status of the neonate in the first days of life is difficult 
but extremely important. Foetal distress, hypoxia and acidosis may lead to encephalopathy 
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and seizures. Hypoxic-ischaemic encephalopathy (HIE) occurs in 3-5 per 1000 live births and 
may have far-reaching consequences including severe neurological disability or death.  
Clinical features range from mild irritability and hyper-alertness to severe coma and death. 
The outcome depends on the severity of the encephalopathy, with mild encephalopathy having 
an excellent outcome, moderate encephalopathy having a 20-40% risk of neurological 
disability and severe encephalopathy almost invariably leading to severe neurological 
impairment or death (4;5). 
 
The accurate grading of encephalopathy is important. This is achieved by clinical scoring, or 
by using the analysis of electroencephalographic (EEG) patterns (6). Early serial EEG and 
amplitude integrated EEG are currently the best available tools with which to predict long-
term neurological outcome (7;8). Early accurate prediction of outcome is becoming more 
important with the advent of neuroprotective therapies such as induced hypothermia, 
glutamate receptor antagonists and calcium channel blockers (9). To be effective, these 
therapies need to be instituted early, usually in the first 6 hours following delivery before 
secondary reperfusion injury occurs (10). Due to possible side effects they will need to be 
targeted at those infants who will benefit most. For these reason the accurate, early diagnosis 
and grading of hypoxic ischaemic encephalopathy is essential. 
 
Early sleep patterns 
It is well known that EEG matures and sleep patterns change rapidly in the first few weeks of 
life (11). The healthy term neonatal EEG shows alternating patterns of high and low amplitude 
signals and differing frequency content which are greatly dependent on sleep state.  In infants 
who have suffered stress or hypoxic injury a burst suppression pattern may evolve (12).  The 
degree of burst suppression is used, along with other factors such as overall voltage and the 
presence or absence of seizures, in the EEG grading system of HIE. It is unclear how much 
suppression of EEG signals might occur following the stress of an eventful labour compared 
to a normal labour, or following instrumental or caesarean deliveries. The effects of different 
methods of maternal analgesia have not been examined. It is known that newborn baby’s sleep 
patterns are different from those of an older infant, with higher percentages of quiet sleep very 
early on in life (13;14). Increased quiet sleep has also been documented in neonates who have 
experienced excessive stimulation or pain (15). Power spectral analysis has been performed 
in small numbers of healthy infants and in those post intra-partum asphyxia (16). However, 
the control infants (n=9) in this group were studied at 24 hours of age when the effects of birth 
stress had probably resolved. Kim et al looked at spectral analysis of the EEG in 27 term 
neonates in the immediate post-natal period following vaginal deliveries (n=10) and caesarean 
sections (n=17). They found some differences in amplitude patterns between the two groups 
(17). However, EEG recordings were limited to only 10 minutes in each infant; a timeframe 
too short to provide meaningful information regarding EEG patterns during differing sleep 
states.  
 
Strong links with the Engineering Department of our affiliated University is the advantage of 
this research study. Successful collaboration of two departments on several projects in the past 
makes it possible to continue the multidisciplinary aspect of this research (8). The 
methodology used in the analysis of the EEG data has been tested and verified in the prior 
research collaborations. To date, early continuous EEG within 3-4 hours of birth for up to 72 
hours post delivery was collected in 55 infants. Recruited infants also have serial neurological 
examination, cerebral Doppler flow velocity measurements, MRI scanning and long term 
neurological follow up to 2 years of age. This work has confirmed the view that normal control 
data are essential. To this end, a pilot study collecting EEG data from 15 normal term infants 
has been conducted. The results have impressed the need to extend this study in order to clearly 
identify what is ‘normal’ and ‘abnormal’ in the early neonatal EEG. 
 
Methods 
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The infants previously recruited for the normal neonatal prospective observational EEG study 
will be invited to participate in a longitudinal study at age 5 years, to assess neurological and 
cognitive function, as well as behaviour and executive function outcomes. At this time a 
neonatologist (Irina Korotchikova) will perform a full neurological assessment. A clinical 
psychologist (Catherine O’Connor) will perform a neurodevelopmental assessment using the 
Wechsler Preschool and Primary Scale of Intelligence – 3rd Edition (UK) (WPPSI-IIIUK) (18), 
the majority of the NEPSY-II (19), and the ‘numbers’ subtest from the Children’s Memory 
Scale. Prior to this assessment the parents will be sent a BRIEF-P (Behaviour Rating Inventory 
of Executive Function – Preschool version) (20) form and the ‘Strengths and Difficulties’ 
Questionnaire (21) to complete. Ms. O’Connor will assist the parents in completing the forms 
where required. Following these assessments, appointments will be arranged for assessment 
of visual acuity which will take place on different dates to avoid fatigue in the children. Parents 
will be asked to provide details of occupation, residence and education for the determination 
of socio-economic grouping and demographics, and a brief medical history will be taken for 
each child to rule out acquired neurological damage since the normal neonatal period. 
 
Subjects and setting: 
The parents of babies, who have already been enrolled in our normal EEG study, will be 
invited to participate in further follow-up assessments when they have reached the age of 5 
years. Those who consent to ongoing participation in the follow-up study will be contacted by 
our project officer and appointments for assessment arranged. These assessments will be 
carried out in an appropriate clinical room in UCC’s Brookfield Health Sciences Building or 
in the Cork University Hospital. An assessment using the WPPSI-IIIUK and selected subtests 
from the NEPSY-II will be administered by Catherine O’Connor, senior clinical psychologist. 
Following psychological assessment, each child will have a routine neurological examination 
to look for tone, power and reflexes. The neurological assessment will be carried out by Dr. 
Korotchikova. Additional appointments will be arranged for assessment of visual acuity in the 
ophthalmology departments of the Cork University Hospital. 
 
Wechsler Primary and Preschool Scale of Intelligence (UK version) WPPSI-IIIUK 
The WPPSI-IIIUK is an individually administered clinical instrument for assessing the 
intelligence of children aged 2 years 6 months to 7 years 3 months, and is used worldwide 
(22). The third version is a major revision of its predecessors, providing updated standardised 
norms and adhering more closely to a hierarchical model of intelligence based on the Cattell-
Horn-Carroll (CHC) model (23). There are two age-range bands (2-6 to 3-11, and 4-0 to 7-3), 
which use different subtests to obtain composite quotients. The administration of the core 
subtests yields a Verbal IQ, Performance IQ and Full Scale IQ. An additional Processing 
Speed Quotient can be calculated for the older age band. A General Language Composite can 
be calculated using supplemental/optional subtests. 
 
The WPPSI-III was normed on a United States sample of 1,700 children, The ‘UK’ version 
was normed on a representative sample of 805 children, which closely approximated the UK 
2001 Census data on similar demographic variables. Reliability and validity information is 
outlined extensively in the WPPSI-III Technical and Interpretative Manual (22). The average 
internal consistency values for individual coefficients are .95 for V-IQ, .93 for P-IQ, .89 for 
PSQ, and .96 for FS-IQ. Test-retest reliability is fairly stable (24). Construct validity is 
supported by factor-analytic studies and with comparisons with other assessments of cognitive 
functioning. 
 
NEPSY-II 
The NEPSY-II assesses neuropsychological development in children aged 3 to 16 years (19). 
It originated in the 1980s in Finland, and evolved throughout the 1980s and 1990s leading 
to the publication of the NEPS in Finland and the NEPSY in America in 1998. This assessed 
children aged 3-12 years on a broad range of tasks assessing five neuropsychological 
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domains, namely, attention and executive functioning, language, memory and learning, 
sensorimotor and visuospatial processing. What distinguished it from other children’s 
neuropsychological assessment batteries was that it was designed exclusively for children, 
rather than depending on downward extensions of adult-based tasks (23). It is based on 
Lurian theory which uses a process-oriented approach to explain cognitive development 
(25). Cognitive areas are viewed as complex capacities mediated by interacting functional 
systems. When one subcomponent is impaired then complex functions can be impacted 
upon and sometimes performance can be affected across functional domains. 
It was originally designed to detect subtle deficiencies both across and within subtest 
domains; to increase understanding of effects of congenital and acquired brain damage to 
enhance treatment strategies and to provide long-term follow up; to study development in 
preschool aged children (26). 
The NEPSY-II was published in 2007 and constitutes a major revision of the NEPSY. It covers 
a broader age range of children aged 3-16 years. It includes a new domain – social 
perception - in addition to the original five domains. Subtests with lower psychometric 
properties have been replaced by subtests with greater clinical sensitivity and construct 
validity. Primary, combined, process and contrast scores can now be calculated, depending 
on the selection of the 32 subtests chosen for administration. It has been standardised on a 
single, well-stratified sample of U.S. citizens and includes clinical groups and a Finnish 
standardisation sample is currently underway. 
 
Numbers subtest from the Children’s Memory Scale 
The Children’s Memory Scale was published in 1997 and is a comprehensive standardised 
assessment designed to evaluate learning and memory functioning in individuals aged 5 
through 16 years.  It evaluates the learning and subsequent retention of information in different 
modalities. There are nine subtests, covering tasks related to short-term memory, working 
memory and long-term memory which include immediate and delayed recall and recognition 
tasks. The scales aim to reflect current theoretical knowledge of memory and learning, and to 
remain sensitive to the developmental changes.  
 
The ‘numbers’ subtest from the attention/concentration domain of the CMS will be 
administered to obtain a measure of verbal short-term and working memory, an important 
component of cognitive functioning not included in the WPPSI-III. 
 
The CMS was standardised on a U.S.A. nationwide sample of 1,000 ‘normally functioning’ 
children and has been linked to the Wechsler intelligence scales using a sample of 300 
children. This allows for discrepancy analysis between intellectual and memory needs and 
abilities. The reliability coefficient for the Numbers total score was .79 (forwards .74 and 
backwards .82).  
 
The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ is a brief screening tool that asks about the behavioural/emotional symptoms and 
positive attributes for 4-16 year olds. For children, the 25-item questionnaire is completed by 
a parent or teacher. It has been validated against other widely used behavioural rating scales 
and has been normed on a UK representative sample numbering 10,438. It yields five scales 
– emotional symptoms, conduct problems, hyperactivity, peer problems and prosocial. The 
summation of the first four scales yields a ‘total difficulties’ score. It is quickly administered 
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and considered more acceptable by informants because of the inclusion of positive attributes. 
The SDQ has been used extensively for research and epidemiological purposes (21;27). 
 
Behaviour Rating Inventory of Executive Function- Preschool Version 
The BRIEF-P is the first standardised measure of executive functioning available for the pre-
school child. It was designed to measure the range of behavioural manifestations of executive 
function in pre-school-aged children. The Brief-P consists of a single Rating form used by 
parents, teachers and day-care providers to rate the child’s executive function within the 
context of their everyday environments. The rating form consists of 63 items that measure 
various aspects of executive functioning: inhibit, shift, emotional control, working memory 
and plan/organise. The clinical scales form three broad indexes (Inhibitory self-control, 
Flexibility and Emergent metacognition) and one composite score (Global Executive 
Composite). 
 
This method of assessment has been shown to demonstrate good internal consistency, 
reliability, and high test-retest reliability. The normative data used is based on child ratings 
from 460 parents and 302 teachers from across differing socioeconomic groups, and in urban, 
suburban and rural areas in the United States. Discriminant validity was demonstrated with 
other measures of inattention, hyperactivity-impulsivity, depression, anxiety and somatic 
complaints (20). 
 
Data analysis: 
Each EEG recording will be visually assessed by an experienced neonatal 
electroencephalographer and the following tasks completed.  
• EEG will be graded for background and sleep activity.  
• Each EEG will also be assessed for the degree of continuity and the presence of focal 
features. A discontinuity index is displayed on the EEG system.    
• Segments of EEG with obvious movement or muscle artefact will be eliminated.  
• The EEG will then be converted to a format suitable for digital signal processing. The 
NicOne EEG system allows us to export all EEG data to ASCII or EDF format which 
can be processed more easily using digital signal processing techniques.  
 
To characterise the EEG, two major signal processing tasks will then be carried out. 
 
1. The automatic elimination of other artefacts (not visually identifiable) in the data set 
using Independent Component Analysis. 
2. Analysis and classification of EEG data in neurologically normal term infants within 
12 hours of birth using time and frequency domain techniques. 
3. Power spectral analysis of heart rate variability to determine ‘normal’ autonomic 
nervous system functioning within the first 24 hours of birth.  
 
Independent Component Analysis (ICA) [ICASSP] is a technique for separating an observed 
set of signals into a set of statistically independent sources, or independent components (ICs). 
A popular analogy is that of following a particular conversation at a noisy party; the human 
brain is able to follow the voice of the person you are trying to listen to and filter out the other 
conversations, music and background noise in the room.  In the area of EEG analysis the set 
of signals can consist of multiple EEG channels.  It is assumed that the information in the 
EEG, i.e. artefact EEG and background EEG, arises from a number of independent sources. 
Therefore, applying an ICA method to the multichannel EEG can separate these various 
signals into separate ICs. One method particularly suited to the extraction of artefacts is 
Constrained ICA (CICA). These methods use some a prior knowledge of the artefact in 
question to find the sources which contain them.  The initial task for the signal processing 
section of this research will be the development of a Constrained Independent Component 
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Analysis system specific to the analysis of EEG data in neurologically normal term infants in 
the first 6, 12 and 24 hours of life. 
 
Time-frequency analysis and processing allows analysis and processing of signals with a time-
varying frequency content.  Such signals are best represented by a time-frequency distribution 
(TFD).  These convey how the energy of a multi-component or mono-component signal is 
distributed over the two-dimensional time-frequency space.  Common uses for TFD’s are the 
analysis of raw signals in the (t,f) domain so as to identify characteristics of the signal e.g. 
time and frequency variations, the number of components and the influence of harmonics on 
those components.  It is also very useful for tracking of the instantaneous frequency, the 
instantaneous amplitude and the instantaneous bandwidth.  The advantages of the time-
frequency domain clearly surpass the advantages of both the time and frequency domains 
individually as neither the time nor the frequency information need be sacrificed at the cost of 
the other, as the team found in the analysis of automated seizure detection techniques. In this 
project the proposal is to use time-frequency analysis to carry out the classification of the EEG 
signals.  Some initial research will be required to identify the “best” TFD method to use in 
this application. 
 
We will examine associations between measures of cognitive, neurological, and behavioural 
outcome at 5 years, and early EEG findings (visual and quantitative analysis). Socioeconomic 
and demographic variables will be correlated with outcome. Results will be compared with 
outcomes from the HIE cohort and dependant outcome variables will controlled for by the 
observation of extraneous variables in the ‘normal’ group.  
 
The Potential Benefits of the Study: 
This is the first study which proposes to prospectively follow the cognitive, neurological and 
behavioural outcome of a cohort of full-term healthy neonates at age 5 years who have 
documented normal EEG recordings and neurological assessments in the first 12 hours of life 
in addition to comprehensive labour and birth data. The outcomes for these children will be 
correlated with their early EEG and neurological assessments. These patterns can be used as 
a unique comparison group for a prospective cohort of children with documented hypoxic-
ischaemic encephalopathy born in Cork who have/are due to receive an identical battery of 
assessments at age five. 
 
Specifically, this study design will (i) allow the normal neonatal EEG data to control for the 
possible confounders of labour, delivery type and maternal analgesics on EEG readings; (ii) 
control for demographic, socioeconomic and cultural variables for five-year outcomes in the 
Cork geographical area. This should provide a more accurate measure for the predictive 
validity of neonatal EEG readings in the HIE cohort. 
 
Protective hypothermia treatment has shown promising results in the treatment of HIE, and is 
now being used at Cork University Maternity Hospital. Improved prognostic and accurate 
follow-up data will help to identify those neonates most likely to benefit from treatment, based 
on more meaningful discrimination between normal and abnormal early EEG analysis. 
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Appendix F  
Ethics Approval letter for five-year follow-up of the ‘Sleep 
patterns of full-term babies in the early postnatal period’ 
study 
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Appendix G  
Comparison group study information letter 
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Appendix H  
Participant information and consent form for the 
comparison group. 
 
UNIVERSITY COLLEGE CORK 
Clinical Research Ethics Committee of the Cork Teaching Hospitals 
 
CONSENT BY SUBJECT FOR PARTICIPATION IN RESEARCH PROTOCOL 
 
Section A 
 
Protocol Number:               Child’s  Name:       
 
9.1.1.1.1 Title of Protocol: Sleep patterns of full-term babies in the early postnatal 
period. 
 
Research directed by:  
Prof. C.A. Ryan  (Tel.021-4920525); Prof. G. Boylan; Dr B. Murphy; Dr D Murray.  
 
You are being asked to participate in a follow up research study. The doctors at University 
College Cork study the nature of disease and attempt to develop improved methods of 
diagnosis and treatment.  In order to decide whether or not you want to be a part of this 
research study, you should understand enough about its risks and benefits to make an 
informed judgement.  This process is known as informed consent.  This consent form gives 
detailed information about the research study and this will be discussed with you.  Once you 
understand the study, you will be asked to sign this form if you wish to participate. 
 
 
Section B 
 
I. NATURE AND DURATION OF PROCEDURE(S): 
 
You may recall that your baby was involved in an important research project which 
studied sleep patterns of normal healthy babies soon after birth. This study used an EEG 
which measured your baby’s brainwaves using small attachments to the scalp. This 
allowed us to gather important information about sleep patterns in newborn babies shortly 
after birth. This helped us to compare the information about normal sleep in babies to the 
sleep patterns of sick babies in the neonatal intensive care unit. This information has now 
been published in international medical journals and will help other babies and their 
families in the future, both in Ireland and worldwide. 
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We would now like to meet you and your child again at the age of 5 years in order to 
gather data about children who we know had a full-term healthy birth. This data will allow 
us to compare healthy children with 5 year old children who spent time in the intensive 
care unit at birth. We wish to organise 2 or 3 assessment appointments to see how your 
child is developing and learning. This will involve tasks such as answering questions, 
remembering things and using pictures and blocks. This will be carried out by an 
experienced child psychologist. We will ask you to fill in two questionnaires about how 
they act when they are at home. We will also ask you general information about your 
child’s health, age, family, and your education and occupation. All information will be 
kept in the strictest confidence. 
 
 
II. POTENTIAL RISKS AND BENEFITS: 
 There are no potential risks. The study will take some of you and your child’s time. We 
will pay for any travel, parking and food costs which you incur while attending the follow 
up sessions in University College Cork. The assessments will be reported to you if you 
wish and will give you a detailed picture of how your child is developing compared to 
other children their age. 
 
 
III. POSSIBLE ALTERNATIVES: 
 The clinical management of your child will not be affected if you do not want to 
participate in this research. 
 
 
Section C  AGREEMENT TO CONSENT 
 
The research project and the treatment procedures associated with it have been fully explained 
to me.  All experimental procedures have been identified and no guarantee has been given 
about the possible results.  I have had the opportunity to ask questions concerning any and all 
aspects of the project and any procedures involved.  I am aware that participation is voluntary 
and that I may withdraw my consent at any time.  I am aware that my decision not to 
participate or to withdraw will not restrict my access to health care services normally available 
to me.  Confidentiality of records concerning my involvement in this project will be 
maintained in an appropriate manner.  When required by law, the records of this research may 
be reviewed by government agencies and sponsors of the research. 
 
I understand that the sponsors and investigators have such insurance as is required by law in 
the event of injury resulting from this research. 
 
I, the undersigned, hereby consent to participate as a subject in the above described project 
conducted at the Cork Teaching Hospitals.  I have received a copy of this consent form for 
my records.  I understand that if I have any questions concerning this research, I can contact 
the doctor(s) listed above.  If I have further queries concerning my rights in connection with 
the research, I can contact the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals, Clinical Sciences Building, Cork University Hospital, Wilton, Cork. 
 
After reading the entire consent form, if you have no further questions about giving consent, 
please sign where indicated. 
 
 
 
Doctor/                                                   
Psychologist     Signature of Subject, Parent or Guardian 
 [280] 
 
     (include a separate line for assent of minor, if applicable) 
 
Witness:                                             Date:                             Time:  AM     
         (Circle)  PM 
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Appendix I  
Parent Interview Questionnaire 
 
Parent Interview Questionnaire 
We would be very grateful if you could complete the following questionnaire. All of 
the information will be kept in the strictest of confidence.  
 
Please state your relationship to the child participating in the study (e.g. mother, 
father, carer): _____________   Date questionnaire completed: ______________ 
 
1. Since last seen by Dr. Deirdre Murray at age 24 months, has your child: 
 
a) Been admitted to hospital?    □  YES □  NO 
If yes, please describe each occasion and include where seen, when, 
reason, outcome 
___________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
 
b) Experienced any head injuries or head trauma?  □  YES □  NO 
If yes, please describe 
___________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
 
c) Had any seizures or been diagnosed with epilepsy? □  YES  □  NO 
If yes, please describe when diagnosed and date of last seizure: 
___________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
 
d) Experienced health conditions that require medical monitoring (such as 
diabetes, asthma, allergies etc). Please list: 
___________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
 
e) Attended a psychologist/SLT/OT/Physiotherapist/early intervention?  
       □  YES □  NO 
If yes, when was he/she last seen and for what reason? Please include any 
names of assessment tests used: 
___________________________________________________________ 
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_____________________________________________________________
_________________________________________________________ 
 
f) Is your child currently taking any medications?   □  YES □  
NO 
If yes, please list names and dosages per day: 
___________________________________________________________ 
_____________________________________________________________
_________________________________________________________ 
 
2. If your child has brothers and/or sisters, what gender and age are they? (e.g. 
Boy - 7 years; Girl - 6 months): ___________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
3. What is your nationality? _______________________________________ 
 
What ethnic group best describes your child? (please tick) 
White: 
□ Irish 
□ Irish Traveller 
□ Any other white background 
 
Black or Black Irish 
□ African 
□ Any other black background 
 
Asian or Asian Irish  
□ Chinese 
□ Any other Asian background 
 
Other, including mixed background: 
_________________________________________________ 
 
Is English your first language?    □  YES □  NO 
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4. At the time of your child’s birth, were you: 
 
□ Single (never married) 
□ Married (first marriage) 
□ Re-married (following widowhood) 
□ Re-married (following divorce/annulment) 
□ Separated (including deserted) 
□ Divorced 
□ Widowed 
 
Has your marital status changed since then?    □  YES □  NO 
 
If yes, please describe current marital status (if you have since married, 
please also state whether the marriage is to the child’s birth father): 
___________________________________________________________ 
 
 
5. At the time of your child’s birth, what was the highest level of education 
(part-time or full-time) completed? Please tick one box only. 
 
□ No formal education 
□ Primary education 
 
      Second Level 
□ Lower secondary education 
     Junior/Intermediate/Group Certificate, ‘O’ Levels/GCSEs, NCVA Foundation 
      Certificate, Basic Skills Training Certificate or equivalent. 
□ Upper secondary education 
     Leaving Certificate (including Applied and Vocational Programmes), ‘A’ Levels, 
NCVA 
      Level 1 Certificate or equivalent. 
□ Technical or Vocational Qualification 
     Completed Apprenticeship, NCVA Level 2/3 Certificate, Teagasc 
Certificate/Diploma 
       or equivalent. 
□ Both Upper Secondary and Technical or Vocational Qualification 
 [284] 
 
 
     Third Level 
□ Non-degree: 
     National Certificate, Diploma NCEA/Institute of Technology or equivalent, 
Nursing 
      Diploma 
□ Primary Degree (Third Level bachelor degree) 
□ Professional qualification (of Degree status at least) 
□ Both a Degree and a Professional Qualification 
□ Postgraduate Certificate or Diploma 
□ Postgraduate Degree (Masters) 
□ Doctorate (Ph-D) 
 
 
6. Have you attended any further education/training since your child’s birth? 
If yes, please describe briefly: 
________________________________________________________________ 
___________________________________________________________________
_____________________________________________________________ 
 
7. Before your child’s birth, had you been working outside of the home?  
        □  YES □  NO 
If yes, please define your job title as clearly and in as much detail as possible (e.g. 
part-time assistant project manager; full-time contract trainee accountant; 
permanent registered nurse; Sessional Grade III clerical officer, etc.) 
________________________________________________________________ 
________________________________________________________________ 
 
 
8. Are you currently working outside of the home?  □  YES □  NO 
Is your current job the same as described above?  □  YES □  NO 
If no, please describe new job title: ____________________________________ 
________________________________________________________________ 
 
 
9. Are you currently living with your child’s birth father? □  YES □  NO 
If NO, does the child’s birth father have regular contact?      □  YES □  NO 
 
Please state birth father’s occupation as fully as possible: __________________ 
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________________________________________________________________ 
 
 
10.        At the time of your child’s birth was your annual household income: 
□ < €9,000    □ €9,001 – €10,000 
□ €10,001 – €15,000   □ €15,001 – €20,000 
□ €20,001 – €25,000   □ €25,001 – €30,000 
□ €30,001 – €35,000   □ €35,001 – €40,000 
□ €40,001 – €45,000   □ €45,001 – €50,000 
□ €50,001 – €60,000   □ €60,001 – €70,000 
□ €70,001 – €80,000   □ €80,001 – €90,000 
□ €90,001 – €100,000  □ >€101,000 
 
 
11.          Is your current annual household income: 
□ < €9,000    □ €9,001 – €10,000 
□ €10,001 – €15,000   □ €15,001 – €20,000 
□ €20,001 – €25,000   □ €25,001 – €30,000 
□ €30,001 – €35,000   □ €35,001 – €40,000 
□ €40,001 – €45,000   □ €45,001 – €50,000 
□ €50,001 – €60,000   □ €60,001 – €70,000 
□ €70,001 – €80,000   □ €80,001 – €90,000 
□ €90,001 – €100,000  □ >€101,000 
 
 
Many thanks again for the help and time that you have given in completing this 
questionnaire. 
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Appendix J  
Amiel-Tison Neurological Assessment at Term: Record Form 
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Reprinted from Gosselin, J, Gahagan, S, Amiel-Tison, C. The Amiel-Tison Neurological 
Assessment at Term: Conceptual and Methodological Continuity in the Course of Follow-
Up. Mental Retardation and Developmental.Disabilities Research Reviews 11: 35-51 (2005). 
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Appendix K  
WPPSI-IIIUK Record Form Cover Page 
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Appendix L  
NEPSY-II Record Form Cover Page 
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Appendix M  
NEPSY-II Scoring Software and Report Generator 
 
 
Figure M 1 Screenshot of NEPSY-II scoring software 
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Appendix N  
Consent Form to obtain clinical copies of psychoeducational 
reports completed within previous 6 months. 
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Appendix O  
The Numbers subtest of the Children’s Memory Scale 
 
 
Figure M 2 Logo of the Children's Memory Scale. Ref: Cohen M. Children's Memory Scale. San 
Antonio, TX: The Psychological Corporation; 1997. 
 
The Numbers subtest of the Children’s Memory Scale (Cohen, 1997) was used to assess 
short-term verbal memory. It consists of a measure of short-term verbal memory using a 
digit recall task, and a measure of short-term verbal working memory using a backwards digit 
recall task. The two raw scores are combined to obtain the Numbers Total Raw Score. An 
age-related scaled score is then calculated. 
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Appendix P  
Vision Appointment information letter 
 
